activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	2147221	CHEMBL929100	Activity of human CK1gamma3 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	113.0	CHEMBL5084	Homo sapiens	Activity	%	113.0
	2147221	CHEMBL929100	Activity of human CK1gamma3 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	113.0	CHEMBL5084	Homo sapiens	Activity	%	113.0
	2470141	CHEMBL1034090	Inhibition of CSNK1G3 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL5084	Homo sapiens	INH	%	10.0
	2721577	CHEMBL1060985	Inhibition of CK1gamma3 at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL5084	Homo sapiens	INH	%	50.0
	2892423	CHEMBL1051284	Binding constant for full-length CSNK1G3	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	uM	10.0
	2892424	CHEMBL1051284	Binding constant for full-length CSNK1G3	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	uM	10.0
	2892425	CHEMBL1051284	Binding constant for full-length CSNK1G3	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	97.0	CHEMBL5084	Homo sapiens	Kd	nM	97.0
	2892426	CHEMBL1051284	Binding constant for full-length CSNK1G3	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	uM	10.0
	2892427	CHEMBL1051284	Binding constant for full-length CSNK1G3	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	uM	10.0
	2892428	CHEMBL1051284	Binding constant for full-length CSNK1G3	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	uM	10.0
	2892429	CHEMBL1051284	Binding constant for full-length CSNK1G3	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	uM	10.0
	2892430	CHEMBL1051284	Binding constant for full-length CSNK1G3	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	uM	10.0
	2892431	CHEMBL1051284	Binding constant for full-length CSNK1G3	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	uM	10.0
	2892432	CHEMBL1051284	Binding constant for full-length CSNK1G3	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	uM	10.0
	2892433	CHEMBL1051284	Binding constant for full-length CSNK1G3	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	uM	10.0
	2892434	CHEMBL1051284	Binding constant for full-length CSNK1G3	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	uM	10.0
	2892435	CHEMBL1051284	Binding constant for full-length CSNK1G3	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	uM	10.0
	2892436	CHEMBL1051284	Binding constant for full-length CSNK1G3	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	uM	10.0
	2892437	CHEMBL1051284	Binding constant for full-length CSNK1G3	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	uM	10.0
	2892438	CHEMBL1051284	Binding constant for full-length CSNK1G3	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	uM	10.0
	2892439	CHEMBL1051284	Binding constant for full-length CSNK1G3	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	uM	10.0
	2892440	CHEMBL1051284	Binding constant for full-length CSNK1G3	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	uM	10.0
	2892441	CHEMBL1051284	Binding constant for full-length CSNK1G3	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	uM	10.0
	2892442	CHEMBL1051284	Binding constant for full-length CSNK1G3	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	7900.0	CHEMBL5084	Homo sapiens	Kd	nM	7900.0
	2892443	CHEMBL1051284	Binding constant for full-length CSNK1G3	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	uM	10.0
	2892444	CHEMBL1051284	Binding constant for full-length CSNK1G3	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	uM	10.0
	2893223	CHEMBL1051284	Binding constant for full-length CSNK1G3	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	uM	10.0
	2893224	CHEMBL1051284	Binding constant for full-length CSNK1G3	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	uM	10.0
	2893225	CHEMBL1051284	Binding constant for full-length CSNK1G3	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	uM	10.0
	2893226	CHEMBL1051284	Binding constant for full-length CSNK1G3	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	uM	10.0
	2893227	CHEMBL1051284	Binding constant for full-length CSNK1G3	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	uM	10.0
	2893228	CHEMBL1051284	Binding constant for full-length CSNK1G3	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Kd	nM	2900.0	CHEMBL5084	Homo sapiens	Kd	nM	2900.0
	2893229	CHEMBL1051284	Binding constant for full-length CSNK1G3	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	uM	10.0
	2893230	CHEMBL1051284	Binding constant for full-length CSNK1G3	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	uM	10.0
	2893231	CHEMBL1051284	Binding constant for full-length CSNK1G3	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	uM	10.0
	2893232	CHEMBL1051284	Binding constant for full-length CSNK1G3	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	uM	10.0
	2893233	CHEMBL1051284	Binding constant for full-length CSNK1G3	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	uM	10.0
	2893234	CHEMBL1051284	Binding constant for full-length CSNK1G3	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	570.0	CHEMBL5084	Homo sapiens	Kd	nM	570.0
	2893235	CHEMBL1051284	Binding constant for full-length CSNK1G3	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	240.0	CHEMBL5084	Homo sapiens	Kd	nM	240.0
	2893236	CHEMBL1051284	Binding constant for full-length CSNK1G3	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	uM	10.0
	2893237	CHEMBL1051284	Binding constant for full-length CSNK1G3	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	uM	10.0
	2893238	CHEMBL1051284	Binding constant for full-length CSNK1G3	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	uM	10.0
	2921387	CHEMBL1055281	Inhibition of CSNK1G3 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL5084	Homo sapiens	Activity	%	100.0
	2995390	CHEMBL1039040	Binding affinity to CSNK1G3 assessed as dissociation constant	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Kd	nM	290.0	CHEMBL5084	Homo sapiens	Kd	nM	290.0
	3052569	CHEMBL1037110	Residual activity of CK1gamma3 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	92.0	CHEMBL5084	Homo sapiens	Residual activity	%	92.0
	3053878	CHEMBL1044278	Residual activity of CK1gamma3 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	105.0	CHEMBL5084	Homo sapiens	Residual activity	%	105.0
	3054130	CHEMBL1066648	Residual activity of CK1gamma3 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	76.0	CHEMBL5084	Homo sapiens	Residual activity	%	76.0
	3055417	CHEMBL1037110	Residual activity of CK1gamma3 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	83.0	CHEMBL5084	Homo sapiens	Residual activity	%	83.0
	3055669	CHEMBL1044278	Residual activity of CK1gamma3 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	107.0	CHEMBL5084	Homo sapiens	Residual activity	%	107.0
	3056974	CHEMBL1066648	Residual activity of CK1gamma3 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	94.0	CHEMBL5084	Homo sapiens	Residual activity	%	94.0
	3058294	CHEMBL1037110	Residual activity of CK1gamma3 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	88.0	CHEMBL5084	Homo sapiens	Residual activity	%	88.0
	3058546	CHEMBL1044278	Residual activity of CK1gamma3 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	101.0	CHEMBL5084	Homo sapiens	Residual activity	%	101.0
	3072892	CHEMBL1066648	Residual activity of CK1gamma3 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	90.0	CHEMBL5084	Homo sapiens	Residual activity	%	90.0
	3213906	CHEMBL1114862	Inhibition of CK1 gamma 3 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	1.0	CHEMBL5084	Homo sapiens	INH	%	1.0
	3224791	CHEMBL1102785	Inhibition of CK1gamma3 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL5084	Homo sapiens	INH	%	50.0
	3225041	CHEMBL1102785	Inhibition of CK1gamma3 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL5084	Homo sapiens	INH	%	50.0
	3331884	CHEMBL1168843	Inhibition of CSNK1G3 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL5084	Homo sapiens	INH	%	50.0
	3333299	CHEMBL1168843	Inhibition of CSNK1G3 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL5084	Homo sapiens	INH	%	50.0
	3334704	CHEMBL1168843	Inhibition of CSNK1G3 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL5084	Homo sapiens	INH	%	50.0
	3336124	CHEMBL1168843	Inhibition of CSNK1G3 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL5084	Homo sapiens	INH	%	50.0
	3337491	CHEMBL1168843	Inhibition of CSNK1G3 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL5084	Homo sapiens	INH	%	50.0
	3337739	CHEMBL1168843	Inhibition of CSNK1G3 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL5084	Homo sapiens	INH	%	50.0
	3339071	CHEMBL1168843	Inhibition of CSNK1G3 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL5084	Homo sapiens	INH	%	50.0
	3340373	CHEMBL1168843	Inhibition of CSNK1G3 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL5084	Homo sapiens	INH	%	50.0
	3340652	CHEMBL1168843	Inhibition of CSNK1G3 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL5084	Homo sapiens	INH	%	50.0
	3342068	CHEMBL1168843	Inhibition of CSNK1G3 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL5084	Homo sapiens	INH	%	50.0
	3358517	CHEMBL1174189	Inhibition of CSNK1G3 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	85.0	CHEMBL5084	Homo sapiens	INH	%	85.0
	3358959	CHEMBL1174189	Inhibition of CSNK1G3 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	22.0	CHEMBL5084	Homo sapiens	INH	%	22.0
	3443370	CHEMBL1244403	Inhibition of CK1gamma3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	-2.0	CHEMBL5084	Homo sapiens	INH	%	-2.0
	3443587	CHEMBL1244403	Inhibition of CK1gamma3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	0.0	CHEMBL5084	Homo sapiens	INH	%	0.0
	3444742	CHEMBL1244403	Inhibition of CK1gamma3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	-9.0	CHEMBL5084	Homo sapiens	INH	%	-9.0
	3445366	CHEMBL1244403	Inhibition of CK1gamma3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	-3.0	CHEMBL5084	Homo sapiens	INH	%	-3.0
	3445583	CHEMBL1244403	Inhibition of CK1gamma3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	15.0	CHEMBL5084	Homo sapiens	INH	%	15.0
	3445795	CHEMBL1244403	Inhibition of CK1gamma3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	15.0	CHEMBL5084	Homo sapiens	INH	%	15.0
	3445985	CHEMBL1244403	Inhibition of CK1gamma3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	6.0	CHEMBL5084	Homo sapiens	INH	%	6.0
	3448389	CHEMBL1244781	Binding affinity to CSNK1G3	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	uM	10.0
	3448724	CHEMBL1244781	Binding affinity to CSNK1G3	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	uM	10.0
	3449143	CHEMBL1244781	Binding affinity to CSNK1G3	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	240.0	CHEMBL5084	Homo sapiens	Kd	nM	240.0
	3449616	CHEMBL1244781	Binding affinity to CSNK1G3	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	uM	10.0
	3449921	CHEMBL1244781	Binding affinity to CSNK1G3	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	uM	10.0
	3450038	CHEMBL1244781	Binding affinity to CSNK1G3	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	uM	10.0
	3450957	CHEMBL1244781	Binding affinity to CSNK1G3	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	uM	10.0
	3463203	CHEMBL1252291	Inhibition of CSNK1G3 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	57.0	CHEMBL5084	Homo sapiens	INH	%	57.0
	3463422	CHEMBL1252291	Inhibition of CSNK1G3 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	8.0	CHEMBL5084	Homo sapiens	INH	%	8.0
	3463966	CHEMBL1252291	Inhibition of CSNK1G3 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	14.0	CHEMBL5084	Homo sapiens	INH	%	14.0
	5120398	CHEMBL1648368	Inhibition of human CK1gamma3 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	108.0	CHEMBL5084	Homo sapiens	INH	%	108.0
	6218830	CHEMBL1786921	Binding affinity to human CSNK1G3 at 10 uM incubated for 1 hr by kinase binding assay relative to untreated control	B	c1ccc(Cc2cnc(N3CCN(c4ncnc5ccccc45)CC3)nc2)cc1		CHEMBL1782075	>	Activity	%	50.0	CHEMBL5084	Homo sapiens	Activity	%	50.0
Not Determined	6218856	CHEMBL1787160	Binding affinity to human CSNK1G3 incubated for 1 hr by kinase binding assay	B	c1ccc(Cc2cnc(N3CCN(c4ncnc5ccccc45)CC3)nc2)cc1		CHEMBL1782075		Kd			CHEMBL5084	Homo sapiens	Kd		
	6219034	CHEMBL1786921	Binding affinity to human CSNK1G3 at 10 uM incubated for 1 hr by kinase binding assay relative to untreated control	B	CCc1cnc(N2CCN(C(=O)c3ccc(CNc4ncnc5ccccc45)cc3)CC2)nc1		CHEMBL1783929	=	Activity	%	24.0	CHEMBL5084	Homo sapiens	Activity	%	24.0
	6220383	CHEMBL1786921	Binding affinity to human CSNK1G3 at 10 uM incubated for 1 hr by kinase binding assay relative to untreated control	B	O=C(c1cccc(Nc2ncnc3ccccc23)c1)N1CCN(c2ncc(Cc3ccccc3)cn2)CC1		CHEMBL1783930	>	Activity	%	50.0	CHEMBL5084	Homo sapiens	Activity	%	50.0
	6341037	CHEMBL1828206	Activity of CSNK1G3 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL5084	Homo sapiens	Activity	%	100.0
	6386350	CHEMBL1839865	Inhibition of recombinant CK1-gamma3	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	>	IC50	nM	10000.0	CHEMBL5084	Homo sapiens	IC50	uM	10.0
	7567347	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7567806	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7568303	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7568735	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	570.0	CHEMBL5084	Homo sapiens	Kd	nM	570.0
	7569320	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7569810	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7570273	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7570700	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	240.0	CHEMBL5084	Homo sapiens	Kd	nM	240.0
	7571296	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	=	Kd	nM	2400.0	CHEMBL5084	Homo sapiens	Kd	nM	2400.0
	7571311	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7571787	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7572250	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7572666	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7573292	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7573768	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7574237	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7574645	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	=	Kd	nM	8700.0	CHEMBL5084	Homo sapiens	Kd	nM	8700.0
	7574813	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7575274	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7575745	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7576210	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7576618	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7576787	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7577246	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7577724	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	1200.0	CHEMBL5084	Homo sapiens	Kd	nM	1200.0
	7578194	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	2600.0	CHEMBL5084	Homo sapiens	Kd	nM	2600.0
	7578599	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7578795	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	Kd	nM	910.0	CHEMBL5084	Homo sapiens	Kd	nM	910.0
	7579169	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7579619	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7580093	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7581153	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7581538	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7581983	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7582476	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7582876	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7583499	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7583896	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7584341	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7584370	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7584832	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7585236	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7585829	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7586237	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7586712	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7587166	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7588220	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7588691	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7589142	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7589313	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7589737	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7590204	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7590678	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7591129	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7591286	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7591708	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7592180	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7592653	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7593106	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7593253	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	97.0	CHEMBL5084	Homo sapiens	Kd	nM	97.0
	7593688	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7594160	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7594633	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7595221	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7595665	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7596139	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7596615	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7597193	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7597646	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7598119	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	=	Kd	nM	7800.0	CHEMBL5084	Homo sapiens	Kd	nM	7800.0
	7598147	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7598589	CHEMBL1908646	Binding constant for CSNK1G3 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	>	Kd	nM	10000.0	CHEMBL5084	Homo sapiens	Kd	nM	10000.0
	7922657	CHEMBL1918896	Inhibition of human recombinant CK1gamma3 at 0.5 uM by radiometric filter-binding assay	B	Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12		CHEMBL1915438	=	Inhibition	%	79.0	CHEMBL5084	Homo sapiens	INH	%	79.0
	8061289	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	0.3	CHEMBL5084	Homo sapiens	Inhibition	%	0.3
	8061466	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-1.86	CHEMBL5084	Homo sapiens	Inhibition	%	-1.86
	8061797	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	61.71	CHEMBL5084	Homo sapiens	Inhibition	%	61.71
	8061988	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	1.67	CHEMBL5084	Homo sapiens	Inhibition	%	1.67
	8062328	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	1.53	CHEMBL5084	Homo sapiens	Inhibition	%	1.53
	8062490	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	3.27	CHEMBL5084	Homo sapiens	Inhibition	%	3.27
	8062714	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	2.62	CHEMBL5084	Homo sapiens	Inhibition	%	2.62
	8062812	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	1.21	CHEMBL5084	Homo sapiens	Inhibition	%	1.21
	8063168	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	3.09	CHEMBL5084	Homo sapiens	Inhibition	%	3.09
	8063335	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	2.03	CHEMBL5084	Homo sapiens	Inhibition	%	2.03
	8063559	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	0.7	CHEMBL5084	Homo sapiens	Inhibition	%	0.7
	8063667	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.05	CHEMBL5084	Homo sapiens	Inhibition	%	1.05
	8063849	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	5.3	CHEMBL5084	Homo sapiens	Inhibition	%	5.3
	8064073	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	1.54	CHEMBL5084	Homo sapiens	Inhibition	%	1.54
	8064188	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	2.15	CHEMBL5084	Homo sapiens	Inhibition	%	2.15
	8064398	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.73	CHEMBL5084	Homo sapiens	Inhibition	%	0.73
	8064622	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	5.49	CHEMBL5084	Homo sapiens	Inhibition	%	5.49
	8064760	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	-0.65	CHEMBL5084	Homo sapiens	Inhibition	%	-0.65
	8065150	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.89	CHEMBL5084	Homo sapiens	Inhibition	%	1.89
	8065266	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	5.91	CHEMBL5084	Homo sapiens	Inhibition	%	5.91
	8065665	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	4.56	CHEMBL5084	Homo sapiens	Inhibition	%	4.56
	8065780	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	0.95	CHEMBL5084	Homo sapiens	Inhibition	%	0.95
	8066004	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	0.52	CHEMBL5084	Homo sapiens	Inhibition	%	0.52
	8066214	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	-0.55	CHEMBL5084	Homo sapiens	Inhibition	%	-0.55
	8066350	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	3.3	CHEMBL5084	Homo sapiens	Inhibition	%	3.3
	8066574	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	3.02	CHEMBL5084	Homo sapiens	Inhibition	%	3.02
	8066740	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	2.61	CHEMBL5084	Homo sapiens	Inhibition	%	2.61
	8066864	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	-0.42	CHEMBL5084	Homo sapiens	Inhibition	%	-0.42
	8067088	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	1.82	CHEMBL5084	Homo sapiens	Inhibition	%	1.82
	8067263	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	2.17	CHEMBL5084	Homo sapiens	Inhibition	%	2.17
	8067608	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	0.7	CHEMBL5084	Homo sapiens	Inhibition	%	0.7
	8067818	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	1.97	CHEMBL5084	Homo sapiens	Inhibition	%	1.97
	8068177	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	34.86	CHEMBL5084	Homo sapiens	Inhibition	%	34.86
	8068341	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	1.94	CHEMBL5084	Homo sapiens	Inhibition	%	1.94
	8068690	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.26	CHEMBL5084	Homo sapiens	Inhibition	%	0.26
	8068864	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	2.25	CHEMBL5084	Homo sapiens	Inhibition	%	2.25
	8069213	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	15.07	CHEMBL5084	Homo sapiens	Inhibition	%	15.07
	8069508	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	24.91	CHEMBL5084	Homo sapiens	Inhibition	%	24.91
	8069669	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	4.11	CHEMBL5084	Homo sapiens	Inhibition	%	4.11
	8070019	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	-1.32	CHEMBL5084	Homo sapiens	Inhibition	%	-1.32
	8070191	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	1.16	CHEMBL5084	Homo sapiens	Inhibition	%	1.16
	8070415	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	3.28	CHEMBL5084	Homo sapiens	Inhibition	%	3.28
	8070540	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	-0.24	CHEMBL5084	Homo sapiens	Inhibition	%	-0.24
	8070838	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	79.91	CHEMBL5084	Homo sapiens	Inhibition	%	79.91
	8070995	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	-0.43	CHEMBL5084	Homo sapiens	Inhibition	%	-0.43
	8071219	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	0.95	CHEMBL5084	Homo sapiens	Inhibition	%	0.95
	8071345	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.08	CHEMBL5084	Homo sapiens	Inhibition	%	0.08
	8071742	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	2.64	CHEMBL5084	Homo sapiens	Inhibition	%	2.64
	8071867	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	3.43	CHEMBL5084	Homo sapiens	Inhibition	%	3.43
	8072091	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	-1.45	CHEMBL5084	Homo sapiens	Inhibition	%	-1.45
	8072181	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-2.32	CHEMBL5084	Homo sapiens	Inhibition	%	-2.32
	8072562	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	0.58	CHEMBL5084	Homo sapiens	Inhibition	%	0.58
	8072687	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	1.59	CHEMBL5084	Homo sapiens	Inhibition	%	1.59
	8072911	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-1.27	CHEMBL5084	Homo sapiens	Inhibition	%	-1.27
	8073078	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	0.87	CHEMBL5084	Homo sapiens	Inhibition	%	0.87
	8073427	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	0.18	CHEMBL5084	Homo sapiens	Inhibition	%	0.18
	8073546	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	1.81	CHEMBL5084	Homo sapiens	Inhibition	%	1.81
	8073779	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-1.3	CHEMBL5084	Homo sapiens	Inhibition	%	-1.3
	8074003	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-1.33	CHEMBL5084	Homo sapiens	Inhibition	%	-1.33
	8074155	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	1.63	CHEMBL5084	Homo sapiens	Inhibition	%	1.63
	8074509	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.6	CHEMBL5084	Homo sapiens	Inhibition	%	0.6
	8074666	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	3.98	CHEMBL5084	Homo sapiens	Inhibition	%	3.98
	8075017	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-2.11	CHEMBL5084	Homo sapiens	Inhibition	%	-2.11
	8075128	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	-0.55	CHEMBL5084	Homo sapiens	Inhibition	%	-0.55
	8075352	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	0.0	CHEMBL5084	Homo sapiens	Inhibition	%	0.0
	8075589	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	0.33	CHEMBL5084	Homo sapiens	Inhibition	%	0.33
	8075730	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	1.59	CHEMBL5084	Homo sapiens	Inhibition	%	1.59
	8076096	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-1.87	CHEMBL5084	Homo sapiens	Inhibition	%	-1.87
	8076244	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	8.65	CHEMBL5084	Homo sapiens	Inhibition	%	8.65
	8076468	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	2.44	CHEMBL5084	Homo sapiens	Inhibition	%	2.44
	8076602	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.2	CHEMBL5084	Homo sapiens	Inhibition	%	0.2
	8076928	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-0.19	CHEMBL5084	Homo sapiens	Inhibition	%	-0.19
	8077175	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-0.48	CHEMBL5084	Homo sapiens	Inhibition	%	-0.48
	8077303	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	0.02	CHEMBL5084	Homo sapiens	Inhibition	%	0.02
	8077527	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	1.46	CHEMBL5084	Homo sapiens	Inhibition	%	1.46
	8077678	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	0.68	CHEMBL5084	Homo sapiens	Inhibition	%	0.68
	8078045	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	6.34	CHEMBL5084	Homo sapiens	Inhibition	%	6.34
	8078184	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-3.13	CHEMBL5084	Homo sapiens	Inhibition	%	-3.13
	8078510	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	1.01	CHEMBL5084	Homo sapiens	Inhibition	%	1.01
	8078760	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	9.88	CHEMBL5084	Homo sapiens	Inhibition	%	9.88
	8079100	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	0.25	CHEMBL5084	Homo sapiens	Inhibition	%	0.25
	8079258	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-1.73	CHEMBL5084	Homo sapiens	Inhibition	%	-1.73
	8079624	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	1.87	CHEMBL5084	Homo sapiens	Inhibition	%	1.87
	8079763	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	4.18	CHEMBL5084	Homo sapiens	Inhibition	%	4.18
	8079987	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	35.38	CHEMBL5084	Homo sapiens	Inhibition	%	35.38
	8080092	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	0.07	CHEMBL5084	Homo sapiens	Inhibition	%	0.07
	8080344	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	-3.31	CHEMBL5084	Homo sapiens	Inhibition	%	-3.31
	8080683	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	-0.66	CHEMBL5084	Homo sapiens	Inhibition	%	-0.66
	8080847	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	1.34	CHEMBL5084	Homo sapiens	Inhibition	%	1.34
	8081071	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-1.77	CHEMBL5084	Homo sapiens	Inhibition	%	-1.77
	8081206	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	3.97	CHEMBL5084	Homo sapiens	Inhibition	%	3.97
	8081574	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	79.75	CHEMBL5084	Homo sapiens	Inhibition	%	79.75
	8081677	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	1.06	CHEMBL5084	Homo sapiens	Inhibition	%	1.06
	8081901	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	0.9	CHEMBL5084	Homo sapiens	Inhibition	%	0.9
	8081929	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	20.64	CHEMBL5084	Homo sapiens	Inhibition	%	20.64
	8082153	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-1.94	CHEMBL5084	Homo sapiens	Inhibition	%	-1.94
	8082266	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.41	CHEMBL5084	Homo sapiens	Inhibition	%	1.41
	8082663	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	15.58	CHEMBL5084	Homo sapiens	Inhibition	%	15.58
	8082786	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	2.2	CHEMBL5084	Homo sapiens	Inhibition	%	2.2
	8083166	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	5.52	CHEMBL5084	Homo sapiens	Inhibition	%	5.52
	8083489	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	0.37	CHEMBL5084	Homo sapiens	Inhibition	%	0.37
	8083743	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	1.85	CHEMBL5084	Homo sapiens	Inhibition	%	1.85
	8083853	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	0.53	CHEMBL5084	Homo sapiens	Inhibition	%	0.53
	8084077	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	10.33	CHEMBL5084	Homo sapiens	Inhibition	%	10.33
	8084262	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	1.94	CHEMBL5084	Homo sapiens	Inhibition	%	1.94
	8084380	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	2.4	CHEMBL5084	Homo sapiens	Inhibition	%	2.4
	8084604	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	1.93	CHEMBL5084	Homo sapiens	Inhibition	%	1.93
	8084765	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	12.91	CHEMBL5084	Homo sapiens	Inhibition	%	12.91
	8085087	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	1.22	CHEMBL5084	Homo sapiens	Inhibition	%	1.22
	8085343	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	0.15	CHEMBL5084	Homo sapiens	Inhibition	%	0.15
	8085675	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	12.39	CHEMBL5084	Homo sapiens	Inhibition	%	12.39
	8085864	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	12.74	CHEMBL5084	Homo sapiens	Inhibition	%	12.74
	8086203	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	2.19	CHEMBL5084	Homo sapiens	Inhibition	%	2.19
	8086365	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	-0.75	CHEMBL5084	Homo sapiens	Inhibition	%	-0.75
	8086688	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	-0.09	CHEMBL5084	Homo sapiens	Inhibition	%	-0.09
	8086899	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	1.61	CHEMBL5084	Homo sapiens	Inhibition	%	1.61
	8087123	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	4.59	CHEMBL5084	Homo sapiens	Inhibition	%	4.59
	8087281	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	1.58	CHEMBL5084	Homo sapiens	Inhibition	%	1.58
	8087619	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	3.77	CHEMBL5084	Homo sapiens	Inhibition	%	3.77
	8087757	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.72	CHEMBL5084	Homo sapiens	Inhibition	%	3.72
	8088123	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	3.18	CHEMBL5084	Homo sapiens	Inhibition	%	3.18
	8088271	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	2.42	CHEMBL5084	Homo sapiens	Inhibition	%	2.42
	8088495	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.43	CHEMBL5084	Homo sapiens	Inhibition	%	0.43
	8088623	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	3.46	CHEMBL5084	Homo sapiens	Inhibition	%	3.46
	8088940	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	4.86	CHEMBL5084	Homo sapiens	Inhibition	%	4.86
	8089068	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	-0.08	CHEMBL5084	Homo sapiens	Inhibition	%	-0.08
	8089292	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	20.9	CHEMBL5084	Homo sapiens	Inhibition	%	20.9
	8089440	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	-0.08	CHEMBL5084	Homo sapiens	Inhibition	%	-0.08
	8089784	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	-0.55	CHEMBL5084	Homo sapiens	Inhibition	%	-0.55
	8089964	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	1.7	CHEMBL5084	Homo sapiens	Inhibition	%	1.7
	8090353	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	7.32	CHEMBL5084	Homo sapiens	Inhibition	%	7.32
	8090520	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	1.6	CHEMBL5084	Homo sapiens	Inhibition	%	1.6
	8090883	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	1.74	CHEMBL5084	Homo sapiens	Inhibition	%	1.74
	8091088	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	2.43	CHEMBL5084	Homo sapiens	Inhibition	%	2.43
	8091449	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	36.07	CHEMBL5084	Homo sapiens	Inhibition	%	36.07
	8091604	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	1.61	CHEMBL5084	Homo sapiens	Inhibition	%	1.61
	8091944	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	5.78	CHEMBL5084	Homo sapiens	Inhibition	%	5.78
	8092081	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-1.46	CHEMBL5084	Homo sapiens	Inhibition	%	-1.46
	8092305	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	10.02	CHEMBL5084	Homo sapiens	Inhibition	%	10.02
	8092456	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	3.07	CHEMBL5084	Homo sapiens	Inhibition	%	3.07
	8092828	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-0.15	CHEMBL5084	Homo sapiens	Inhibition	%	-0.15
	8092957	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	3.53	CHEMBL5084	Homo sapiens	Inhibition	%	3.53
	8093269	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	1.62	CHEMBL5084	Homo sapiens	Inhibition	%	1.62
	8093633	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-1.72	CHEMBL5084	Homo sapiens	Inhibition	%	-1.72
	8093772	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	2.43	CHEMBL5084	Homo sapiens	Inhibition	%	2.43
	8094116	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	0.35	CHEMBL5084	Homo sapiens	Inhibition	%	0.35
	8094296	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.9	CHEMBL5084	Homo sapiens	Inhibition	%	0.9
	8094520	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	2.3	CHEMBL5084	Homo sapiens	Inhibition	%	2.3
	8094695	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	14.7	CHEMBL5084	Homo sapiens	Inhibition	%	14.7
	8094851	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	1.78	CHEMBL5084	Homo sapiens	Inhibition	%	1.78
	8095215	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	2.37	CHEMBL5084	Homo sapiens	Inhibition	%	2.37
	8095418	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	1.23	CHEMBL5084	Homo sapiens	Inhibition	%	1.23
	8095783	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	69.3	CHEMBL5084	Homo sapiens	Inhibition	%	69.3
	8095931	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	0.8	CHEMBL5084	Homo sapiens	Inhibition	%	0.8
	8096155	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	1.75	CHEMBL5084	Homo sapiens	Inhibition	%	1.75
	8096272	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	4.32	CHEMBL5084	Homo sapiens	Inhibition	%	4.32
	8096635	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	0.73	CHEMBL5084	Homo sapiens	Inhibition	%	0.73
	8096791	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	1.92	CHEMBL5084	Homo sapiens	Inhibition	%	1.92
	8097162	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	0.1	CHEMBL5084	Homo sapiens	Inhibition	%	0.1
	8097469	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	7.33	CHEMBL5084	Homo sapiens	Inhibition	%	7.33
	8097843	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	1.57	CHEMBL5084	Homo sapiens	Inhibition	%	1.57
	8097976	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-2.29	CHEMBL5084	Homo sapiens	Inhibition	%	-2.29
	8098200	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-0.39	CHEMBL5084	Homo sapiens	Inhibition	%	-0.39
	8098320	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.42	CHEMBL5084	Homo sapiens	Inhibition	%	0.42
	8098724	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	0.33	CHEMBL5084	Homo sapiens	Inhibition	%	0.33
	8098909	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	58.95	CHEMBL5084	Homo sapiens	Inhibition	%	58.95
	8099053	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	1.74	CHEMBL5084	Homo sapiens	Inhibition	%	1.74
	8099277	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	1.31	CHEMBL5084	Homo sapiens	Inhibition	%	1.31
	8099419	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	2.1	CHEMBL5084	Homo sapiens	Inhibition	%	2.1
	8099613	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	2.06	CHEMBL5084	Homo sapiens	Inhibition	%	2.06
	8099837	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	5.03	CHEMBL5084	Homo sapiens	Inhibition	%	5.03
	8099984	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	6.01	CHEMBL5084	Homo sapiens	Inhibition	%	6.01
	8100354	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	-3.27	CHEMBL5084	Homo sapiens	Inhibition	%	-3.27
	8100470	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	18.39	CHEMBL5084	Homo sapiens	Inhibition	%	18.39
	8100834	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	4.22	CHEMBL5084	Homo sapiens	Inhibition	%	4.22
	8100994	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	3.17	CHEMBL5084	Homo sapiens	Inhibition	%	3.17
	8101218	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	1.39	CHEMBL5084	Homo sapiens	Inhibition	%	1.39
	8101360	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-0.27	CHEMBL5084	Homo sapiens	Inhibition	%	-0.27
	8101545	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-0.98	CHEMBL5084	Homo sapiens	Inhibition	%	-0.98
	8101769	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-2.81	CHEMBL5084	Homo sapiens	Inhibition	%	-2.81
	8101798	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	1.09	CHEMBL5084	Homo sapiens	Inhibition	%	1.09
	8102022	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	4.42	CHEMBL5084	Homo sapiens	Inhibition	%	4.42
	8102177	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-2.55	CHEMBL5084	Homo sapiens	Inhibition	%	-2.55
	8102532	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	-0.78	CHEMBL5084	Homo sapiens	Inhibition	%	-0.78
	8102652	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	1.21	CHEMBL5084	Homo sapiens	Inhibition	%	1.21
	8102876	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-0.46	CHEMBL5084	Homo sapiens	Inhibition	%	-0.46
	8103054	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.68	CHEMBL5084	Homo sapiens	Inhibition	%	1.68
	8103250	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	1.72	CHEMBL5084	Homo sapiens	Inhibition	%	1.72
	8103612	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	0.99	CHEMBL5084	Homo sapiens	Inhibition	%	0.99
	8103762	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	2.97	CHEMBL5084	Homo sapiens	Inhibition	%	2.97
	8104171	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	0.53	CHEMBL5084	Homo sapiens	Inhibition	%	0.53
	8104319	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	8.48	CHEMBL5084	Homo sapiens	Inhibition	%	8.48
	8104689	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	0.29	CHEMBL5084	Homo sapiens	Inhibition	%	0.29
	8104803	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	1.83	CHEMBL5084	Homo sapiens	Inhibition	%	1.83
	8105027	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	5.34	CHEMBL5084	Homo sapiens	Inhibition	%	5.34
	8105167	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-0.22	CHEMBL5084	Homo sapiens	Inhibition	%	-0.22
	8105557	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	-1.77	CHEMBL5084	Homo sapiens	Inhibition	%	-1.77
	8105695	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-0.18	CHEMBL5084	Homo sapiens	Inhibition	%	-0.18
	8105975	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	2.41	CHEMBL5084	Homo sapiens	Inhibition	%	2.41
	8106364	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-3.53	CHEMBL5084	Homo sapiens	Inhibition	%	-3.53
	8106520	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	9.56	CHEMBL5084	Homo sapiens	Inhibition	%	9.56
	8106873	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	1.34	CHEMBL5084	Homo sapiens	Inhibition	%	1.34
	8107218	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	0.79	CHEMBL5084	Homo sapiens	Inhibition	%	0.79
	8107390	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.52	CHEMBL5084	Homo sapiens	Inhibition	%	1.52
	8107591	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	4.23	CHEMBL5084	Homo sapiens	Inhibition	%	4.23
	8107815	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	2.18	CHEMBL5084	Homo sapiens	Inhibition	%	2.18
	8107950	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	0.09	CHEMBL5084	Homo sapiens	Inhibition	%	0.09
	8108108	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	3.86	CHEMBL5084	Homo sapiens	Inhibition	%	3.86
	8108332	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	4.26	CHEMBL5084	Homo sapiens	Inhibition	%	4.26
	8108507	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	1.25	CHEMBL5084	Homo sapiens	Inhibition	%	1.25
	8108654	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	3.89	CHEMBL5084	Homo sapiens	Inhibition	%	3.89
	8108878	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	5.6	CHEMBL5084	Homo sapiens	Inhibition	%	5.6
	8109020	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.25	CHEMBL5084	Homo sapiens	Inhibition	%	0.25
	8109358	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	3.94	CHEMBL5084	Homo sapiens	Inhibition	%	3.94
	8109488	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	7.47	CHEMBL5084	Homo sapiens	Inhibition	%	7.47
	8109712	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	0.77	CHEMBL5084	Homo sapiens	Inhibition	%	0.77
	8109883	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	-4.38	CHEMBL5084	Homo sapiens	Inhibition	%	-4.38
	8110015	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	5.09	CHEMBL5084	Homo sapiens	Inhibition	%	5.09
	8110239	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	3.43	CHEMBL5084	Homo sapiens	Inhibition	%	3.43
	8110294	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	1.12	CHEMBL5084	Homo sapiens	Inhibition	%	1.12
	8110518	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	2.21	CHEMBL5084	Homo sapiens	Inhibition	%	2.21
	8110684	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-1.67	CHEMBL5084	Homo sapiens	Inhibition	%	-1.67
	8110842	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-1.84	CHEMBL5084	Homo sapiens	Inhibition	%	-1.84
	8111066	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-2.94	CHEMBL5084	Homo sapiens	Inhibition	%	-2.94
	8111189	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	0.13	CHEMBL5084	Homo sapiens	Inhibition	%	0.13
	8111540	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	0.87	CHEMBL5084	Homo sapiens	Inhibition	%	0.87
	8111706	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.06	CHEMBL5084	Homo sapiens	Inhibition	%	1.06
	8112135	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	2.99	CHEMBL5084	Homo sapiens	Inhibition	%	2.99
	8112272	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-0.15	CHEMBL5084	Homo sapiens	Inhibition	%	-0.15
	8112664	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	2.58	CHEMBL5084	Homo sapiens	Inhibition	%	2.58
	8112836	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	1.14	CHEMBL5084	Homo sapiens	Inhibition	%	1.14
	8113212	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	2.99	CHEMBL5084	Homo sapiens	Inhibition	%	2.99
	8113348	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.46	CHEMBL5084	Homo sapiens	Inhibition	%	0.46
	8113696	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	15.41	CHEMBL5084	Homo sapiens	Inhibition	%	15.41
	8114036	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	1.23	CHEMBL5084	Homo sapiens	Inhibition	%	1.23
	8114212	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	3.14	CHEMBL5084	Homo sapiens	Inhibition	%	3.14
	8114568	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	3.95	CHEMBL5084	Homo sapiens	Inhibition	%	3.95
	8114844	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	2.73	CHEMBL5084	Homo sapiens	Inhibition	%	2.73
	8115010	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	0.69	CHEMBL5084	Homo sapiens	Inhibition	%	0.69
	8115399	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-0.5	CHEMBL5084	Homo sapiens	Inhibition	%	-0.5
	8115519	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	2.93	CHEMBL5084	Homo sapiens	Inhibition	%	2.93
	8115743	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	2.39	CHEMBL5084	Homo sapiens	Inhibition	%	2.39
	8115876	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	3.35	CHEMBL5084	Homo sapiens	Inhibition	%	3.35
	8116035	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	1.31	CHEMBL5084	Homo sapiens	Inhibition	%	1.31
	8116259	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	8.37	CHEMBL5084	Homo sapiens	Inhibition	%	8.37
	8116462	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	2.65	CHEMBL5084	Homo sapiens	Inhibition	%	2.65
	8116596	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-0.59	CHEMBL5084	Homo sapiens	Inhibition	%	-0.59
	8116820	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	1.05	CHEMBL5084	Homo sapiens	Inhibition	%	1.05
	8116992	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	4.97	CHEMBL5084	Homo sapiens	Inhibition	%	4.97
	8117163	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	0.44	CHEMBL5084	Homo sapiens	Inhibition	%	0.44
	8117387	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	0.32	CHEMBL5084	Homo sapiens	Inhibition	%	0.32
	8117545	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	1.61	CHEMBL5084	Homo sapiens	Inhibition	%	1.61
	8117675	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	0.7	CHEMBL5084	Homo sapiens	Inhibition	%	0.7
	8117899	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-0.59	CHEMBL5084	Homo sapiens	Inhibition	%	-0.59
	8118037	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	-0.68	CHEMBL5084	Homo sapiens	Inhibition	%	-0.68
	8118377	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	3.12	CHEMBL5084	Homo sapiens	Inhibition	%	3.12
	8118549	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	2.45	CHEMBL5084	Homo sapiens	Inhibition	%	2.45
	8118909	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	3.97	CHEMBL5084	Homo sapiens	Inhibition	%	3.97
	8119180	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	1.69	CHEMBL5084	Homo sapiens	Inhibition	%	1.69
	8119339	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	6.26	CHEMBL5084	Homo sapiens	Inhibition	%	6.26
	8119563	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	1.55	CHEMBL5084	Homo sapiens	Inhibition	%	1.55
	8119730	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-0.34	CHEMBL5084	Homo sapiens	Inhibition	%	-0.34
	8120073	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	3.39	CHEMBL5084	Homo sapiens	Inhibition	%	3.39
	8120212	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	1.42	CHEMBL5084	Homo sapiens	Inhibition	%	1.42
	8120596	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-1.09	CHEMBL5084	Homo sapiens	Inhibition	%	-1.09
	8120797	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	3.15	CHEMBL5084	Homo sapiens	Inhibition	%	3.15
	8121149	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	0.02	CHEMBL5084	Homo sapiens	Inhibition	%	0.02
	8121321	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	2.83	CHEMBL5084	Homo sapiens	Inhibition	%	2.83
	8121712	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	0.29	CHEMBL5084	Homo sapiens	Inhibition	%	0.29
	8121875	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	2.52	CHEMBL5084	Homo sapiens	Inhibition	%	2.52
	8122220	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	0.19	CHEMBL5084	Homo sapiens	Inhibition	%	0.19
	8122358	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	1.74	CHEMBL5084	Homo sapiens	Inhibition	%	1.74
	8122582	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	5.65	CHEMBL5084	Homo sapiens	Inhibition	%	5.65
	8122702	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	5.9	CHEMBL5084	Homo sapiens	Inhibition	%	5.9
	8122869	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	2.68	CHEMBL5084	Homo sapiens	Inhibition	%	2.68
	8123093	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	7.42	CHEMBL5084	Homo sapiens	Inhibition	%	7.42
	8123235	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	-0.01	CHEMBL5084	Homo sapiens	Inhibition	%	-0.01
	8123513	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	20.58	CHEMBL5084	Homo sapiens	Inhibition	%	20.58
	8123887	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	5.99	CHEMBL5084	Homo sapiens	Inhibition	%	5.99
	8124054	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-3.39	CHEMBL5084	Homo sapiens	Inhibition	%	-3.39
	8124397	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	3.61	CHEMBL5084	Homo sapiens	Inhibition	%	3.61
	8124536	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	1.29	CHEMBL5084	Homo sapiens	Inhibition	%	1.29
	8124760	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	1.54	CHEMBL5084	Homo sapiens	Inhibition	%	1.54
	8124925	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	1.79	CHEMBL5084	Homo sapiens	Inhibition	%	1.79
	8125126	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	6.23	CHEMBL5084	Homo sapiens	Inhibition	%	6.23
	8125480	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-0.12	CHEMBL5084	Homo sapiens	Inhibition	%	-0.12
	8125648	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	0.75	CHEMBL5084	Homo sapiens	Inhibition	%	0.75
	8125872	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	3.44	CHEMBL5084	Homo sapiens	Inhibition	%	3.44
	8126036	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.17	CHEMBL5084	Homo sapiens	Inhibition	%	0.17
	8126200	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	3.56	CHEMBL5084	Homo sapiens	Inhibition	%	3.56
	8126539	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	0.91	CHEMBL5084	Homo sapiens	Inhibition	%	0.91
	8126899	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	14.4	CHEMBL5084	Homo sapiens	Inhibition	%	14.4
	8127021	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	7.8	CHEMBL5084	Homo sapiens	Inhibition	%	7.8
	8127412	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	3.7	CHEMBL5084	Homo sapiens	Inhibition	%	3.7
	8127554	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	1.63	CHEMBL5084	Homo sapiens	Inhibition	%	1.63
	8127778	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	3.11	CHEMBL5084	Homo sapiens	Inhibition	%	3.11
	8127842	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	1.22	CHEMBL5084	Homo sapiens	Inhibition	%	1.22
	8128218	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	0.86	CHEMBL5084	Homo sapiens	Inhibition	%	0.86
	8128385	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-3.3	CHEMBL5084	Homo sapiens	Inhibition	%	-3.3
	8128609	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	0.25	CHEMBL5084	Homo sapiens	Inhibition	%	0.25
	8128728	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	38.56	CHEMBL5084	Homo sapiens	Inhibition	%	38.56
	8129089	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	2.61	CHEMBL5084	Homo sapiens	Inhibition	%	2.61
	8129260	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.76	CHEMBL5084	Homo sapiens	Inhibition	%	-0.76
	8129449	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	30.01	CHEMBL5084	Homo sapiens	Inhibition	%	30.01
	8129673	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	1.17	CHEMBL5084	Homo sapiens	Inhibition	%	1.17
	8129812	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.24	CHEMBL5084	Homo sapiens	Inhibition	%	0.24
	8130197	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	10.61	CHEMBL5084	Homo sapiens	Inhibition	%	10.61
	8130369	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	1.35	CHEMBL5084	Homo sapiens	Inhibition	%	1.35
	8130529	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	0.62	CHEMBL5084	Homo sapiens	Inhibition	%	0.62
	8130753	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	10.55	CHEMBL5084	Homo sapiens	Inhibition	%	10.55
	8130869	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	2.91	CHEMBL5084	Homo sapiens	Inhibition	%	2.91
	8131232	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	3.7	CHEMBL5084	Homo sapiens	Inhibition	%	3.7
	8131352	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	26.31	CHEMBL5084	Homo sapiens	Inhibition	%	26.31
	8131576	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	0.63	CHEMBL5084	Homo sapiens	Inhibition	%	0.63
	8131743	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	4.58	CHEMBL5084	Homo sapiens	Inhibition	%	4.58
	8132108	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	10.3	CHEMBL5084	Homo sapiens	Inhibition	%	10.3
	8132170	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	5.12	CHEMBL5084	Homo sapiens	Inhibition	%	5.12
	8132394	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-0.15	CHEMBL5084	Homo sapiens	Inhibition	%	-0.15
	8132541	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	-0.84	CHEMBL5084	Homo sapiens	Inhibition	%	-0.84
	8132933	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	-0.89	CHEMBL5084	Homo sapiens	Inhibition	%	-0.89
	8133054	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	-0.98	CHEMBL5084	Homo sapiens	Inhibition	%	-0.98
	8133416	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	-0.19	CHEMBL5084	Homo sapiens	Inhibition	%	-0.19
	8133588	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.08	CHEMBL5084	Homo sapiens	Inhibition	%	-0.08
	8133992	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	1.29	CHEMBL5084	Homo sapiens	Inhibition	%	1.29
	8134140	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-0.97	CHEMBL5084	Homo sapiens	Inhibition	%	-0.97
	8134524	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	2.63	CHEMBL5084	Homo sapiens	Inhibition	%	2.63
	8134708	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	0.3	CHEMBL5084	Homo sapiens	Inhibition	%	0.3
	8135092	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	2.01	CHEMBL5084	Homo sapiens	Inhibition	%	2.01
	8135207	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	4.08	CHEMBL5084	Homo sapiens	Inhibition	%	4.08
	8135431	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	3.19	CHEMBL5084	Homo sapiens	Inhibition	%	3.19
	8135572	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	11.13	CHEMBL5084	Homo sapiens	Inhibition	%	11.13
	8135917	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	2.01	CHEMBL5084	Homo sapiens	Inhibition	%	2.01
	8136085	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	2.41	CHEMBL5084	Homo sapiens	Inhibition	%	2.41
	8136453	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	4.73	CHEMBL5084	Homo sapiens	Inhibition	%	4.73
	8136743	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	26.58	CHEMBL5084	Homo sapiens	Inhibition	%	26.58
	8136878	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	-0.44	CHEMBL5084	Homo sapiens	Inhibition	%	-0.44
	8137265	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	1.29	CHEMBL5084	Homo sapiens	Inhibition	%	1.29
	8137385	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	12.89	CHEMBL5084	Homo sapiens	Inhibition	%	12.89
	8137609	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-1.38	CHEMBL5084	Homo sapiens	Inhibition	%	-1.38
	8137757	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.47	CHEMBL5084	Homo sapiens	Inhibition	%	1.47
	8137923	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-2.12	CHEMBL5084	Homo sapiens	Inhibition	%	-2.12
	8138147	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-0.42	CHEMBL5084	Homo sapiens	Inhibition	%	-0.42
	8138326	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	0.51	CHEMBL5084	Homo sapiens	Inhibition	%	0.51
	8138474	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	0.61	CHEMBL5084	Homo sapiens	Inhibition	%	0.61
	8138698	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-2.79	CHEMBL5084	Homo sapiens	Inhibition	%	-2.79
	8138856	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	2.71	CHEMBL5084	Homo sapiens	Inhibition	%	2.71
	8139041	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	3.9	CHEMBL5084	Homo sapiens	Inhibition	%	3.9
	8139265	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	3.79	CHEMBL5084	Homo sapiens	Inhibition	%	3.79
	8139424	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	4.69	CHEMBL5084	Homo sapiens	Inhibition	%	4.69
	8139762	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	2.56	CHEMBL5084	Homo sapiens	Inhibition	%	2.56
	8139903	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	4.15	CHEMBL5084	Homo sapiens	Inhibition	%	4.15
	8140250	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	6.15	CHEMBL5084	Homo sapiens	Inhibition	%	6.15
	8140409	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	1.09	CHEMBL5084	Homo sapiens	Inhibition	%	1.09
	8140633	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	3.27	CHEMBL5084	Homo sapiens	Inhibition	%	3.27
	8140776	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	17.85	CHEMBL5084	Homo sapiens	Inhibition	%	17.85
	8141078	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.55	CHEMBL5084	Homo sapiens	Inhibition	%	0.55
	8141208	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	1.59	CHEMBL5084	Homo sapiens	Inhibition	%	1.59
	8141432	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	-1.28	CHEMBL5084	Homo sapiens	Inhibition	%	-1.28
	8141592	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	0.9	CHEMBL5084	Homo sapiens	Inhibition	%	0.9
	8141935	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-0.55	CHEMBL5084	Homo sapiens	Inhibition	%	-0.55
	8142096	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	0.17	CHEMBL5084	Homo sapiens	Inhibition	%	0.17
	8142488	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-1.08	CHEMBL5084	Homo sapiens	Inhibition	%	-1.08
	8142664	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	-0.03	CHEMBL5084	Homo sapiens	Inhibition	%	-0.03
	8143037	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-1.44	CHEMBL5084	Homo sapiens	Inhibition	%	-1.44
	8143192	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	2.45	CHEMBL5084	Homo sapiens	Inhibition	%	2.45
	8143603	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	3.16	CHEMBL5084	Homo sapiens	Inhibition	%	3.16
	8143762	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	4.25	CHEMBL5084	Homo sapiens	Inhibition	%	4.25
	8144100	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-0.8	CHEMBL5084	Homo sapiens	Inhibition	%	-0.8
	8144239	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	2.36	CHEMBL5084	Homo sapiens	Inhibition	%	2.36
	8144463	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	8.9	CHEMBL5084	Homo sapiens	Inhibition	%	8.9
	8144593	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	7.57	CHEMBL5084	Homo sapiens	Inhibition	%	7.57
	8144970	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	0.61	CHEMBL5084	Homo sapiens	Inhibition	%	0.61
	8145107	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	4.59	CHEMBL5084	Homo sapiens	Inhibition	%	4.59
	8145420	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	4.52	CHEMBL5084	Homo sapiens	Inhibition	%	4.52
	8145768	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	0.46	CHEMBL5084	Homo sapiens	Inhibition	%	0.46
	8145929	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	1.67	CHEMBL5084	Homo sapiens	Inhibition	%	1.67
	8146273	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.1	CHEMBL5084	Homo sapiens	Inhibition	%	0.1
	8146433	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	1.38	CHEMBL5084	Homo sapiens	Inhibition	%	1.38
	8146657	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	1.11	CHEMBL5084	Homo sapiens	Inhibition	%	1.11
	8146824	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-3.59	CHEMBL5084	Homo sapiens	Inhibition	%	-3.59
	8146993	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	1.55	CHEMBL5084	Homo sapiens	Inhibition	%	1.55
	8147217	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	0.25	CHEMBL5084	Homo sapiens	Inhibition	%	0.25
	8147359	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	1.84	CHEMBL5084	Homo sapiens	Inhibition	%	1.84
	8147512	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	2.75	CHEMBL5084	Homo sapiens	Inhibition	%	2.75
	8147736	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	2.44	CHEMBL5084	Homo sapiens	Inhibition	%	2.44
	8147923	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	3.75	CHEMBL5084	Homo sapiens	Inhibition	%	3.75
	8148081	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	24.83	CHEMBL5084	Homo sapiens	Inhibition	%	24.83
	8148305	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	4.05	CHEMBL5084	Homo sapiens	Inhibition	%	4.05
	8148419	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-2.02	CHEMBL5084	Homo sapiens	Inhibition	%	-2.02
	8148782	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	37.12	CHEMBL5084	Homo sapiens	Inhibition	%	37.12
	8148920	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	4.74	CHEMBL5084	Homo sapiens	Inhibition	%	4.74
	8149144	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	9.02	CHEMBL5084	Homo sapiens	Inhibition	%	9.02
	8149303	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-1.66	CHEMBL5084	Homo sapiens	Inhibition	%	-1.66
	8149437	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	5.14	CHEMBL5084	Homo sapiens	Inhibition	%	5.14
	8149661	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	3.69	CHEMBL5084	Homo sapiens	Inhibition	%	3.69
	8149759	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	1.68	CHEMBL5084	Homo sapiens	Inhibition	%	1.68
	8150108	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-2.82	CHEMBL5084	Homo sapiens	Inhibition	%	-2.82
	8150268	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	-1.25	CHEMBL5084	Homo sapiens	Inhibition	%	-1.25
	8150492	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	2.38	CHEMBL5084	Homo sapiens	Inhibition	%	2.38
	8150612	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.39	CHEMBL5084	Homo sapiens	Inhibition	%	0.39
	8151001	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	10.34	CHEMBL5084	Homo sapiens	Inhibition	%	10.34
	8151164	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-2.17	CHEMBL5084	Homo sapiens	Inhibition	%	-2.17
	8151565	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	1.24	CHEMBL5084	Homo sapiens	Inhibition	%	1.24
	8151703	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	2.44	CHEMBL5084	Homo sapiens	Inhibition	%	2.44
	8152081	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	1.71	CHEMBL5084	Homo sapiens	Inhibition	%	1.71
	8152269	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	5.04	CHEMBL5084	Homo sapiens	Inhibition	%	5.04
	8152651	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	4.99	CHEMBL5084	Homo sapiens	Inhibition	%	4.99
	8152765	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	3.36	CHEMBL5084	Homo sapiens	Inhibition	%	3.36
	8152989	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	3.45	CHEMBL5084	Homo sapiens	Inhibition	%	3.45
	8153128	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.07	CHEMBL5084	Homo sapiens	Inhibition	%	2.07
	8153489	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	3.46	CHEMBL5084	Homo sapiens	Inhibition	%	3.46
	8153646	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-4.35	CHEMBL5084	Homo sapiens	Inhibition	%	-4.35
	8154003	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	3.84	CHEMBL5084	Homo sapiens	Inhibition	%	3.84
	8154100	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	4.49	CHEMBL5084	Homo sapiens	Inhibition	%	4.49
	8154324	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	0.54	CHEMBL5084	Homo sapiens	Inhibition	%	0.54
	8154450	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-2.32	CHEMBL5084	Homo sapiens	Inhibition	%	-2.32
	8154833	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	0.88	CHEMBL5084	Homo sapiens	Inhibition	%	0.88
	8154953	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	-1.54	CHEMBL5084	Homo sapiens	Inhibition	%	-1.54
	8155177	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.39	CHEMBL5084	Homo sapiens	Inhibition	%	0.39
	8155353	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.79	CHEMBL5084	Homo sapiens	Inhibition	%	0.79
	8155514	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-1.12	CHEMBL5084	Homo sapiens	Inhibition	%	-1.12
	8155738	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	3.51	CHEMBL5084	Homo sapiens	Inhibition	%	3.51
	8155916	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	0.68	CHEMBL5084	Homo sapiens	Inhibition	%	0.68
	8156054	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	1.18	CHEMBL5084	Homo sapiens	Inhibition	%	1.18
	8156278	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	1.86	CHEMBL5084	Homo sapiens	Inhibition	%	1.86
	8156490	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	2.01	CHEMBL5084	Homo sapiens	Inhibition	%	2.01
	8156640	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	1.37	CHEMBL5084	Homo sapiens	Inhibition	%	1.37
	8157007	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	3.96	CHEMBL5084	Homo sapiens	Inhibition	%	3.96
	8157127	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	2.16	CHEMBL5084	Homo sapiens	Inhibition	%	2.16
	8157351	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	2.2	CHEMBL5084	Homo sapiens	Inhibition	%	2.2
	8157492	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	2.45	CHEMBL5084	Homo sapiens	Inhibition	%	2.45
	8157846	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	2.41	CHEMBL5084	Homo sapiens	Inhibition	%	2.41
	8158007	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	0.85	CHEMBL5084	Homo sapiens	Inhibition	%	0.85
	8158257	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	2.13	CHEMBL5084	Homo sapiens	Inhibition	%	2.13
	8158481	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	2.49	CHEMBL5084	Homo sapiens	Inhibition	%	2.49
	8158639	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	2.49	CHEMBL5084	Homo sapiens	Inhibition	%	2.49
	8158808	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	1.27	CHEMBL5084	Homo sapiens	Inhibition	%	1.27
	8159032	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	2.99	CHEMBL5084	Homo sapiens	Inhibition	%	2.99
	8159167	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	4.52	CHEMBL5084	Homo sapiens	Inhibition	%	4.52
	8159511	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-3.04	CHEMBL5084	Homo sapiens	Inhibition	%	-3.04
	8159642	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	2.14	CHEMBL5084	Homo sapiens	Inhibition	%	2.14
	8159866	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	44.26	CHEMBL5084	Homo sapiens	Inhibition	%	44.26
	8160007	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	4.18	CHEMBL5084	Homo sapiens	Inhibition	%	4.18
	8160144	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	4.84	CHEMBL5084	Homo sapiens	Inhibition	%	4.84
	8160368	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	6.07	CHEMBL5084	Homo sapiens	Inhibition	%	6.07
	8160518	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-1.07	CHEMBL5084	Homo sapiens	Inhibition	%	-1.07
	8160812	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	3.1	CHEMBL5084	Homo sapiens	Inhibition	%	3.1
	8160962	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	2.29	CHEMBL5084	Homo sapiens	Inhibition	%	2.29
	8161186	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	2.32	CHEMBL5084	Homo sapiens	Inhibition	%	2.32
	8161329	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	6.57	CHEMBL5084	Homo sapiens	Inhibition	%	6.57
	8161678	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	0.98	CHEMBL5084	Homo sapiens	Inhibition	%	0.98
	8161816	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	4.96	CHEMBL5084	Homo sapiens	Inhibition	%	4.96
	8162040	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	1.83	CHEMBL5084	Homo sapiens	Inhibition	%	1.83
	8162170	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	3.26	CHEMBL5084	Homo sapiens	Inhibition	%	3.26
	8162330	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-3.59	CHEMBL5084	Homo sapiens	Inhibition	%	-3.59
	8162554	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-4.66	CHEMBL5084	Homo sapiens	Inhibition	%	-4.66
	8162807	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	2.9	CHEMBL5084	Homo sapiens	Inhibition	%	2.9
	8162955	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	6.11	CHEMBL5084	Homo sapiens	Inhibition	%	6.11
	8163348	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	2.06	CHEMBL5084	Homo sapiens	Inhibition	%	2.06
	8163482	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	3.53	CHEMBL5084	Homo sapiens	Inhibition	%	3.53
	8163829	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-1.19	CHEMBL5084	Homo sapiens	Inhibition	%	-1.19
	8164187	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	83.49	CHEMBL5084	Homo sapiens	Inhibition	%	83.49
	8164327	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-0.9	CHEMBL5084	Homo sapiens	Inhibition	%	-0.9
	8164706	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	8.75	CHEMBL5084	Homo sapiens	Inhibition	%	8.75
	8164850	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	10.81	CHEMBL5084	Homo sapiens	Inhibition	%	10.81
	8165144	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	2.52	CHEMBL5084	Homo sapiens	Inhibition	%	2.52
	8165509	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	3.24	CHEMBL5084	Homo sapiens	Inhibition	%	3.24
	8165652	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	38.03	CHEMBL5084	Homo sapiens	Inhibition	%	38.03
	8166002	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	1.47	CHEMBL5084	Homo sapiens	Inhibition	%	1.47
	8166364	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	4.57	CHEMBL5084	Homo sapiens	Inhibition	%	4.57
	8166494	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	2.62	CHEMBL5084	Homo sapiens	Inhibition	%	2.62
	8166819	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	-0.68	CHEMBL5084	Homo sapiens	Inhibition	%	-0.68
	8167131	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	1.57	CHEMBL5084	Homo sapiens	Inhibition	%	1.57
	8167272	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	26.29	CHEMBL5084	Homo sapiens	Inhibition	%	26.29
	8167496	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	4.29	CHEMBL5084	Homo sapiens	Inhibition	%	4.29
	8167660	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	2.66	CHEMBL5084	Homo sapiens	Inhibition	%	2.66
	8167793	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	5.66	CHEMBL5084	Homo sapiens	Inhibition	%	5.66
	8168017	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	3.59	CHEMBL5084	Homo sapiens	Inhibition	%	3.59
	8168141	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	0.29	CHEMBL5084	Homo sapiens	Inhibition	%	0.29
	8168506	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	8.09	CHEMBL5084	Homo sapiens	Inhibition	%	8.09
	8168642	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	5.01	CHEMBL5084	Homo sapiens	Inhibition	%	5.01
	8168866	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-0.89	CHEMBL5084	Homo sapiens	Inhibition	%	-0.89
	8169030	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	43.05	CHEMBL5084	Homo sapiens	Inhibition	%	43.05
	8169172	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	4.47	CHEMBL5084	Homo sapiens	Inhibition	%	4.47
	8169396	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	2.66	CHEMBL5084	Homo sapiens	Inhibition	%	2.66
	8169476	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	6.23	CHEMBL5084	Homo sapiens	Inhibition	%	6.23
	8169700	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	5.54	CHEMBL5084	Homo sapiens	Inhibition	%	5.54
	8169834	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	3.77	CHEMBL5084	Homo sapiens	Inhibition	%	3.77
	8169979	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	1.91	CHEMBL5084	Homo sapiens	Inhibition	%	1.91
	8170203	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	1.31	CHEMBL5084	Homo sapiens	Inhibition	%	1.31
	8170328	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	0.83	CHEMBL5084	Homo sapiens	Inhibition	%	0.83
	8170692	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	-1.65	CHEMBL5084	Homo sapiens	Inhibition	%	-1.65
	8170827	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	2.68	CHEMBL5084	Homo sapiens	Inhibition	%	2.68
	8171051	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	1.13	CHEMBL5084	Homo sapiens	Inhibition	%	1.13
	8171248	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	0.39	CHEMBL5084	Homo sapiens	Inhibition	%	0.39
	8171465	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	1.58	CHEMBL5084	Homo sapiens	Inhibition	%	1.58
	8171830	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	24.29	CHEMBL5084	Homo sapiens	Inhibition	%	24.29
	8171983	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-1.77	CHEMBL5084	Homo sapiens	Inhibition	%	-1.77
	8172339	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	3.84	CHEMBL5084	Homo sapiens	Inhibition	%	3.84
	8172467	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	0.47	CHEMBL5084	Homo sapiens	Inhibition	%	0.47
	8172691	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	0.42	CHEMBL5084	Homo sapiens	Inhibition	%	0.42
	8172833	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	28.98	CHEMBL5084	Homo sapiens	Inhibition	%	28.98
	8173193	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	2.47	CHEMBL5084	Homo sapiens	Inhibition	%	2.47
	8173358	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	5.28	CHEMBL5084	Homo sapiens	Inhibition	%	5.28
	8173723	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	3.31	CHEMBL5084	Homo sapiens	Inhibition	%	3.31
	8174034	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	16.45	CHEMBL5084	Homo sapiens	Inhibition	%	16.45
	8174166	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	2.67	CHEMBL5084	Homo sapiens	Inhibition	%	2.67
	8174538	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	0.19	CHEMBL5084	Homo sapiens	Inhibition	%	0.19
	8174660	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	1.98	CHEMBL5084	Homo sapiens	Inhibition	%	1.98
	8174884	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	3.84	CHEMBL5084	Homo sapiens	Inhibition	%	3.84
	8175027	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	-0.62	CHEMBL5084	Homo sapiens	Inhibition	%	-0.62
	8175387	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	13.56	CHEMBL5084	Homo sapiens	Inhibition	%	13.56
	8175643	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	5.16	CHEMBL5084	Homo sapiens	Inhibition	%	5.16
	8175806	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	0.54	CHEMBL5084	Homo sapiens	Inhibition	%	0.54
	8176183	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	2.05	CHEMBL5084	Homo sapiens	Inhibition	%	2.05
	8176332	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	0.64	CHEMBL5084	Homo sapiens	Inhibition	%	0.64
	8176556	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	0.48	CHEMBL5084	Homo sapiens	Inhibition	%	0.48
	8176688	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	7.65	CHEMBL5084	Homo sapiens	Inhibition	%	7.65
	8177042	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	5.22	CHEMBL5084	Homo sapiens	Inhibition	%	5.22
	8177184	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	-0.15	CHEMBL5084	Homo sapiens	Inhibition	%	-0.15
	8177546	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	4.06	CHEMBL5084	Homo sapiens	Inhibition	%	4.06
	8177710	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	6.59	CHEMBL5084	Homo sapiens	Inhibition	%	6.59
	8177934	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	4.7	CHEMBL5084	Homo sapiens	Inhibition	%	4.7
	8178074	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	3.74	CHEMBL5084	Homo sapiens	Inhibition	%	3.74
	8178386	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	1.79	CHEMBL5084	Homo sapiens	Inhibition	%	1.79
	8178513	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	3.39	CHEMBL5084	Homo sapiens	Inhibition	%	3.39
	8178737	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	3.39	CHEMBL5084	Homo sapiens	Inhibition	%	3.39
	8178886	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	2.3	CHEMBL5084	Homo sapiens	Inhibition	%	2.3
	8179233	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	0.57	CHEMBL5084	Homo sapiens	Inhibition	%	0.57
	8179377	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	1.86	CHEMBL5084	Homo sapiens	Inhibition	%	1.86
	8179738	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	-1.08	CHEMBL5084	Homo sapiens	Inhibition	%	-1.08
	8179995	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	2.15	CHEMBL5084	Homo sapiens	Inhibition	%	2.15
	8180149	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	3.06	CHEMBL5084	Homo sapiens	Inhibition	%	3.06
	8180373	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-2.89	CHEMBL5084	Homo sapiens	Inhibition	%	-2.89
	8180529	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	10.74	CHEMBL5084	Homo sapiens	Inhibition	%	10.74
	8180901	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	0.92	CHEMBL5084	Homo sapiens	Inhibition	%	0.92
	8181034	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	3.71	CHEMBL5084	Homo sapiens	Inhibition	%	3.71
	8181389	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-1.23	CHEMBL5084	Homo sapiens	Inhibition	%	-1.23
	8181529	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	1.13	CHEMBL5084	Homo sapiens	Inhibition	%	1.13
	8181753	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	4.39	CHEMBL5084	Homo sapiens	Inhibition	%	4.39
	8181892	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	5.0	CHEMBL5084	Homo sapiens	Inhibition	%	5.0
	8182279	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	16.85	CHEMBL5084	Homo sapiens	Inhibition	%	16.85
	8182419	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	3.32	CHEMBL5084	Homo sapiens	Inhibition	%	3.32
	8182735	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	0.71	CHEMBL5084	Homo sapiens	Inhibition	%	0.71
	8183081	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	3.4	CHEMBL5084	Homo sapiens	Inhibition	%	3.4
	8183230	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	3.1	CHEMBL5084	Homo sapiens	Inhibition	%	3.1
	8183583	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	0.18	CHEMBL5084	Homo sapiens	Inhibition	%	0.18
	8183725	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	5.91	CHEMBL5084	Homo sapiens	Inhibition	%	5.91
	8183949	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	1.35	CHEMBL5084	Homo sapiens	Inhibition	%	1.35
	8184085	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	1.11	CHEMBL5084	Homo sapiens	Inhibition	%	1.11
	8184351	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	4.71	CHEMBL5084	Homo sapiens	Inhibition	%	4.71
	8184722	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-1.56	CHEMBL5084	Homo sapiens	Inhibition	%	-1.56
	8184879	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	23.91	CHEMBL5084	Homo sapiens	Inhibition	%	23.91
	8185252	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-1.04	CHEMBL5084	Homo sapiens	Inhibition	%	-1.04
	8185383	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	9.28	CHEMBL5084	Homo sapiens	Inhibition	%	9.28
	8185607	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	-0.3	CHEMBL5084	Homo sapiens	Inhibition	%	-0.3
	8185738	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	19.05	CHEMBL5084	Homo sapiens	Inhibition	%	19.05
	8186101	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	4.52	CHEMBL5084	Homo sapiens	Inhibition	%	4.52
	8186242	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	3.89	CHEMBL5084	Homo sapiens	Inhibition	%	3.89
	8186630	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	1.81	CHEMBL5084	Homo sapiens	Inhibition	%	1.81
	8186769	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	3.74	CHEMBL5084	Homo sapiens	Inhibition	%	3.74
	8186993	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	2.93	CHEMBL5084	Homo sapiens	Inhibition	%	2.93
	8187091	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	2.87	CHEMBL5084	Homo sapiens	Inhibition	%	2.87
	8187439	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	4.96	CHEMBL5084	Homo sapiens	Inhibition	%	4.96
	8187587	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	5.62	CHEMBL5084	Homo sapiens	Inhibition	%	5.62
	8187811	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	2.87	CHEMBL5084	Homo sapiens	Inhibition	%	2.87
	8187940	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	1.72	CHEMBL5084	Homo sapiens	Inhibition	%	1.72
	8188307	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	3.48	CHEMBL5084	Homo sapiens	Inhibition	%	3.48
	8188442	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	-4.22	CHEMBL5084	Homo sapiens	Inhibition	%	-4.22
	8188666	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	-2.43	CHEMBL5084	Homo sapiens	Inhibition	%	-2.43
	8188716	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.73	CHEMBL5084	Homo sapiens	Inhibition	%	2.73
	8188940	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	4.9	CHEMBL5084	Homo sapiens	Inhibition	%	4.9
	8189088	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	1.47	CHEMBL5084	Homo sapiens	Inhibition	%	1.47
	8189244	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	76.09	CHEMBL5084	Homo sapiens	Inhibition	%	76.09
	8189468	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	5.4	CHEMBL5084	Homo sapiens	Inhibition	%	5.4
	8189617	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-0.37	CHEMBL5084	Homo sapiens	Inhibition	%	-0.37
	8189973	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	0.33	CHEMBL5084	Homo sapiens	Inhibition	%	0.33
	8190105	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	4.08	CHEMBL5084	Homo sapiens	Inhibition	%	4.08
	8190469	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	4.56	CHEMBL5084	Homo sapiens	Inhibition	%	4.56
	8190606	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	3.22	CHEMBL5084	Homo sapiens	Inhibition	%	3.22
	8190830	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	4.27	CHEMBL5084	Homo sapiens	Inhibition	%	4.27
	8190994	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	3.33	CHEMBL5084	Homo sapiens	Inhibition	%	3.33
	8191356	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	4.26	CHEMBL5084	Homo sapiens	Inhibition	%	4.26
	8191452	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	2.49	CHEMBL5084	Homo sapiens	Inhibition	%	2.49
	8191676	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	0.89	CHEMBL5084	Homo sapiens	Inhibition	%	0.89
	8191798	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	6.47	CHEMBL5084	Homo sapiens	Inhibition	%	6.47
	8192171	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	4.99	CHEMBL5084	Homo sapiens	Inhibition	%	4.99
	8192300	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	0.01	CHEMBL5084	Homo sapiens	Inhibition	%	0.01
	8192524	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	0.83	CHEMBL5084	Homo sapiens	Inhibition	%	0.83
	8192668	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	2.23	CHEMBL5084	Homo sapiens	Inhibition	%	2.23
	8193028	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	-2.09	CHEMBL5084	Homo sapiens	Inhibition	%	-2.09
	8193300	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	4.13	CHEMBL5084	Homo sapiens	Inhibition	%	4.13
	8193445	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	2.79	CHEMBL5084	Homo sapiens	Inhibition	%	2.79
	8193826	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	14.03	CHEMBL5084	Homo sapiens	Inhibition	%	14.03
	8193975	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-0.94	CHEMBL5084	Homo sapiens	Inhibition	%	-0.94
	8194330	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	1.97	CHEMBL5084	Homo sapiens	Inhibition	%	1.97
	8194461	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	3.37	CHEMBL5084	Homo sapiens	Inhibition	%	3.37
	8194685	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	4.47	CHEMBL5084	Homo sapiens	Inhibition	%	4.47
	8194828	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	4.47	CHEMBL5084	Homo sapiens	Inhibition	%	4.47
	8195185	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	10.23	CHEMBL5084	Homo sapiens	Inhibition	%	10.23
	8195349	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	1.18	CHEMBL5084	Homo sapiens	Inhibition	%	1.18
	8195712	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	3.67	CHEMBL5084	Homo sapiens	Inhibition	%	3.67
	8196034	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	1.64	CHEMBL5084	Homo sapiens	Inhibition	%	1.64
	8196151	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	3.41	CHEMBL5084	Homo sapiens	Inhibition	%	3.41
	8196375	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	5.53	CHEMBL5084	Homo sapiens	Inhibition	%	5.53
	8196525	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	7.8	CHEMBL5084	Homo sapiens	Inhibition	%	7.8
	8196877	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	-0.97	CHEMBL5084	Homo sapiens	Inhibition	%	-0.97
	8197018	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	3.55	CHEMBL5084	Homo sapiens	Inhibition	%	3.55
	8197379	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	2.37	CHEMBL5084	Homo sapiens	Inhibition	%	2.37
	8197654	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	2.66	CHEMBL5084	Homo sapiens	Inhibition	%	2.66
	8197794	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	1.38	CHEMBL5084	Homo sapiens	Inhibition	%	1.38
	8198018	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	2.71	CHEMBL5084	Homo sapiens	Inhibition	%	2.71
	8198175	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	0.7	CHEMBL5084	Homo sapiens	Inhibition	%	0.7
	8198313	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-0.62	CHEMBL5084	Homo sapiens	Inhibition	%	-0.62
	8198537	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	4.09	CHEMBL5084	Homo sapiens	Inhibition	%	4.09
	8198667	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	4.02	CHEMBL5084	Homo sapiens	Inhibition	%	4.02
	8199022	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	3.56	CHEMBL5084	Homo sapiens	Inhibition	%	3.56
	8199170	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	3.73	CHEMBL5084	Homo sapiens	Inhibition	%	3.73
	8199394	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	4.56	CHEMBL5084	Homo sapiens	Inhibition	%	4.56
	8199528	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	4.31	CHEMBL5084	Homo sapiens	Inhibition	%	4.31
	8199691	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	6.13	CHEMBL5084	Homo sapiens	Inhibition	%	6.13
	8199915	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	2.26	CHEMBL5084	Homo sapiens	Inhibition	%	2.26
	8200053	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	4.78	CHEMBL5084	Homo sapiens	Inhibition	%	4.78
	8200381	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	1.6	CHEMBL5084	Homo sapiens	Inhibition	%	1.6
	8200720	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	3.84	CHEMBL5084	Homo sapiens	Inhibition	%	3.84
	8200870	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	51.51	CHEMBL5084	Homo sapiens	Inhibition	%	51.51
	8201224	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	-0.06	CHEMBL5084	Homo sapiens	Inhibition	%	-0.06
	8201359	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	1.53	CHEMBL5084	Homo sapiens	Inhibition	%	1.53
	8201583	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	4.76	CHEMBL5084	Homo sapiens	Inhibition	%	4.76
	8201716	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-1.01	CHEMBL5084	Homo sapiens	Inhibition	%	-1.01
	8201995	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	2.34	CHEMBL5084	Homo sapiens	Inhibition	%	2.34
	8202359	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-2.56	CHEMBL5084	Homo sapiens	Inhibition	%	-2.56
	8202526	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	8.82	CHEMBL5084	Homo sapiens	Inhibition	%	8.82
	8202875	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	6.73	CHEMBL5084	Homo sapiens	Inhibition	%	6.73
	8203005	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	2.44	CHEMBL5084	Homo sapiens	Inhibition	%	2.44
	8203229	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	4.27	CHEMBL5084	Homo sapiens	Inhibition	%	4.27
	8203360	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	-0.12	CHEMBL5084	Homo sapiens	Inhibition	%	-0.12
	8203730	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	1.77	CHEMBL5084	Homo sapiens	Inhibition	%	1.77
	8203864	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	4.88	CHEMBL5084	Homo sapiens	Inhibition	%	4.88
	8204254	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	3.16	CHEMBL5084	Homo sapiens	Inhibition	%	3.16
	8204391	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	4.03	CHEMBL5084	Homo sapiens	Inhibition	%	4.03
	8204615	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	6.72	CHEMBL5084	Homo sapiens	Inhibition	%	6.72
	8204720	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	4.02	CHEMBL5084	Homo sapiens	Inhibition	%	4.02
	8205059	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	19.99	CHEMBL5084	Homo sapiens	Inhibition	%	19.99
	8205208	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	2.89	CHEMBL5084	Homo sapiens	Inhibition	%	2.89
	8205432	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	8.91	CHEMBL5084	Homo sapiens	Inhibition	%	8.91
	8205568	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	1.1	CHEMBL5084	Homo sapiens	Inhibition	%	1.1
	8205931	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	0.5	CHEMBL5084	Homo sapiens	Inhibition	%	0.5
	8206063	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-1.93	CHEMBL5084	Homo sapiens	Inhibition	%	-1.93
	8206339	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	1.71	CHEMBL5084	Homo sapiens	Inhibition	%	1.71
	8206706	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	0.95	CHEMBL5084	Homo sapiens	Inhibition	%	0.95
	8206886	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	1.5	CHEMBL5084	Homo sapiens	Inhibition	%	1.5
	8207236	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	6.72	CHEMBL5084	Homo sapiens	Inhibition	%	6.72
	8207590	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	1.39	CHEMBL5084	Homo sapiens	Inhibition	%	1.39
	8207722	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	1.23	CHEMBL5084	Homo sapiens	Inhibition	%	1.23
	8208091	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	4.33	CHEMBL5084	Homo sapiens	Inhibition	%	4.33
	8208223	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	3.68	CHEMBL5084	Homo sapiens	Inhibition	%	3.68
	8208447	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	6.59	CHEMBL5084	Homo sapiens	Inhibition	%	6.59
	8208613	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	0.93	CHEMBL5084	Homo sapiens	Inhibition	%	0.93
	8208970	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	3.26	CHEMBL5084	Homo sapiens	Inhibition	%	3.26
	8209075	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	0.39	CHEMBL5084	Homo sapiens	Inhibition	%	0.39
	8209299	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	0.12	CHEMBL5084	Homo sapiens	Inhibition	%	0.12
	8209415	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	4.0	CHEMBL5084	Homo sapiens	Inhibition	%	4.0
	8209789	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	0.52	CHEMBL5084	Homo sapiens	Inhibition	%	0.52
	8209925	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	0.56	CHEMBL5084	Homo sapiens	Inhibition	%	0.56
	8210290	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	2.08	CHEMBL5084	Homo sapiens	Inhibition	%	2.08
	8210426	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-2.3	CHEMBL5084	Homo sapiens	Inhibition	%	-2.3
	8210650	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	0.47	CHEMBL5084	Homo sapiens	Inhibition	%	0.47
	8210685	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	-1.5	CHEMBL5084	Homo sapiens	Inhibition	%	-1.5
	8210909	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	-0.65	CHEMBL5084	Homo sapiens	Inhibition	%	-0.65
	8211053	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	3.9	CHEMBL5084	Homo sapiens	Inhibition	%	3.9
	8211223	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	3.26	CHEMBL5084	Homo sapiens	Inhibition	%	3.26
	8211447	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	2.96	CHEMBL5084	Homo sapiens	Inhibition	%	2.96
	8211570	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	24.66	CHEMBL5084	Homo sapiens	Inhibition	%	24.66
	8211923	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	4.72	CHEMBL5084	Homo sapiens	Inhibition	%	4.72
	8212055	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	4.33	CHEMBL5084	Homo sapiens	Inhibition	%	4.33
	8212279	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	2.71	CHEMBL5084	Homo sapiens	Inhibition	%	2.71
	8212420	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	1.93	CHEMBL5084	Homo sapiens	Inhibition	%	1.93
	8212777	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	3.29	CHEMBL5084	Homo sapiens	Inhibition	%	3.29
	8212947	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	3.24	CHEMBL5084	Homo sapiens	Inhibition	%	3.24
	8213300	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	2.82	CHEMBL5084	Homo sapiens	Inhibition	%	2.82
	8213628	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-0.68	CHEMBL5084	Homo sapiens	Inhibition	%	-0.68
	8213741	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	17.39	CHEMBL5084	Homo sapiens	Inhibition	%	17.39
	8214112	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	-0.19	CHEMBL5084	Homo sapiens	Inhibition	%	-0.19
	8214249	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	2.15	CHEMBL5084	Homo sapiens	Inhibition	%	2.15
	8214473	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	3.1	CHEMBL5084	Homo sapiens	Inhibition	%	3.1
	8214607	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	-2.96	CHEMBL5084	Homo sapiens	Inhibition	%	-2.96
	8214983	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-0.5	CHEMBL5084	Homo sapiens	Inhibition	%	-0.5
	8215234	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	3.31	CHEMBL5084	Homo sapiens	Inhibition	%	3.31
	8215387	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	2.94	CHEMBL5084	Homo sapiens	Inhibition	%	2.94
	8215775	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	4.98	CHEMBL5084	Homo sapiens	Inhibition	%	4.98
	8215894	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	2.74	CHEMBL5084	Homo sapiens	Inhibition	%	2.74
	8216118	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	31.75	CHEMBL5084	Homo sapiens	Inhibition	%	31.75
	8216237	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	1.35	CHEMBL5084	Homo sapiens	Inhibition	%	1.35
	8216597	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	4.01	CHEMBL5084	Homo sapiens	Inhibition	%	4.01
	8216735	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	3.02	CHEMBL5084	Homo sapiens	Inhibition	%	3.02
	8217093	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	3.17	CHEMBL5084	Homo sapiens	Inhibition	%	3.17
	8217267	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	-0.2	CHEMBL5084	Homo sapiens	Inhibition	%	-0.2
	8217491	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	1.13	CHEMBL5084	Homo sapiens	Inhibition	%	1.13
	8217622	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	2.68	CHEMBL5084	Homo sapiens	Inhibition	%	2.68
	8217947	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-1.39	CHEMBL5084	Homo sapiens	Inhibition	%	-1.39
	8218062	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	3.08	CHEMBL5084	Homo sapiens	Inhibition	%	3.08
	8218286	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	3.59	CHEMBL5084	Homo sapiens	Inhibition	%	3.59
	8218413	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	1.94	CHEMBL5084	Homo sapiens	Inhibition	%	1.94
	8218780	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	0.82	CHEMBL5084	Homo sapiens	Inhibition	%	0.82
	8218911	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	0.07	CHEMBL5084	Homo sapiens	Inhibition	%	0.07
	8219135	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	1.5	CHEMBL5084	Homo sapiens	Inhibition	%	1.5
	8219295	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	2.07	CHEMBL5084	Homo sapiens	Inhibition	%	2.07
	8219545	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	6.54	CHEMBL5084	Homo sapiens	Inhibition	%	6.54
	8219706	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	3.42	CHEMBL5084	Homo sapiens	Inhibition	%	3.42
	8219930	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	5.14	CHEMBL5084	Homo sapiens	Inhibition	%	5.14
	8220099	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	5.49	CHEMBL5084	Homo sapiens	Inhibition	%	5.49
	8220452	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	4.84	CHEMBL5084	Homo sapiens	Inhibition	%	4.84
	8220566	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	2.37	CHEMBL5084	Homo sapiens	Inhibition	%	2.37
	8220928	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	6.11	CHEMBL5084	Homo sapiens	Inhibition	%	6.11
	8221064	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	-1.06	CHEMBL5084	Homo sapiens	Inhibition	%	-1.06
	8221288	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	0.84	CHEMBL5084	Homo sapiens	Inhibition	%	0.84
	8221421	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	1.83	CHEMBL5084	Homo sapiens	Inhibition	%	1.83
	8221810	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.52	CHEMBL5084	Homo sapiens	Inhibition	%	1.52
	8221941	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	2.61	CHEMBL5084	Homo sapiens	Inhibition	%	2.61
	8222263	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	1.93	CHEMBL5084	Homo sapiens	Inhibition	%	1.93
	8222621	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	3.53	CHEMBL5084	Homo sapiens	Inhibition	%	3.53
	8222739	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	11.91	CHEMBL5084	Homo sapiens	Inhibition	%	11.91
	8223107	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	3.84	CHEMBL5084	Homo sapiens	Inhibition	%	3.84
	8223460	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	2.93	CHEMBL5084	Homo sapiens	Inhibition	%	2.93
	8223621	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	-0.67	CHEMBL5084	Homo sapiens	Inhibition	%	-0.67
	8223871	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	3.31	CHEMBL5084	Homo sapiens	Inhibition	%	3.31
	8224257	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	0.96	CHEMBL5084	Homo sapiens	Inhibition	%	0.96
	8224427	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	5.13	CHEMBL5084	Homo sapiens	Inhibition	%	5.13
	8224786	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	5.46	CHEMBL5084	Homo sapiens	Inhibition	%	5.46
	8224900	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	1.59	CHEMBL5084	Homo sapiens	Inhibition	%	1.59
	8225124	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	2.92	CHEMBL5084	Homo sapiens	Inhibition	%	2.92
	8225258	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	7.49	CHEMBL5084	Homo sapiens	Inhibition	%	7.49
	8225620	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	0.57	CHEMBL5084	Homo sapiens	Inhibition	%	0.57
	8225755	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	4.22	CHEMBL5084	Homo sapiens	Inhibition	%	4.22
	8226137	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	20.3	CHEMBL5084	Homo sapiens	Inhibition	%	20.3
	8226262	CHEMBL1962016	GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	3.42	CHEMBL5084	Homo sapiens	Inhibition	%	3.42
	8226486	CHEMBL1962017	GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	3.02	CHEMBL5084	Homo sapiens	Inhibition	%	3.02
active	9536179	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cccc(-c2[nH]c(-c3ccnc(N)n3)cc2C(N)=O)c1C		CHEMBL1964290	=	Ki	nM	79.43	CHEMBL5084	Homo sapiens	pKi		7.1
active	9536180	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)c(OC)c1		CHEMBL2003768	=	Ki	nM	3981.07	CHEMBL5084	Homo sapiens	pKi		5.4
active	9536181	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL213505	=	Ki	nM	3162.28	CHEMBL5084	Homo sapiens	pKi		5.5
inactive	9536182	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1		CHEMBL1987034	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536183	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1993941	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536184	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536185	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12		CHEMBL2005886	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536186	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL481491	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536187	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(=O)Nc1c(C(N)=O)sc2ccc(Cl)c(Cl)c12		CHEMBL1973142	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536188	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1		CHEMBL1973145	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536189	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982924	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9536190	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL2005936	=	Ki	nM	501.19	CHEMBL5084	Homo sapiens	pKi		6.3
active	9536191	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NC1CCC(Nc2nccc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1966628	=	Ki	nM	50.12	CHEMBL5084	Homo sapiens	pKi		7.3
inactive	9536192	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1		CHEMBL1971141	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9536193	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NC1CCCCC1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1995813	=	Ki	nM	251.19	CHEMBL5084	Homo sapiens	pKi		6.6
active	9536194	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3cn[nH]c3c2)n1		CHEMBL244378	=	Ki	nM	398.11	CHEMBL5084	Homo sapiens	pKi		6.4
inactive	9536195	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL362558	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9536196	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(OCC(F)(F)F)nccn23)n1		CHEMBL2001957	=	Ki	nM	3981.07	CHEMBL5084	Homo sapiens	pKi		5.4
active	9536197	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1969372	=	Ki	nM	1995.26	CHEMBL5084	Homo sapiens	pKi		5.7
active	9536198	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	630.96	CHEMBL5084	Homo sapiens	pKi		6.2
active	9536199	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1nc2ccc(NS(=O)(=O)c3ccc(N)cc3)cc2nc1C		CHEMBL2006263	=	Ki	nM	1995.26	CHEMBL5084	Homo sapiens	pKi		5.7
inactive	9536200	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1993584	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9536201	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O		CHEMBL1986263	=	Ki	nM	1000.0	CHEMBL5084	Homo sapiens	pKi		6.0
inactive	9536202	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CSc1c[nH]c2ncnc(NCCCO)c12		CHEMBL2000114	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536203	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12		CHEMBL1975647	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9536204	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1968380	=	Ki	nM	794.33	CHEMBL5084	Homo sapiens	pKi		6.1
inactive	9536205	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(NCc1ccccc1)Nc1ncc([N+](=O)[O-])s1		CHEMBL1964644	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9536206	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1		CHEMBL1981782	=	Ki	nM	3162.28	CHEMBL5084	Homo sapiens	pKi		5.5
active	9536207	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1		CHEMBL1977681	=	Ki	nM	1000.0	CHEMBL5084	Homo sapiens	pKi		6.0
inactive	9536208	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CNC(=O)C(C)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(C)cc5)cc4)csc23)cn1		CHEMBL1970142	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536209	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	OCCNc1cc2cc(-c3cccnc3)ccc2cn1		CHEMBL1990912	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536210	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536211	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(-c4ccccc4)c3n2)c1		CHEMBL1988163	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536212	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C1CCCc2oc3cc(C(F)(F)F)ccc3c(=O)c21		CHEMBL2006493	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536213	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Clc1cc2nn[nH]c2cc1Cl		CHEMBL1996923	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9536214	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1C		CHEMBL1983449	=	Ki	nM	1000.0	CHEMBL5084	Homo sapiens	pKi		6.0
inactive	9536215	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=c1[nH]cnc2c1oc1ccc(Cl)cc12		CHEMBL1992323	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536216	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(Cl)nccn23)n1		CHEMBL1969735	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536217	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2		CHEMBL2002649	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536218	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Brc1ccc2c(c1)-c1[nH]ncc1C2		CHEMBL1995172	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536219	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NC(=O)c1cc(Cl)cc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1984788	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9536220	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1		CHEMBL2000508	=	Ki	nM	630.96	CHEMBL5084	Homo sapiens	pKi		6.2
inactive	9536221	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCCCNc1n[s+]([O-])nc1Nc1ccc(F)cc1		CHEMBL1971694	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9536222	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2001547	=	Ki	nM	2511.89	CHEMBL5084	Homo sapiens	pKi		5.6
inactive	9536223	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536224	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cc(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(-n4cccn4)cc3)s2)no1		CHEMBL1986603	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536225	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9536226	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2)cc1		CHEMBL1977148	=	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9536227	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1cc(C=C2SC(=O)NC2=O)ccc1O		CHEMBL2003286	=	Ki	nM	3162.28	CHEMBL5084	Homo sapiens	pKi		5.5
inactive	9536228	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccn1		CHEMBL1992306	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536229	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(O)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2002165	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536230	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=c1[nH]cc(I)c2nc(-c3ccccc3)cn12		CHEMBL2001668	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536231	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1n[nH]c2c1C(c1ccccc1I)C(C#N)=C(N)O2		CHEMBL1979318	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536232	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1989518	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536233	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1998585	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536234	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cn1cncc1C(OCc1c(-c2ccc(OC(F)(F)F)cc2)cc(C#N)c(=O)n1C)c1ccc(C#N)cc1		CHEMBL127898	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9536235	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2C		CHEMBL519697	=	Ki	nM	2511.89	CHEMBL5084	Homo sapiens	pKi		5.6
inactive	9536236	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(F)c2)c1		CHEMBL2004934	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536237	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NC(=O)C1CCCN(C(=O)c2cc(-c3ccc4[nH]ncc4c3)on2)C1		CHEMBL1970369	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536238	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C(C)C(=O)N(C)C)c5)cnc(N)c34)cc2)cc1		CHEMBL2001485	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536239	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9536240	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CN(C)CCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1966425	=	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536241	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1984363	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536242	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CNC(=O)COc1ccc(Nc2nc(Nc3ccc(C)c(S(N)(=O)=O)c3)ncc2F)cc1		CHEMBL1978099	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536243	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(=O)Nc1cccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)c1		CHEMBL1988608	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536244	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C		CHEMBL184847	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536245	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1		CHEMBL1984367	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536246	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCOCC1)CC2		CHEMBL178737	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9536247	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1n[nH]c2cnc(-c3cncc(OCC(N)Cc4cccc(C(F)(F)F)c4)c3)cc12		CHEMBL1998159	=	Ki	nM	79.43	CHEMBL5084	Homo sapiens	pKi		7.1
active	9536248	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COCC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(C)nccn23)n1		CHEMBL1982563	=	Ki	nM	2511.89	CHEMBL5084	Homo sapiens	pKi		5.6
inactive	9536249	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C1CCCN1Cc1ccc2c(c1)[nH]c(=O)c1cccn12		CHEMBL539474	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536250	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1987679	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536251	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(OC(F)F)cc5)cc4)csc23)cn1		CHEMBL1988387	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536252	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9536253	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	=	Ki	nM	199.53	CHEMBL5084	Homo sapiens	pKi		6.7
inactive	9536254	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=c1[nH]c2cc(Cl)cc(Cl)c2c(-c2cc(Cl)ccc2O)c1O		CHEMBL1974803	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536255	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1986970	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536256	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC1=NN(c2cccc(Br)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2005112	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9536257	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=c1cc(-c2ccncc2)nc(NC2CCCCC2)[nH]1		CHEMBL1958401	=	Ki	nM	2511.89	CHEMBL5084	Homo sapiens	pKi		5.6
inactive	9536258	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCN(CC)CCOc1ccc(-c2nc3c(C(N)=O)cccc3[nH]2)cc1		CHEMBL1984044	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536259	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=c1[nH]c2cc(-c3ccccc3)cnc2[nH]1		CHEMBL2003456	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9536260	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)cccc12		CHEMBL1966816	=	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536261	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536262	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	N#Cc1cnc(NC(=O)Nc2ccc3cc(C(=O)O)ccc3c2)cn1		CHEMBL560813	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536263	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1		CHEMBL1968791	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536264	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cccc(Cl)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)NCCOCCOCCN)[nH]c12		CHEMBL2002682	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9536265	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Fc1ccc(-c2nc3occn3c2-c2ccnc(NC3CCNCC3)n2)cc1		CHEMBL1971186	=	Ki	nM	251.19	CHEMBL5084	Homo sapiens	pKi		6.6
inactive	9536266	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(Cc1ccc(Cl)cc1)Nc1[nH]nc2c1CCC2		CHEMBL2003482	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9536267	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1		CHEMBL1973211	=	Ki	nM	1584.89	CHEMBL5084	Homo sapiens	pKi		5.8
active	9536268	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1984700	=	Ki	nM	5011.87	CHEMBL5084	Homo sapiens	pKi		5.3
inactive	9536269	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536270	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1		CHEMBL1972125	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536271	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(Nc1ccc2[nH]ncc2c1)c1cccc(F)c1		CHEMBL1461728	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536272	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9536273	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	c1cc2cc(-c3ccc4cn[nH]c4c3)cnc2[nH]1		CHEMBL1976134	=	Ki	nM	3981.07	CHEMBL5084	Homo sapiens	pKi		5.4
inactive	9536274	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1ccc(C(=O)Nc2c(C(N)=O)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL1965131	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9536275	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL1972158	=	Ki	nM	501.19	CHEMBL5084	Homo sapiens	pKi		6.3
inactive	9536276	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9536277	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Oc1ccc(Nc2ncnc3scc(Cl)c23)cc1		CHEMBL2006580	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540198	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCCC1		CHEMBL2006481	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540199	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCC#N)c2)n1		CHEMBL1979855	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540200	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540201	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1		CHEMBL2005186	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540202	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCNc1nc2cc(Cl)c(OC)cc2nc1NCC		CHEMBL1995927	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540203	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21		CHEMBL1975534	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540204	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(Cc4ccccc4)c3n2)c1		CHEMBL1993424	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540205	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1n[nH]c2c1C(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2		CHEMBL1966703	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540206	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540207	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CN(C)c1cc2sncc2cc1NC(=O)C(=O)O		CHEMBL1997023	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540208	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1964687	=	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540209	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540210	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCOc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1974254	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540211	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1ccc(C(=O)N2c3ccccc3Sc3c(Cl)cncc32)cc1		CHEMBL1988537	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540212	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(C)c2)c1		CHEMBL1969049	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540213	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1		CHEMBL2005828	=	Ki	nM	1995.26	CHEMBL5084	Homo sapiens	pKi		5.7
inactive	9540214	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccc3ccccc3c2)n1		CHEMBL2002240	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540215	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	=	Ki	nM	5011.87	CHEMBL5084	Homo sapiens	pKi		5.3
inactive	9540216	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1ccc(-n2nc(C)c3c(=O)c4cc(Cl)ccc4n(O)c32)cc1		CHEMBL1991143	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540217	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NC(=O)c1sc2c(Br)ccc(Cl)c2c1N		CHEMBL1998611	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540218	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=c1c(NCc2ccc(Cl)c(Cl)c2)c(Nc2ccncc2)c1=O		CHEMBL1975900	=	Ki	nM	125.89	CHEMBL5084	Homo sapiens	pKi		6.9
active	9540219	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1cc(C=C2SC(=S)NC2=O)ccc1O		CHEMBL1973098	=	Ki	nM	1258.93	CHEMBL5084	Homo sapiens	pKi		5.9
inactive	9540220	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1		CHEMBL1972221	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540221	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540222	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F		CHEMBL1996979	=	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540223	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1968406	=	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540224	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C1C(=NNc2cccc3c(=O)[nH][nH]c(=O)c23)C(c2ccccc2)=NN1c1ccccc1		CHEMBL1984274	=	Ki	nM	1584.89	CHEMBL5084	Homo sapiens	pKi		5.8
inactive	9540225	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1998545	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540226	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1csc(NC(=O)c2sc3nc(-c4ccncc4)ccc3c2N)n1		CHEMBL1986869	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540227	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)c(Cl)ccc12		CHEMBL2006010	=	Ki	nM	3162.28	CHEMBL5084	Homo sapiens	pKi		5.5
inactive	9540228	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682558	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540229	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540230	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccc(Cl)cc5o4)cc3)c1)CNC2=O		CHEMBL2002479	=	Ki	nM	1995.26	CHEMBL5084	Homo sapiens	pKi		5.7
active	9540231	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCCn1c(=O)c2[nH]c(-c3cnn(Cc4cccc(C(F)(F)F)c4)c3)nc2n(CC)c1=O		CHEMBL260933	=	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540232	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(NCc1ccc(Cl)cc1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL1967094	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540233	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL1966035	=	Ki	nM	5011.87	CHEMBL5084	Homo sapiens	pKi		5.3
inactive	9540234	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(NC(CO)c1cc(Cl)cc(Cl)c1)c1ccc(-c2ccncc2)cc1		CHEMBL2003341	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540235	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Oc1cccc(Nc2ncnc3scc(Cl)c23)c1		CHEMBL1982992	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540236	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cc(-c2ccccc2)n(-c2cc(NN=Cc3ccco3)ncn2)n1		CHEMBL1999590	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540237	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1F		CHEMBL1981079	=	Ki	nM	31.62	CHEMBL5084	Homo sapiens	pKi		7.5
inactive	9540238	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCN(CC)CCCNc1cccc(-c2nc3c(C(N)=O)cccc3[nH]2)n1		CHEMBL1972276	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540239	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O		CHEMBL1980489	=	Ki	nM	158.49	CHEMBL5084	Homo sapiens	pKi		6.8
active	9540240	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O		CHEMBL2000832	=	Ki	nM	3162.28	CHEMBL5084	Homo sapiens	pKi		5.5
inactive	9540241	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1nc2ccccn2c1-c1csc(Nc2ccc(O)cc2)n1		CHEMBL513846	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540242	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(NCc1ccc(Br)cc1)Nc1ccc2[nH]ncc2c1		CHEMBL1970709	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540243	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	10.0	CHEMBL5084	Homo sapiens	pKi		8.0
inactive	9540244	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1ccc(-c2cc3nccn3c(Nc3ccccc3C(N)=O)n2)cc1OC		CHEMBL1998112	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540245	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(C)n1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)cc21		CHEMBL1969126	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540246	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12		CHEMBL1980896	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540247	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(=O)NC1CCN(c2nc3[nH]cc(C(=O)O)c(=O)c3c(C)c2F)C1		CHEMBL1975208	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540248	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540249	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1		CHEMBL1991429	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540250	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NC(=O)c1cc2c(Oc3cccc(F)c3)cncc2s1		CHEMBL1964777	=	Ki	nM	1995.26	CHEMBL5084	Homo sapiens	pKi		5.7
inactive	9540251	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1ccc2c(c1)NC(=O)c1ccccc1N2		CHEMBL1999714	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540252	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)C(=O)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1971149	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540253	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(Cc1ccccc1Cl)Nc1ccc2cn[nH]c2c1		CHEMBL1987533	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540254	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1		CHEMBL1994040	=	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540255	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL1967302	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540256	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1cc2cnc3c(c2cc1OC)C(=O)NC3=O		CHEMBL1982506	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540257	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCN(CC)CCNC(=O)C=Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2004716	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540258	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1		CHEMBL1968127	=	Ki	nM	1000.0	CHEMBL5084	Homo sapiens	pKi		6.0
inactive	9540259	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1975233	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540260	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL1985406	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540261	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cn1nc(C(F)(F)F)c2c(=O)c3cc(Cl)ccc3n(O)c21		CHEMBL207400	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540262	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cc(O)ccc1-n1cc(C(=O)NN)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL2000894	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540263	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1ccccc1NC(=O)Nc1ccc2c(c1)CCc1sc3ncnc(N)c3c1-2		CHEMBL1982135	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540264	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Nc1ncnc2c1sc1ncnc(N)c12		CHEMBL1976090	=	Ki	nM	1258.93	CHEMBL5084	Homo sapiens	pKi		5.9
inactive	9540265	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12		CHEMBL1993243	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540266	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3o2)cc1		CHEMBL2004771	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540267	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1997597	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540268	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	S=c1[nH]nc2c3c4c(sc3n3c(=S)[nH]nc3n12)CCC4		CHEMBL1969537	=	Ki	nM	3162.28	CHEMBL5084	Homo sapiens	pKi		5.5
inactive	9540269	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1976093	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540270	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1		CHEMBL1975256	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540271	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1		CHEMBL508928	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540272	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1cccc(-c2cc3c(=O)[nH]c4ccccc4n3c2)c1		CHEMBL1991356	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540273	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1ccc(C(=O)Nc2nc3ccc(Cl)cc3s2)c(OC)c1		CHEMBL1983309	=	Ki	nM	3162.28	CHEMBL5084	Homo sapiens	pKi		5.5
inactive	9540274	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL2004892	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540275	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC1=NN(c2ccccc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1999126	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540276	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(C)Oc1ccc(-c2noc(-c3ccc(NC4CCC(C(=O)O)C4)cc3)n2)cc1Cl		CHEMBL1997503	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540277	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NC(=O)c1cc2c(Oc3ccc(Br)cc3)cncc2s1		CHEMBL116070	=	Ki	nM	794.33	CHEMBL5084	Homo sapiens	pKi		6.1
inactive	9540278	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cc(C)c(C)c(OCCCc2c(C(=O)O)[nH]c3c(-c4ccccc4C)cccc23)c1		CHEMBL1990821	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540279	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NC(=O)c1cc(-c2cccc(N)c2)cc2cccnc12		CHEMBL1970314	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540280	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	OCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL2004871	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540281	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncn3)cc2)c1		CHEMBL2004872	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540282	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C1Nc2ccccc2Nc2ccccc21		CHEMBL1727312	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540283	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC1CCN(C(=O)CO)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1969879	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540284	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(N)COc1cnc(Cl)c(C=Cc2ccncc2)c1		CHEMBL1993548	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540285	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL262433	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540286	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540287	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(NNC(=S)Nc1ccc(Cl)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1966722	=	Ki	nM	1000.0	CHEMBL5084	Homo sapiens	pKi		6.0
inactive	9540288	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O		CHEMBL1975500	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540289	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540290	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(O)c1c2c(nc3ccccc13)C(=C1CCCC1)CC2		CHEMBL1996831	=	Ki	nM	1000.0	CHEMBL5084	Homo sapiens	pKi		6.0
inactive	9540291	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc1)CCN2		CHEMBL411903	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540292	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540293	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL1989646	=	Ki	nM	100.0	CHEMBL5084	Homo sapiens	pKi		7.0
active	9540294	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	=	Ki	nM	158.49	CHEMBL5084	Homo sapiens	pKi		6.8
active	9540295	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1978200	=	Ki	nM	3162.28	CHEMBL5084	Homo sapiens	pKi		5.5
active	9540296	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1cc(C=C2SC(=Nc3ccccc3)NC2=O)ccc1O		CHEMBL1970522	=	Ki	nM	2511.89	CHEMBL5084	Homo sapiens	pKi		5.6
active	9540297	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	=	Ki	nM	1584.89	CHEMBL5084	Homo sapiens	pKi		5.8
inactive	9540298	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(Nc1n[nH]c2nc3ccccc3cc12)c1ccncc1		CHEMBL1990415	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540299	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	C(=Cc1cncc(OC2CCNC2)c1)c1ccncc1		CHEMBL1966087	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540300	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cncc21		CHEMBL1964692	=	Ki	nM	630.96	CHEMBL5084	Homo sapiens	pKi		6.2
inactive	9540301	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(NC(CO)Cc1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1		CHEMBL1996931	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540302	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL1973483	=	Ki	nM	2511.89	CHEMBL5084	Homo sapiens	pKi		5.6
inactive	9540303	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL1970735	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540304	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1		CHEMBL1997340	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540305	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCOC(=O)C1=C(N)n2c(sc(=Cc3cccs3)c2=O)=C(C(N)=O)C1c1cccs1		CHEMBL2004365	=	Ki	nM	1584.89	CHEMBL5084	Homo sapiens	pKi		5.8
inactive	9540306	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540307	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540308	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cn1cc(-c2ccncn2)c(-c2ccc(F)cc2)n1		CHEMBL1989474	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540309	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540310	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1		CHEMBL210887	=	Ki	nM	3981.07	CHEMBL5084	Homo sapiens	pKi		5.4
inactive	9540311	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540312	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(OC(F)(F)F)c4)c3)cc12		CHEMBL1965836	=	Ki	nM	501.19	CHEMBL5084	Homo sapiens	pKi		6.3
inactive	9540313	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C(F)(F)F)c2)c1		CHEMBL1971021	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540314	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12		CHEMBL583144	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540315	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1		CHEMBL1974310	=	Ki	nM	2511.89	CHEMBL5084	Homo sapiens	pKi		5.6
inactive	9540316	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540317	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2ccccc2)cc1CC3		CHEMBL1994693	=	Ki	nM	5011.87	CHEMBL5084	Homo sapiens	pKi		5.3
inactive	9540318	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982957	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540319	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Ki	nM	1000.0	CHEMBL5084	Homo sapiens	pKi		6.0
inactive	9540320	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(NNC(=S)Nc1ccc(F)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1975138	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540321	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC1=NN(c2ccc(C(=O)O)cc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2006836	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540322	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cc2nnc(SCc3cn4ccccc4n3)n2c2ccccc12		CHEMBL1980704	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540323	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1		CHEMBL2003271	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540324	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccncc4)nn12)CCCC3		CHEMBL1966808	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540325	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL2004447	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540326	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540327	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	OCCNc1cc2cc(-c3ccsc3)ccc2cn1		CHEMBL1973860	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540328	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540329	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		CHEMBL220241	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540330	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=S(=O)(O)c1ccc(NCc2ccc3c(c2)OCO3)c2c(O)cccc12		CHEMBL2004544	=	Ki	nM	1995.26	CHEMBL5084	Homo sapiens	pKi		5.7
inactive	9540331	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=c1[nH]cc(I)c2nc(-c3cccc(Cl)c3)cn12		CHEMBL1982610	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540332	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cccc(C2(c3cccc(C)c3)CC2C(=O)Nc2ccncc2)c1		CHEMBL1999496	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540333	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Nc1ccc(-c2csc3c(C=Cc4nc5ccccc5[nH]4)cnc(N)c23)cc1		CHEMBL1988300	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540334	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC		CHEMBL1991078	=	Ki	nM	79.43	CHEMBL5084	Homo sapiens	pKi		7.1
inactive	9540335	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCCCNc1ccc2c3c(cccc13)C(=O)N(CCNCCO)C2=O		CHEMBL1987359	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540336	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540337	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)cc3n21		CHEMBL1989265	=	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540338	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	10.0	CHEMBL5084	Homo sapiens	pKi		8.0
active	9540339	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C1NN=Cc2c[nH]c3cc(NC(=O)C4CC4c4ccccc4)cc1c23		CHEMBL1969502	=	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540340	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540341	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cccc(-c2c(-c3ccncc3)nc(NCC(N)Cc3ccccc3)n(C)c2=O)c1		CHEMBL1971430	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540342	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1ccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL1997764	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540343	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL1983963	=	Ki	nM	2511.89	CHEMBL5084	Homo sapiens	pKi		5.6
active	9540344	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1		CHEMBL1985092	=	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540345	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1ccccc1		CHEMBL2004692	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540346	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CNc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL1981410	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540347	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1		CHEMBL1996234	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540348	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1ccc(C=C2C(=O)ON=C2c2ccc(Br)cc2)cc1OC		CHEMBL1991434	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540349	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12		CHEMBL1967544	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540350	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL340384	=	Ki	nM	2511.89	CHEMBL5084	Homo sapiens	pKi		5.6
inactive	9540351	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1996587	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540352	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CS(=O)(=O)NCCOc1cncc(-c2ccc3cnccc3c2)c1		CHEMBL1964804	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540353	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O		CHEMBL2000354	=	Ki	nM	3981.07	CHEMBL5084	Homo sapiens	pKi		5.4
inactive	9540354	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1965507	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540355	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCCC(=O)Nc1n[nH]c2nc3ccccc3cc12		CHEMBL1967564	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540356	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540357	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL2000071	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540358	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1ccc2c(NC(=O)Nc3cc(C(F)(F)F)ccn3)ccnc2c1		CHEMBL1979176	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540359	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc2c(C)n1		CHEMBL2000408	=	Ki	nM	3981.07	CHEMBL5084	Homo sapiens	pKi		5.4
active	9540360	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1		CHEMBL1978014	=	Ki	nM	630.96	CHEMBL5084	Homo sapiens	pKi		6.2
inactive	9540361	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1994538	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540362	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCN(CC)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1983195	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540363	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1975490	=	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540364	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1964444	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540365	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Clc1csc2ncnc(Nc3ccccc3)c12		CHEMBL1986139	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540366	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)cccc12		CHEMBL1980540	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540367	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	=	Ki	nM	5011.87	CHEMBL5084	Homo sapiens	pKi		5.3
active	9540368	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C(C)(C)C		CHEMBL1986186	=	Ki	nM	501.19	CHEMBL5084	Homo sapiens	pKi		6.3
inactive	9540369	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1n[nH]c2c1C(c1ccccc1Cl)C(C#N)=C(N)O2		CHEMBL1970189	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540370	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540371	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Nc1ncnc2c1c(I)nn2C1CCC(O)CC1		CHEMBL1996791	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540372	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1ccc(C=NNc2ncnc3c2[nH]c2ccccc23)cc1OC		CHEMBL1974664	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540373	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540374	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1974288	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540375	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	=	Ki	nM	5011.87	CHEMBL5084	Homo sapiens	pKi		5.3
inactive	9540376	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC		CHEMBL1190711	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540377	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540378	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1		CHEMBL1966343	=	Ki	nM	1584.89	CHEMBL5084	Homo sapiens	pKi		5.8
active	9540379	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	=	Ki	nM	794.33	CHEMBL5084	Homo sapiens	pKi		6.1
active	9540380	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	=	Ki	nM	3162.28	CHEMBL5084	Homo sapiens	pKi		5.5
inactive	9540381	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540382	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)cc1C		CHEMBL2000335	=	Ki	nM	2511.89	CHEMBL5084	Homo sapiens	pKi		5.6
inactive	9540383	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)c(F)c3n21		CHEMBL1977604	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540384	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540385	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cn1cc(-c2cnn3c(N)c(-c4ccc(NC(=O)Nc5cccc(C(F)(F)F)c5)cc4)cnc23)cn1		CHEMBL1988717	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540386	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	=	Ki	nM	2511.89	CHEMBL5084	Homo sapiens	pKi		5.6
inactive	9540387	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540388	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1		CHEMBL1973808	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540389	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2000429	=	Ki	nM	3162.28	CHEMBL5084	Homo sapiens	pKi		5.5
inactive	9540390	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1ccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)cc1		CHEMBL1972576	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540391	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540392	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(NN=Cc1ccc(Sc2nc3ccccc3[nH]2)o1)c1cccc([N+](=O)[O-])c1		CHEMBL1992555	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540393	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1992342	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540394	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cc(Cl)ccc1NC(=S)NNC(=O)C(O)(c1ccccc1)c1ccccc1		CHEMBL1988173	=	Ki	nM	316.23	CHEMBL5084	Homo sapiens	pKi		6.5
inactive	9540395	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	C(=NNc1nc2ccccc2[nH]1)c1c[nH]c2ccccc12		CHEMBL535331	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540396	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	N#CC1=C(N)n2c(sc(=Cc3ccco3)c2=O)=C(C(N)=O)C1c1ccco1		CHEMBL1989805	=	Ki	nM	1584.89	CHEMBL5084	Homo sapiens	pKi		5.8
inactive	9540397	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL1965423	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540398	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(C)=C(C)c1cccc2c(CCCOc3cccc(Cl)c3Cl)c(C(=O)O)[nH]c12		CHEMBL1982980	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540399	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540400	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(NCc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1977135	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540401	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C1NC(=S)SC1=C1C(=O)Nc2ccc(Br)cc21		CHEMBL2001920	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540402	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	=	Ki	nM	158.49	CHEMBL5084	Homo sapiens	pKi		6.8
inactive	9540403	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NCCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1972258	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540404	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	=	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540405	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1ccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)cc1		CHEMBL1992536	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540406	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1ccccc1-c1c(C(=O)O)n(CCCOc2cccc3ccccc23)c2ccccc12		CHEMBL1987793	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540407	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1cccc(Cl)c1		CHEMBL1973348	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540408	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	OCCCn1cnc(-c2ccccc2)c1-c1ccncc1		CHEMBL2002373	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540409	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2NCCCN)c1		CHEMBL2006188	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540410	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1967531	=	Ki	nM	1000.0	CHEMBL5084	Homo sapiens	pKi		6.0
inactive	9540411	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1		CHEMBL1973893	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540412	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCCC(=O)Nc1nn(C(=O)CC)c2nc3ccccc3cc12		CHEMBL1970913	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540413	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCOC(=O)c1cccc2[nH]c(-c3ccc(N4CCC(N)C4)cc3)nc12		CHEMBL1995736	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540414	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1cccc(C(C)NC(=O)c2cc(C)c(-c3ccc4[nH]nc(C)c4c3)s2)c1		CHEMBL1997534	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540415	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540416	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540417	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NC(=O)Cn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL1985095	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540418	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1977374	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540419	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(C)(O)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1998551	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540420	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	<	Ki	nM	3981.07	CHEMBL5084	Homo sapiens	pKi		5.4
active	9540421	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1		CHEMBL1682540	=	Ki	nM	1584.89	CHEMBL5084	Homo sapiens	pKi		5.8
inactive	9540422	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12		CHEMBL1976420	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540423	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1		CHEMBL1994864	=	Ki	nM	251.19	CHEMBL5084	Homo sapiens	pKi		6.6
active	9540424	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1		CHEMBL497151	=	Ki	nM	1995.26	CHEMBL5084	Homo sapiens	pKi		5.7
inactive	9540425	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246970	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540426	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL340921	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540427	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	N#Cc1ccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)nc1		CHEMBL1999718	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540428	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C1Nc2ccc3ncsc3c2C1=CNc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1973540	=	Ki	nM	1584.89	CHEMBL5084	Homo sapiens	pKi		5.8
inactive	9540429	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C1Nc2ccccc2Nc2nnc(I)cc21		CHEMBL1977346	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540430	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL1971649	=	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540431	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	OCCNc1cc2cc(-c3ccncc3)ccc2cn1		CHEMBL1998435	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9540432	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1		CHEMBL2006439	=	Ki	nM	31.62	CHEMBL5084	Homo sapiens	pKi		7.5
active	9540433	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(C)N(C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1)C(C)C		CHEMBL2006156	=	Ki	nM	3162.28	CHEMBL5084	Homo sapiens	pKi		5.5
inactive	9540434	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1ccc(-c2ccc(NC(=O)Nc3cc(F)cc(F)c3)cc2)c2c(N)noc12		CHEMBL1969190	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9540435	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12		CHEMBL1973937	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544334	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9544335	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	=	Ki	nM	5011.87	CHEMBL5084	Homo sapiens	pKi		5.3
active	9544336	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	=	Ki	nM	1584.89	CHEMBL5084	Homo sapiens	pKi		5.8
inactive	9544337	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1ccc(Cl)cc1		CHEMBL1998829	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544338	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cnc(Nc2cccc(S(N)(=O)=O)c2)nc1Nc1ccc(OCC(N)=O)cc1		CHEMBL1988838	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544339	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccc(C(=O)Nc6ccccc6F)c5)nc5ccccn45)n3)cc2)CC1		CHEMBL1981725	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544340	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1		CHEMBL1982866	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544341	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	c1ccc(CSc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL1968926	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544342	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Nc1c(-c2ccccc2)c2cc(Cl)ccc2[nH]c1=O		CHEMBL462120	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9544343	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12		CHEMBL1965570	=	Ki	nM	1584.89	CHEMBL5084	Homo sapiens	pKi		5.8
inactive	9544344	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccccc4)nn12)CCCC3		CHEMBL2007592	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544345	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544346	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3F)c2-c2ccncn2)CC1		CHEMBL1614705	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544347	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)s2)c1		CHEMBL1984633	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544348	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544349	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CNc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2007372	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544350	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1cccc(C(C)NC(=O)N2CC=C(c3c[nH]c4ncccc34)CC2)c1		CHEMBL1965845	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544351	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1)c1c(F)cccc1F		CHEMBL2006715	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544352	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NC(=O)c1cccc2[nH]c(-c3ccc(NC(=O)c4cccc(S(=O)(=O)N5CCOCC5)c4)cc3)nc12		CHEMBL1986597	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544353	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9544354	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1		CHEMBL1990904	=	Ki	nM	1000.0	CHEMBL5084	Homo sapiens	pKi		6.0
inactive	9544355	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544356	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL2005475	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9544357	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	=	Ki	nM	1584.89	CHEMBL5084	Homo sapiens	pKi		5.8
inactive	9544358	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2C)c1		CHEMBL183844	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9544359	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC1=NN(c2ccc(Cl)c(Cl)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1997349	=	Ki	nM	1258.93	CHEMBL5084	Homo sapiens	pKi		5.9
inactive	9544360	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL220057	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544361	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682545	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9544362	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1974935	=	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544363	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL2001224	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544364	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544365	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(C)(O)Cc1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1976732	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544366	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(NC(CO)c1ccccc1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1964937	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544367	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(S(N)(=O)=O)cc4)c(=O)c3=O)ccc21		CHEMBL1969506	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544368	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	c1ccc(COc2ccc(Nc3ncnc4ccccc34)cc2)cc1		CHEMBL1980163	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9544369	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(=O)N(c1ccncc1)c1c(NC(C)C(C)(C)C)c(=O)c1=O		CHEMBL2005899	=	Ki	nM	630.96	CHEMBL5084	Homo sapiens	pKi		6.2
active	9544370	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	=	Ki	nM	794.33	CHEMBL5084	Homo sapiens	pKi		6.1
inactive	9544371	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1cncc(C=Cc2ccncc2)c1		CHEMBL1972568	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9544372	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12		CHEMBL1974870	=	Ki	nM	251.19	CHEMBL5084	Homo sapiens	pKi		6.6
active	9544373	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1		CHEMBL2002702	=	Ki	nM	3981.07	CHEMBL5084	Homo sapiens	pKi		5.4
active	9544374	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL1970903	=	Ki	nM	100.0	CHEMBL5084	Homo sapiens	pKi		7.0
inactive	9544375	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1988995	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9544376	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1		CHEMBL1986781	=	Ki	nM	316.23	CHEMBL5084	Homo sapiens	pKi		6.5
active	9544377	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=c1nc(-c2ccc3[nH]ncc3c2)cc(-c2ccccc2)[nH]1		CHEMBL526133	=	Ki	nM	1584.89	CHEMBL5084	Homo sapiens	pKi		5.8
inactive	9544378	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544379	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1		CHEMBL387971	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544380	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3[nH]2)cc1		CHEMBL1979057	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544381	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1999428	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544382	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1		CHEMBL211378	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544383	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9544384	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccco2)C(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL2001751	=	Ki	nM	1258.93	CHEMBL5084	Homo sapiens	pKi		5.9
inactive	9544385	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(NCCCCCCNC(=O)NCc1cccnc1)NCc1cccnc1		CHEMBL2003420	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9544386	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL1984586	=	Ki	nM	3162.28	CHEMBL5084	Homo sapiens	pKi		5.5
inactive	9544387	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1c(O)ccc2c1CCCC2=NNC(=O)Cc1cccc2ccccc12		CHEMBL1972659	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544388	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1Cl		CHEMBL272453	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544389	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3C)cc2)c1		CHEMBL1970217	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544390	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCOC(=O)c1ccc2[nH]c3c(c2c1)CCNC3=O		CHEMBL2005528	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544391	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1		CHEMBL185569	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9544392	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	c1cc2[nH]ncc2cc1-c1cn(CC2CCOCC2)nn1		CHEMBL1969843	=	Ki	nM	158.49	CHEMBL5084	Homo sapiens	pKi		6.8
inactive	9544393	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O		CHEMBL2007002	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9544394	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	=	Ki	nM	31.62	CHEMBL5084	Homo sapiens	pKi		7.5
inactive	9544395	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CN1CCC(NC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)CC1		CHEMBL1987007	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9544396	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Clc1cc(-c2c[nH]c3ncccc23)cc(NCc2ccccc2)n1		CHEMBL1969588	=	Ki	nM	19.95	CHEMBL5084	Homo sapiens	pKi		7.7
active	9544397	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	=	Ki	nM	1995.26	CHEMBL5084	Homo sapiens	pKi		5.7
inactive	9544398	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9544399	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL484390	=	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9544400	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O		CHEMBL1979252	=	Ki	nM	501.19	CHEMBL5084	Homo sapiens	pKi		6.3
active	9544401	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1986499	=	Ki	nM	1258.93	CHEMBL5084	Homo sapiens	pKi		5.9
inactive	9544402	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544403	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1cccc(C=C2SC(=Nc3ccccc3)NC2=O)c1		CHEMBL1972937	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544404	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21		CHEMBL2000393	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544405	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C)c2)c1		CHEMBL2004311	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544406	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Brc1cnc2[nH]cc(-c3ccccc3)c2c1		CHEMBL1992634	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544407	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1242373	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544408	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1ccc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1988075	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544409	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL316264	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9544410	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Nc1ncnc(Nc2cc(CNC(=O)C(F)(F)F)c(O)c(-c3ccc(Cl)cc3)c2)n1		CHEMBL2001239	=	Ki	nM	2511.89	CHEMBL5084	Homo sapiens	pKi		5.6
inactive	9544411	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Nc1ncnc2scc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1988594	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544412	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O		CHEMBL2001288	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544413	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9544414	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12		CHEMBL1999811	=	Ki	nM	1584.89	CHEMBL5084	Homo sapiens	pKi		5.8
inactive	9544415	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CSc1ccc2nc3c(c(Cl)c2c1)CCNC3=O		CHEMBL1985074	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544416	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Nc1nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc2n1CC1CC1		CHEMBL1982874	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544417	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL2000481	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544418	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1991725	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544419	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2007296	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9544420	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3[nH]ncc3c2)n1		CHEMBL396523	=	Ki	nM	158.49	CHEMBL5084	Homo sapiens	pKi		6.8
inactive	9544421	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544422	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cc(C)cc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1970203	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544423	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=c1c(NCCc2ccc(Oc3ccccc3)cc2)c(Nc2ccncc2)c1=O		CHEMBL1999321	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544424	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(c1cc(Cc2n[nH]c(=O)c3c2CCCC3)ccc1F)N1CCN(c2ncccn2)CC1		CHEMBL1986530	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544425	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4sc(C)nc4c3)csc12		CHEMBL1968590	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9544426	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL2005375	=	Ki	nM	3162.28	CHEMBL5084	Homo sapiens	pKi		5.5
inactive	9544427	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl		CHEMBL1984191	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544428	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CN1CCCC1COc1cncc(CCc2ccccc2)c1		CHEMBL1972183	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544429	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL394790	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9544430	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1996111	=	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544431	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1		CHEMBL1974702	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544432	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1965589	<	Ki	nM	5011.87	CHEMBL5084	Homo sapiens	pKi		5.3
inactive	9544433	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(NCCCCCCNC(=O)Nc1cccnc1)Nc1cccnc1		CHEMBL1998193	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9544434	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1nnc(-c2cc3c(Oc4ccc(C(F)(F)F)cc4)cncc3s2)o1		CHEMBL1988153	=	Ki	nM	501.19	CHEMBL5084	Homo sapiens	pKi		6.3
inactive	9544435	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544436	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9544437	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NCCC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL1998121	=	Ki	nM	794.33	CHEMBL5084	Homo sapiens	pKi		6.1
inactive	9544438	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL52387	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544439	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1nn(-c2ccccc2)c2c1c(=O)c1cc(Cl)ccc1n2O		CHEMBL379835	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544440	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21		CHEMBL1979357	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544441	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1996817	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544442	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2ccncc2)c1-c1ccccc1		CHEMBL1419458	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544443	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544444	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL468280	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544445	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cc(C)c2oc(Nc3ccc(-c4cccc(C(N)=O)c4N)cc3F)nc2c1		CHEMBL1990884	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9544446	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	=	Ki	nM	501.19	CHEMBL5084	Homo sapiens	pKi		6.3
inactive	9544447	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL256835	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544448	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1980142	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544449	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL41783	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544450	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1cccc2c1Nc1cc(Nc3ccncc3)ccc1C(=O)N2		CHEMBL2006276	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544451	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12		CHEMBL271381	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544452	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL2006785	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544453	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1982466	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9544454	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	630.96	CHEMBL5084	Homo sapiens	pKi		6.2
active	9544455	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1995832	=	Ki	nM	3162.28	CHEMBL5084	Homo sapiens	pKi		5.5
active	9544456	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1n[nH]c2sc(C(=O)NCCc3ccc(Cl)cc3)cc12		CHEMBL1998414	=	Ki	nM	501.19	CHEMBL5084	Homo sapiens	pKi		6.3
inactive	9544457	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Oc1ccc(Nc2[nH]nc(-c3ccc(O)cc3)c2-c2ccc(O)cc2)cc1		CHEMBL1969042	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9544458	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccccc1		CHEMBL1999931	=	Ki	nM	7.943	CHEMBL5084	Homo sapiens	pKi		8.1
inactive	9544459	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1375418	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544460	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL2007064	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544461	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9544462	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccc(Cl)c(Cl)c4)c3)cc12		CHEMBL1991063	=	Ki	nM	158.49	CHEMBL5084	Homo sapiens	pKi		6.8
inactive	9544463	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1cccc(C(CN)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1976240	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544464	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(C)c3)cc2)c2c(N)noc12		CHEMBL1979093	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544465	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=c1[nH]c2sccc2c2nc(-c3ccncc3)nn12		CHEMBL1968151	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9544466	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1cccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)c1		CHEMBL1987009	=	Ki	nM	3162.28	CHEMBL5084	Homo sapiens	pKi		5.5
active	9544467	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12		CHEMBL2002726	=	Ki	nM	501.19	CHEMBL5084	Homo sapiens	pKi		6.3
inactive	9544468	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(Nc1cnccn1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL2003817	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9544469	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1		CHEMBL1994830	=	Ki	nM	100.0	CHEMBL5084	Homo sapiens	pKi		7.0
inactive	9544470	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12		CHEMBL1994938	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544471	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544472	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NCCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL1966279	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9544473	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1		CHEMBL1997846	=	Ki	nM	1995.26	CHEMBL5084	Homo sapiens	pKi		5.7
inactive	9544474	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2004419	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544475	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(Nc1ccc2cn[nH]c2c1)c1ccc(Cl)cc1		CHEMBL1972489	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544476	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Brc1ccc2[nH]nc(-c3ccccc3)c2c1		CHEMBL1994074	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544477	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(Nc1cccc(N2CCOCC2)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1972119	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544478	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1090356	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544479	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9544480	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CN(C)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1986328	=	Ki	nM	2511.89	CHEMBL5084	Homo sapiens	pKi		5.6
active	9544481	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(C(F)(F)F)cc12		CHEMBL1976455	=	Ki	nM	2511.89	CHEMBL5084	Homo sapiens	pKi		5.6
active	9544482	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=c1c(NCc2ccccc2F)c(Nc2ccncc2)c1=O		CHEMBL1982361	=	Ki	nM	125.89	CHEMBL5084	Homo sapiens	pKi		6.9
inactive	9544483	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	c1ccc(CNc2nc3ccc(-c4ccncc4)cc3s2)cc1		CHEMBL1983534	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544484	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544485	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9544486	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	OCCC(Nc1nc2ccc(-c3ccncc3)cc2s1)c1ccccc1		CHEMBL1982122	=	Ki	nM	1584.89	CHEMBL5084	Homo sapiens	pKi		5.8
inactive	9544487	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL2000801	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544488	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1		CHEMBL1999112	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544489	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682546	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9544490	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1991395	=	Ki	nM	3981.07	CHEMBL5084	Homo sapiens	pKi		5.4
inactive	9544491	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CN1CCN(c2cccc(Nc3nccc(-c4c(C(N)=O)nc5ccccn45)n3)c2)CC1		CHEMBL1971245	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544492	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL1972142	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9544493	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(F)c1		CHEMBL2003638	=	Ki	nM	19.95	CHEMBL5084	Homo sapiens	pKi		7.7
active	9544494	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	N#Cc1ccc2nc(N)n(-c3nc(-c4ccccc4)cs3)c2c1		CHEMBL1996066	=	Ki	nM	39.81	CHEMBL5084	Homo sapiens	pKi		7.4
inactive	9544495	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=c1[nH]c2sc3c(c2c2nc(-c4cccnc4)nn12)CCCC3		CHEMBL1970806	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9544496	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1nc(COc2ccccc2Cl)sc1-c1ccnc(N)n1		CHEMBL1375640	=	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544497	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CN1CCN(CCCNc2cccc(-c3nc4c(C(N)=O)cccc4[nH]3)n2)CC1		CHEMBL2006237	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9544498	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(C)(C(N)=O)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1967720	=	Ki	nM	5011.87	CHEMBL5084	Homo sapiens	pKi		5.3
inactive	9544499	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NC1C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)CC12		CHEMBL1624529	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544500	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1F		CHEMBL1969755	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544501	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1979516	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544502	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Nc1nccn2c(C3CC(CN4CCCC4)C3)nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1991138	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544503	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(O)c1ccc(N2C(=O)c3ccccc3C2=O)cc1O		CHEMBL1972820	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544504	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	NNc1cc(N2CCOCC2)nc(OCCc2ccccn2)n1		CHEMBL1996208	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544505	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12		CHEMBL1989029	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9544506	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CSc1ccccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1		CHEMBL392642	=	Ki	nM	3981.07	CHEMBL5084	Homo sapiens	pKi		5.4
active	9544507	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1ccccc1NC(=O)Nc1ccc(NC(=O)c2csc3ncnc(N)c23)cc1		CHEMBL1980144	=	Ki	nM	5011.87	CHEMBL5084	Homo sapiens	pKi		5.3
inactive	9544508	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2OC)c1		CHEMBL1991188	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544509	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1972849	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544510	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL231209	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544511	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12		CHEMBL1976220	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544512	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CN1CCN(C2CCC(n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1997617	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544513	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9544514	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CCN)nccn23)n1		CHEMBL1982383	=	Ki	nM	1258.93	CHEMBL5084	Homo sapiens	pKi		5.9
active	9544515	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CCCCn1c(NC(=O)c2cccc(C#N)c2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL1969301	=	Ki	nM	794.33	CHEMBL5084	Homo sapiens	pKi		6.1
active	9544516	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17370	=	Ki	nM	3981.07	CHEMBL5084	Homo sapiens	pKi		5.4
inactive	9544517	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)c12		CHEMBL1987910	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544518	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1ccc2c(NC(=O)Nc3cccc(Br)n3)ccnc2c1		CHEMBL1983932	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544519	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544520	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL1991285	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544521	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544522	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
active	9544523	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1		CHEMBL243088	=	Ki	nM	251.19	CHEMBL5084	Homo sapiens	pKi		6.6
inactive	9544524	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544525	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1cccc(F)c1F		CHEMBL1974416	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544526	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	Cc1nn(C)c(C)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)O)[nH]c12		CHEMBL1984039	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544527	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	CSc1nn(-c2ccccn2)c(N)c1C(N)=O		CHEMBL2004615	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544528	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
inactive	9544529	CHEMBL1964116	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3	F	O=C(c1cccc(-c2cnc3[nH]ccc3c2)c1)N1CCOCC1		CHEMBL1997872	<	Ki	nM	6309.57	CHEMBL5084	Homo sapiens	pKi		5.2
	10838679	CHEMBL2014905	Inhibition of CK1g3 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	53.0	CHEMBL5084	Homo sapiens	INH	%	53.0
	10850641	CHEMBL2019919	Inhibition of human CK1gamma3 at 10 uM	B	O=C(c1ccc(-c2ccc(Cl)cc2)o1)N(Cc1ccccn1)c1ccc(N2CCNCC2)cc1		CHEMBL1938681	>	Inhibition	%	50.0	CHEMBL5084	Homo sapiens	INH	%	50.0
	12046270	CHEMBL2156507	Inhibition of CK1gamma3 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	-4.1	CHEMBL5084	Homo sapiens	INH	%	-4.1
	12173673	CHEMBL2209309	Inhibition of CSNK1G3 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	26.0	CHEMBL5084	Homo sapiens	Activity	%	26.0
	12183900	CHEMBL2211486	Inhibition of CSNK1G3	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL5084	Homo sapiens	pIC50		5.0
	12207901	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	109.0	CHEMBL5084	Homo sapiens	Residual Activity	%	109.0
	12207902	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	61.0	CHEMBL5084	Homo sapiens	Residual Activity	%	61.0
	12207903	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	76.0	CHEMBL5084	Homo sapiens	Residual Activity	%	76.0
	12207904	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	85.0	CHEMBL5084	Homo sapiens	Residual Activity	%	85.0
	12207905	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	74.0	CHEMBL5084	Homo sapiens	Residual Activity	%	74.0
	12207906	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	131.0	CHEMBL5084	Homo sapiens	Residual Activity	%	131.0
	12207907	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	108.0	CHEMBL5084	Homo sapiens	Residual Activity	%	108.0
	12207908	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	48.0	CHEMBL5084	Homo sapiens	Residual Activity	%	48.0
	12207909	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	32.0	CHEMBL5084	Homo sapiens	Residual Activity	%	32.0
	12207910	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	35.0	CHEMBL5084	Homo sapiens	Residual Activity	%	35.0
	12207911	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	97.0	CHEMBL5084	Homo sapiens	Residual Activity	%	97.0
	12207912	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	102.0	CHEMBL5084	Homo sapiens	Residual Activity	%	102.0
	12207913	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	25.0	CHEMBL5084	Homo sapiens	Residual Activity	%	25.0
	12207914	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	105.0	CHEMBL5084	Homo sapiens	Residual Activity	%	105.0
	12207915	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	75.0	CHEMBL5084	Homo sapiens	Residual Activity	%	75.0
	12207916	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	82.0	CHEMBL5084	Homo sapiens	Residual Activity	%	82.0
	12207917	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	51.0	CHEMBL5084	Homo sapiens	Residual Activity	%	51.0
	12207918	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	20.0	CHEMBL5084	Homo sapiens	Residual Activity	%	20.0
	12207919	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	90.0	CHEMBL5084	Homo sapiens	Residual Activity	%	90.0
	12207920	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	95.0	CHEMBL5084	Homo sapiens	Residual Activity	%	95.0
	12207921	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	88.0	CHEMBL5084	Homo sapiens	Residual Activity	%	88.0
	12207922	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	65.0	CHEMBL5084	Homo sapiens	Residual Activity	%	65.0
	12207923	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	29.0	CHEMBL5084	Homo sapiens	Residual Activity	%	29.0
	12207924	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	66.0	CHEMBL5084	Homo sapiens	Residual Activity	%	66.0
	12207925	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	63.0	CHEMBL5084	Homo sapiens	Residual Activity	%	63.0
	12207926	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	36.0	CHEMBL5084	Homo sapiens	Residual Activity	%	36.0
	12207927	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	14.0	CHEMBL5084	Homo sapiens	Residual Activity	%	14.0
	12207928	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	75.0	CHEMBL5084	Homo sapiens	Residual Activity	%	75.0
	12207929	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	83.0	CHEMBL5084	Homo sapiens	Residual Activity	%	83.0
	12207930	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	69.0	CHEMBL5084	Homo sapiens	Residual Activity	%	69.0
	12207931	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	54.0	CHEMBL5084	Homo sapiens	Residual Activity	%	54.0
	12207932	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	68.0	CHEMBL5084	Homo sapiens	Residual Activity	%	68.0
	12207933	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	70.0	CHEMBL5084	Homo sapiens	Residual Activity	%	70.0
	12207934	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	14.0	CHEMBL5084	Homo sapiens	Residual Activity	%	14.0
	12207935	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	106.0	CHEMBL5084	Homo sapiens	Residual Activity	%	106.0
	12207936	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	69.0	CHEMBL5084	Homo sapiens	Residual Activity	%	69.0
	12207937	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	54.0	CHEMBL5084	Homo sapiens	Residual Activity	%	54.0
	12207938	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	78.0	CHEMBL5084	Homo sapiens	Residual Activity	%	78.0
	12207939	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	73.0	CHEMBL5084	Homo sapiens	Residual Activity	%	73.0
	12207940	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	65.0	CHEMBL5084	Homo sapiens	Residual Activity	%	65.0
	12207941	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	135.0	CHEMBL5084	Homo sapiens	Residual Activity	%	135.0
	12207942	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	49.0	CHEMBL5084	Homo sapiens	Residual Activity	%	49.0
	12207943	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	11.0	CHEMBL5084	Homo sapiens	Residual Activity	%	11.0
	12207944	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	71.0	CHEMBL5084	Homo sapiens	Residual Activity	%	71.0
	12207945	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	58.0	CHEMBL5084	Homo sapiens	Residual Activity	%	58.0
	12207946	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	26.0	CHEMBL5084	Homo sapiens	Residual Activity	%	26.0
	12207947	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	39.0	CHEMBL5084	Homo sapiens	Residual Activity	%	39.0
	12207948	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	71.0	CHEMBL5084	Homo sapiens	Residual Activity	%	71.0
	12207949	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	96.0	CHEMBL5084	Homo sapiens	Residual Activity	%	96.0
	12207950	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	62.0	CHEMBL5084	Homo sapiens	Residual Activity	%	62.0
	12207951	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	93.0	CHEMBL5084	Homo sapiens	Residual Activity	%	93.0
	12207952	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	21.0	CHEMBL5084	Homo sapiens	Residual Activity	%	21.0
	12207953	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	68.0	CHEMBL5084	Homo sapiens	Residual Activity	%	68.0
	12207954	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	49.0	CHEMBL5084	Homo sapiens	Residual Activity	%	49.0
	12207955	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	20.0	CHEMBL5084	Homo sapiens	Residual Activity	%	20.0
	12207956	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	70.0	CHEMBL5084	Homo sapiens	Residual Activity	%	70.0
	12207957	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	83.0	CHEMBL5084	Homo sapiens	Residual Activity	%	83.0
	12207958	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	41.0	CHEMBL5084	Homo sapiens	Residual Activity	%	41.0
	12207959	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	74.0	CHEMBL5084	Homo sapiens	Residual Activity	%	74.0
	12207960	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	71.0	CHEMBL5084	Homo sapiens	Residual Activity	%	71.0
	12207961	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	107.0	CHEMBL5084	Homo sapiens	Residual Activity	%	107.0
	12207962	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	48.0	CHEMBL5084	Homo sapiens	Residual Activity	%	48.0
	12207963	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	91.0	CHEMBL5084	Homo sapiens	Residual Activity	%	91.0
	12207964	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	83.0	CHEMBL5084	Homo sapiens	Residual Activity	%	83.0
	12207965	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	86.0	CHEMBL5084	Homo sapiens	Residual Activity	%	86.0
	12207966	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	13.0	CHEMBL5084	Homo sapiens	Residual Activity	%	13.0
	12207967	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	58.0	CHEMBL5084	Homo sapiens	Residual Activity	%	58.0
	12207968	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	93.0	CHEMBL5084	Homo sapiens	Residual Activity	%	93.0
	12207969	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	51.0	CHEMBL5084	Homo sapiens	Residual Activity	%	51.0
	12207970	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	44.0	CHEMBL5084	Homo sapiens	Residual Activity	%	44.0
	12207971	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	36.0	CHEMBL5084	Homo sapiens	Residual Activity	%	36.0
	12207972	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	11.0	CHEMBL5084	Homo sapiens	Residual Activity	%	11.0
	12207973	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	73.0	CHEMBL5084	Homo sapiens	Residual Activity	%	73.0
	12207974	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	69.0	CHEMBL5084	Homo sapiens	Residual Activity	%	69.0
	12207975	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	73.0	CHEMBL5084	Homo sapiens	Residual Activity	%	73.0
	12207976	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	66.0	CHEMBL5084	Homo sapiens	Residual Activity	%	66.0
	12207977	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	86.0	CHEMBL5084	Homo sapiens	Residual Activity	%	86.0
	12207978	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	13.0	CHEMBL5084	Homo sapiens	Residual Activity	%	13.0
	12207979	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	56.0	CHEMBL5084	Homo sapiens	Residual Activity	%	56.0
	12207980	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	60.0	CHEMBL5084	Homo sapiens	Residual Activity	%	60.0
	12207981	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	65.0	CHEMBL5084	Homo sapiens	Residual Activity	%	65.0
	12207982	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	79.0	CHEMBL5084	Homo sapiens	Residual Activity	%	79.0
	12207983	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	73.0	CHEMBL5084	Homo sapiens	Residual Activity	%	73.0
	12207984	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	28.0	CHEMBL5084	Homo sapiens	Residual Activity	%	28.0
	12207985	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	37.0	CHEMBL5084	Homo sapiens	Residual Activity	%	37.0
	12207986	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	48.0	CHEMBL5084	Homo sapiens	Residual Activity	%	48.0
	12207987	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	34.0	CHEMBL5084	Homo sapiens	Residual Activity	%	34.0
	12207988	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	13.0	CHEMBL5084	Homo sapiens	Residual Activity	%	13.0
	12207989	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	59.0	CHEMBL5084	Homo sapiens	Residual Activity	%	59.0
	12207990	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	42.0	CHEMBL5084	Homo sapiens	Residual Activity	%	42.0
	12207991	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	82.0	CHEMBL5084	Homo sapiens	Residual Activity	%	82.0
	12207992	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	13.0	CHEMBL5084	Homo sapiens	Residual Activity	%	13.0
	12207993	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	99.0	CHEMBL5084	Homo sapiens	Residual Activity	%	99.0
	12207994	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	69.0	CHEMBL5084	Homo sapiens	Residual Activity	%	69.0
	12207995	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	7.0	CHEMBL5084	Homo sapiens	Residual Activity	%	7.0
	12207996	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	17.0	CHEMBL5084	Homo sapiens	Residual Activity	%	17.0
	12207997	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	63.0	CHEMBL5084	Homo sapiens	Residual Activity	%	63.0
	12207998	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	31.0	CHEMBL5084	Homo sapiens	Residual Activity	%	31.0
	12207999	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	73.0	CHEMBL5084	Homo sapiens	Residual Activity	%	73.0
	12208000	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	50.0	CHEMBL5084	Homo sapiens	Residual Activity	%	50.0
	12208001	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	16.0	CHEMBL5084	Homo sapiens	Residual Activity	%	16.0
	12208002	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	69.0	CHEMBL5084	Homo sapiens	Residual Activity	%	69.0
	12208003	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	11.0	CHEMBL5084	Homo sapiens	Residual Activity	%	11.0
	12208004	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	28.0	CHEMBL5084	Homo sapiens	Residual Activity	%	28.0
	12208005	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	36.0	CHEMBL5084	Homo sapiens	Residual Activity	%	36.0
	12208006	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	66.0	CHEMBL5084	Homo sapiens	Residual Activity	%	66.0
	12208007	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	86.0	CHEMBL5084	Homo sapiens	Residual Activity	%	86.0
	12208008	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	45.0	CHEMBL5084	Homo sapiens	Residual Activity	%	45.0
	12208009	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	25.0	CHEMBL5084	Homo sapiens	Residual Activity	%	25.0
	12208010	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	47.0	CHEMBL5084	Homo sapiens	Residual Activity	%	47.0
	12208011	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	66.0	CHEMBL5084	Homo sapiens	Residual Activity	%	66.0
	12208012	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	54.0	CHEMBL5084	Homo sapiens	Residual Activity	%	54.0
	12208013	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	14.0	CHEMBL5084	Homo sapiens	Residual Activity	%	14.0
	12208014	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	66.0	CHEMBL5084	Homo sapiens	Residual Activity	%	66.0
	12208015	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	71.0	CHEMBL5084	Homo sapiens	Residual Activity	%	71.0
	12208016	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	49.0	CHEMBL5084	Homo sapiens	Residual Activity	%	49.0
	12208017	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	40.0	CHEMBL5084	Homo sapiens	Residual Activity	%	40.0
	12208018	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	54.0	CHEMBL5084	Homo sapiens	Residual Activity	%	54.0
	12208019	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	70.0	CHEMBL5084	Homo sapiens	Residual Activity	%	70.0
	12208020	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	54.0	CHEMBL5084	Homo sapiens	Residual Activity	%	54.0
	12208021	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	64.0	CHEMBL5084	Homo sapiens	Residual Activity	%	64.0
	12208022	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	41.0	CHEMBL5084	Homo sapiens	Residual Activity	%	41.0
	12208023	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	59.0	CHEMBL5084	Homo sapiens	Residual Activity	%	59.0
	12250026	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	101.0	CHEMBL5084	Homo sapiens	Residual Activity	%	101.0
	12250027	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	120.0	CHEMBL5084	Homo sapiens	Residual Activity	%	120.0
	12250028	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	97.0	CHEMBL5084	Homo sapiens	Residual Activity	%	97.0
	12250029	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	110.0	CHEMBL5084	Homo sapiens	Residual Activity	%	110.0
	12250030	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	107.0	CHEMBL5084	Homo sapiens	Residual Activity	%	107.0
	12250031	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	116.0	CHEMBL5084	Homo sapiens	Residual Activity	%	116.0
	12250032	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	97.0	CHEMBL5084	Homo sapiens	Residual Activity	%	97.0
	12250033	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	128.0	CHEMBL5084	Homo sapiens	Residual Activity	%	128.0
	12250034	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	109.0	CHEMBL5084	Homo sapiens	Residual Activity	%	109.0
	12250035	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	112.0	CHEMBL5084	Homo sapiens	Residual Activity	%	112.0
	12250036	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	108.0	CHEMBL5084	Homo sapiens	Residual Activity	%	108.0
	12250037	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	89.0	CHEMBL5084	Homo sapiens	Residual Activity	%	89.0
	12250038	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	113.0	CHEMBL5084	Homo sapiens	Residual Activity	%	113.0
	12250039	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	113.0	CHEMBL5084	Homo sapiens	Residual Activity	%	113.0
	12250040	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	115.0	CHEMBL5084	Homo sapiens	Residual Activity	%	115.0
	12250041	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	101.0	CHEMBL5084	Homo sapiens	Residual Activity	%	101.0
	12250042	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	113.0	CHEMBL5084	Homo sapiens	Residual Activity	%	113.0
	12250043	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	101.0	CHEMBL5084	Homo sapiens	Residual Activity	%	101.0
	12250044	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	107.0	CHEMBL5084	Homo sapiens	Residual Activity	%	107.0
	12250045	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	111.0	CHEMBL5084	Homo sapiens	Residual Activity	%	111.0
	12250046	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	90.0	CHEMBL5084	Homo sapiens	Residual Activity	%	90.0
	12250047	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	122.0	CHEMBL5084	Homo sapiens	Residual Activity	%	122.0
	12250048	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	107.0	CHEMBL5084	Homo sapiens	Residual Activity	%	107.0
	12250049	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	82.0	CHEMBL5084	Homo sapiens	Residual Activity	%	82.0
	12250050	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	97.0	CHEMBL5084	Homo sapiens	Residual Activity	%	97.0
	12250051	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	92.0	CHEMBL5084	Homo sapiens	Residual Activity	%	92.0
	12250052	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	79.0	CHEMBL5084	Homo sapiens	Residual Activity	%	79.0
	12250053	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	97.0	CHEMBL5084	Homo sapiens	Residual Activity	%	97.0
	12250054	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	116.0	CHEMBL5084	Homo sapiens	Residual Activity	%	116.0
	12250055	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	129.0	CHEMBL5084	Homo sapiens	Residual Activity	%	129.0
	12250056	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	90.0	CHEMBL5084	Homo sapiens	Residual Activity	%	90.0
	12250057	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	104.0	CHEMBL5084	Homo sapiens	Residual Activity	%	104.0
	12250058	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	95.0	CHEMBL5084	Homo sapiens	Residual Activity	%	95.0
	12250059	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	102.0	CHEMBL5084	Homo sapiens	Residual Activity	%	102.0
	12250060	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	103.0	CHEMBL5084	Homo sapiens	Residual Activity	%	103.0
	12250061	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	91.0	CHEMBL5084	Homo sapiens	Residual Activity	%	91.0
	12250062	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	92.0	CHEMBL5084	Homo sapiens	Residual Activity	%	92.0
	12250063	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	96.0	CHEMBL5084	Homo sapiens	Residual Activity	%	96.0
	12250064	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	105.0	CHEMBL5084	Homo sapiens	Residual Activity	%	105.0
	12250065	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	118.0	CHEMBL5084	Homo sapiens	Residual Activity	%	118.0
	12250066	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	109.0	CHEMBL5084	Homo sapiens	Residual Activity	%	109.0
	12250067	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	121.0	CHEMBL5084	Homo sapiens	Residual Activity	%	121.0
	12250068	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	74.0	CHEMBL5084	Homo sapiens	Residual Activity	%	74.0
	12250069	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	92.0	CHEMBL5084	Homo sapiens	Residual Activity	%	92.0
	12250070	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	82.0	CHEMBL5084	Homo sapiens	Residual Activity	%	82.0
	12250071	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	110.0	CHEMBL5084	Homo sapiens	Residual Activity	%	110.0
	12250072	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	116.0	CHEMBL5084	Homo sapiens	Residual Activity	%	116.0
	12250073	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	83.0	CHEMBL5084	Homo sapiens	Residual Activity	%	83.0
	12250074	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	113.0	CHEMBL5084	Homo sapiens	Residual Activity	%	113.0
	12250075	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	115.0	CHEMBL5084	Homo sapiens	Residual Activity	%	115.0
	12250076	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	111.0	CHEMBL5084	Homo sapiens	Residual Activity	%	111.0
	12250077	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	86.0	CHEMBL5084	Homo sapiens	Residual Activity	%	86.0
	12250078	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	61.0	CHEMBL5084	Homo sapiens	Residual Activity	%	61.0
	12250079	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	93.0	CHEMBL5084	Homo sapiens	Residual Activity	%	93.0
	12250080	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	109.0	CHEMBL5084	Homo sapiens	Residual Activity	%	109.0
	12250081	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	86.0	CHEMBL5084	Homo sapiens	Residual Activity	%	86.0
	12250082	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	103.0	CHEMBL5084	Homo sapiens	Residual Activity	%	103.0
	12250083	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	88.0	CHEMBL5084	Homo sapiens	Residual Activity	%	88.0
	12250084	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	101.0	CHEMBL5084	Homo sapiens	Residual Activity	%	101.0
	12250085	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	90.0	CHEMBL5084	Homo sapiens	Residual Activity	%	90.0
	12250086	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	83.0	CHEMBL5084	Homo sapiens	Residual Activity	%	83.0
	12250087	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	66.0	CHEMBL5084	Homo sapiens	Residual Activity	%	66.0
	12250088	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	90.0	CHEMBL5084	Homo sapiens	Residual Activity	%	90.0
	12250089	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	101.0	CHEMBL5084	Homo sapiens	Residual Activity	%	101.0
	12250090	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	79.0	CHEMBL5084	Homo sapiens	Residual Activity	%	79.0
	12250091	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	85.0	CHEMBL5084	Homo sapiens	Residual Activity	%	85.0
	12250092	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	87.0	CHEMBL5084	Homo sapiens	Residual Activity	%	87.0
	12250093	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	88.0	CHEMBL5084	Homo sapiens	Residual Activity	%	88.0
	12250094	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	64.0	CHEMBL5084	Homo sapiens	Residual Activity	%	64.0
	12250095	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	77.0	CHEMBL5084	Homo sapiens	Residual Activity	%	77.0
	12250096	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	85.0	CHEMBL5084	Homo sapiens	Residual Activity	%	85.0
	12250097	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	93.0	CHEMBL5084	Homo sapiens	Residual Activity	%	93.0
	12250098	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	83.0	CHEMBL5084	Homo sapiens	Residual Activity	%	83.0
	12250099	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	71.0	CHEMBL5084	Homo sapiens	Residual Activity	%	71.0
	12250100	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	84.0	CHEMBL5084	Homo sapiens	Residual Activity	%	84.0
	12250101	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	84.0	CHEMBL5084	Homo sapiens	Residual Activity	%	84.0
	12250102	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	91.0	CHEMBL5084	Homo sapiens	Residual Activity	%	91.0
	12250103	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	42.0	CHEMBL5084	Homo sapiens	Residual Activity	%	42.0
	12250104	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	96.0	CHEMBL5084	Homo sapiens	Residual Activity	%	96.0
	12250105	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	91.0	CHEMBL5084	Homo sapiens	Residual Activity	%	91.0
	12250106	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	90.0	CHEMBL5084	Homo sapiens	Residual Activity	%	90.0
	12250107	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	102.0	CHEMBL5084	Homo sapiens	Residual Activity	%	102.0
	12250108	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	80.0	CHEMBL5084	Homo sapiens	Residual Activity	%	80.0
	12250109	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	96.0	CHEMBL5084	Homo sapiens	Residual Activity	%	96.0
	12250110	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	93.0	CHEMBL5084	Homo sapiens	Residual Activity	%	93.0
	12250111	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	118.0	CHEMBL5084	Homo sapiens	Residual Activity	%	118.0
	12250112	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	96.0	CHEMBL5084	Homo sapiens	Residual Activity	%	96.0
	12250113	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	125.0	CHEMBL5084	Homo sapiens	Residual Activity	%	125.0
	12250114	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	90.0	CHEMBL5084	Homo sapiens	Residual Activity	%	90.0
	12250115	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	63.0	CHEMBL5084	Homo sapiens	Residual Activity	%	63.0
	12250116	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	99.0	CHEMBL5084	Homo sapiens	Residual Activity	%	99.0
	12250117	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	99.0	CHEMBL5084	Homo sapiens	Residual Activity	%	99.0
	12250118	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	96.0	CHEMBL5084	Homo sapiens	Residual Activity	%	96.0
	12250119	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	115.0	CHEMBL5084	Homo sapiens	Residual Activity	%	115.0
	12250120	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	101.0	CHEMBL5084	Homo sapiens	Residual Activity	%	101.0
	12250121	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	127.0	CHEMBL5084	Homo sapiens	Residual Activity	%	127.0
	12250122	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	110.0	CHEMBL5084	Homo sapiens	Residual Activity	%	110.0
	12250123	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	100.0	CHEMBL5084	Homo sapiens	Residual Activity	%	100.0
	12250124	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	94.0	CHEMBL5084	Homo sapiens	Residual Activity	%	94.0
	12250125	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	99.0	CHEMBL5084	Homo sapiens	Residual Activity	%	99.0
	12250126	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	46.0	CHEMBL5084	Homo sapiens	Residual Activity	%	46.0
	12250127	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	99.0	CHEMBL5084	Homo sapiens	Residual Activity	%	99.0
	12250128	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	85.0	CHEMBL5084	Homo sapiens	Residual Activity	%	85.0
	12250129	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	61.0	CHEMBL5084	Homo sapiens	Residual Activity	%	61.0
	12250130	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	90.0	CHEMBL5084	Homo sapiens	Residual Activity	%	90.0
	12250131	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	85.0	CHEMBL5084	Homo sapiens	Residual Activity	%	85.0
	12250132	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	51.0	CHEMBL5084	Homo sapiens	Residual Activity	%	51.0
	12250133	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	83.0	CHEMBL5084	Homo sapiens	Residual Activity	%	83.0
	12250134	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	106.0	CHEMBL5084	Homo sapiens	Residual Activity	%	106.0
	12250135	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	101.0	CHEMBL5084	Homo sapiens	Residual Activity	%	101.0
	12250136	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	81.0	CHEMBL5084	Homo sapiens	Residual Activity	%	81.0
	12250137	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	107.0	CHEMBL5084	Homo sapiens	Residual Activity	%	107.0
	12250138	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	102.0	CHEMBL5084	Homo sapiens	Residual Activity	%	102.0
	12250139	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	85.0	CHEMBL5084	Homo sapiens	Residual Activity	%	85.0
	12250140	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	96.0	CHEMBL5084	Homo sapiens	Residual Activity	%	96.0
	12250141	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	83.0	CHEMBL5084	Homo sapiens	Residual Activity	%	83.0
	12250142	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	94.0	CHEMBL5084	Homo sapiens	Residual Activity	%	94.0
	12250143	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	102.0	CHEMBL5084	Homo sapiens	Residual Activity	%	102.0
	12250144	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	84.0	CHEMBL5084	Homo sapiens	Residual Activity	%	84.0
	12250145	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	92.0	CHEMBL5084	Homo sapiens	Residual Activity	%	92.0
	12250146	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	90.0	CHEMBL5084	Homo sapiens	Residual Activity	%	90.0
	12250147	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	88.0	CHEMBL5084	Homo sapiens	Residual Activity	%	88.0
	12250148	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	56.0	CHEMBL5084	Homo sapiens	Residual Activity	%	56.0
	12250149	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	80.0	CHEMBL5084	Homo sapiens	Residual Activity	%	80.0
	12250150	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	88.0	CHEMBL5084	Homo sapiens	Residual Activity	%	88.0
	12250151	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	103.0	CHEMBL5084	Homo sapiens	Residual Activity	%	103.0
	12250152	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	72.0	CHEMBL5084	Homo sapiens	Residual Activity	%	72.0
	12250153	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	100.0	CHEMBL5084	Homo sapiens	Residual Activity	%	100.0
	12250154	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	102.0	CHEMBL5084	Homo sapiens	Residual Activity	%	102.0
	12250155	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	29.0	CHEMBL5084	Homo sapiens	Residual Activity	%	29.0
	12250156	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	67.0	CHEMBL5084	Homo sapiens	Residual Activity	%	67.0
	12250157	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	81.0	CHEMBL5084	Homo sapiens	Residual Activity	%	81.0
	12250158	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	83.0	CHEMBL5084	Homo sapiens	Residual Activity	%	83.0
	12250159	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	85.0	CHEMBL5084	Homo sapiens	Residual Activity	%	85.0
	12250160	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	97.0	CHEMBL5084	Homo sapiens	Residual Activity	%	97.0
	12250161	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	75.0	CHEMBL5084	Homo sapiens	Residual Activity	%	75.0
	12250162	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	82.0	CHEMBL5084	Homo sapiens	Residual Activity	%	82.0
	12250163	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	51.0	CHEMBL5084	Homo sapiens	Residual Activity	%	51.0
	12250164	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	54.0	CHEMBL5084	Homo sapiens	Residual Activity	%	54.0
	12250165	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	80.0	CHEMBL5084	Homo sapiens	Residual Activity	%	80.0
	12250166	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	82.0	CHEMBL5084	Homo sapiens	Residual Activity	%	82.0
	12250167	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	96.0	CHEMBL5084	Homo sapiens	Residual Activity	%	96.0
	12250168	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	91.0	CHEMBL5084	Homo sapiens	Residual Activity	%	91.0
	12250169	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	55.0	CHEMBL5084	Homo sapiens	Residual Activity	%	55.0
	12250170	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	76.0	CHEMBL5084	Homo sapiens	Residual Activity	%	76.0
	12250171	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	86.0	CHEMBL5084	Homo sapiens	Residual Activity	%	86.0
	12250172	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	69.0	CHEMBL5084	Homo sapiens	Residual Activity	%	69.0
	12250173	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	60.0	CHEMBL5084	Homo sapiens	Residual Activity	%	60.0
	12250174	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	85.0	CHEMBL5084	Homo sapiens	Residual Activity	%	85.0
	12250175	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	90.0	CHEMBL5084	Homo sapiens	Residual Activity	%	90.0
	12250176	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	88.0	CHEMBL5084	Homo sapiens	Residual Activity	%	88.0
	12250177	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	74.0	CHEMBL5084	Homo sapiens	Residual Activity	%	74.0
	12250178	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	77.0	CHEMBL5084	Homo sapiens	Residual Activity	%	77.0
	12250179	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	81.0	CHEMBL5084	Homo sapiens	Residual Activity	%	81.0
	12250180	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	78.0	CHEMBL5084	Homo sapiens	Residual Activity	%	78.0
	12250181	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	86.0	CHEMBL5084	Homo sapiens	Residual Activity	%	86.0
	12250182	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	92.0	CHEMBL5084	Homo sapiens	Residual Activity	%	92.0
	12250183	CHEMBL2218994	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	94.0	CHEMBL5084	Homo sapiens	Residual Activity	%	94.0
	12250184	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	87.0	CHEMBL5084	Homo sapiens	Residual Activity	%	87.0
	12250185	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	90.0	CHEMBL5084	Homo sapiens	Residual Activity	%	90.0
	12250186	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	57.0	CHEMBL5084	Homo sapiens	Residual Activity	%	57.0
	12250187	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	125.0	CHEMBL5084	Homo sapiens	Residual Activity	%	125.0
	12250188	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	78.0	CHEMBL5084	Homo sapiens	Residual Activity	%	78.0
	12250189	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	113.0	CHEMBL5084	Homo sapiens	Residual Activity	%	113.0
	12250190	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	72.0	CHEMBL5084	Homo sapiens	Residual Activity	%	72.0
	12250191	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	94.0	CHEMBL5084	Homo sapiens	Residual Activity	%	94.0
	12250192	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	63.0	CHEMBL5084	Homo sapiens	Residual Activity	%	63.0
	12250193	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	76.0	CHEMBL5084	Homo sapiens	Residual Activity	%	76.0
	12250194	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	102.0	CHEMBL5084	Homo sapiens	Residual Activity	%	102.0
	12250195	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	67.0	CHEMBL5084	Homo sapiens	Residual Activity	%	67.0
	12250196	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	70.0	CHEMBL5084	Homo sapiens	Residual Activity	%	70.0
	12250197	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	92.0	CHEMBL5084	Homo sapiens	Residual Activity	%	92.0
	12250198	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	101.0	CHEMBL5084	Homo sapiens	Residual Activity	%	101.0
	12250199	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	84.0	CHEMBL5084	Homo sapiens	Residual Activity	%	84.0
	12250200	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	113.0	CHEMBL5084	Homo sapiens	Residual Activity	%	113.0
	12250201	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	72.0	CHEMBL5084	Homo sapiens	Residual Activity	%	72.0
	12250202	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	99.0	CHEMBL5084	Homo sapiens	Residual Activity	%	99.0
	12250203	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	87.0	CHEMBL5084	Homo sapiens	Residual Activity	%	87.0
	12250204	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	51.0	CHEMBL5084	Homo sapiens	Residual Activity	%	51.0
	12250205	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	62.0	CHEMBL5084	Homo sapiens	Residual Activity	%	62.0
	12250206	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	86.0	CHEMBL5084	Homo sapiens	Residual Activity	%	86.0
	12250207	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	87.0	CHEMBL5084	Homo sapiens	Residual Activity	%	87.0
	12250208	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	97.0	CHEMBL5084	Homo sapiens	Residual Activity	%	97.0
	12250209	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	63.0	CHEMBL5084	Homo sapiens	Residual Activity	%	63.0
	12250210	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	18.0	CHEMBL5084	Homo sapiens	Residual Activity	%	18.0
	12250211	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	62.0	CHEMBL5084	Homo sapiens	Residual Activity	%	62.0
	12250212	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	71.0	CHEMBL5084	Homo sapiens	Residual Activity	%	71.0
	12250213	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	73.0	CHEMBL5084	Homo sapiens	Residual Activity	%	73.0
	12250214	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	50.0	CHEMBL5084	Homo sapiens	Residual Activity	%	50.0
	12250215	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	49.0	CHEMBL5084	Homo sapiens	Residual Activity	%	49.0
	12250216	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	48.0	CHEMBL5084	Homo sapiens	Residual Activity	%	48.0
	12250217	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	61.0	CHEMBL5084	Homo sapiens	Residual Activity	%	61.0
	12250218	CHEMBL2218995	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	70.0	CHEMBL5084	Homo sapiens	Residual Activity	%	70.0
	12728872	CHEMBL2349954	Inhibition of CK1gamma3 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	103.0	CHEMBL5084	Homo sapiens	Activity	%	103.0
	12730014	CHEMBL2353890	Inhibition of CK1gamma3 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	97.0	CHEMBL5084	Homo sapiens	Activity	%	97.0
	12730262	CHEMBL2349954	Inhibition of CK1gamma3 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	99.0	CHEMBL5084	Homo sapiens	Activity	%	99.0
	12730894	CHEMBL2349822	Inhibition of CK1g3 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	92.0	CHEMBL5084	Homo sapiens	Activity	%	92.0
	13375901	CHEMBL2405309	Inhibition of CK1gamma3 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	0.0	CHEMBL5084	Homo sapiens	INH	%	0.0
	13439876	CHEMBL2428166	Competitive binding affinity to CSNK1G3 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL5084	Homo sapiens	INH	%	50.0
	13448441	CHEMBL2428166	Competitive binding affinity to CSNK1G3 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL5084	Homo sapiens	INH	%	50.0
	13451696	CHEMBL2428166	Competitive binding affinity to CSNK1G3 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	=	Inhibition	%	96.0	CHEMBL5084	Homo sapiens	INH	%	96.0
	13872181	CHEMBL3101933	Inhibition of human CK1gamma3 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	37.0	CHEMBL5084	Homo sapiens	Activity	%	37.0
	14582467	CHEMBL3240427	Inhibition of human CK1gamma3 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	91.5	CHEMBL5084	Homo sapiens	Activity	%	91.5
	15104954	CHEMBL3386216	Inhibition of GST-tagged human CK1gamma3 expressed in Escherichia coli using using alpha casein substrate by SDS-PAGE based autoradiography	B	COc1cccc(C(=O)Nc2nc3cc4c(cc3[nH]2)OC(F)(F)O4)c1		CHEMBL3337846	=	IC50	nM	800.0	CHEMBL5084	Homo sapiens	IC50	uM	0.8
	15104955	CHEMBL3386216	Inhibition of GST-tagged human CK1gamma3 expressed in Escherichia coli using using alpha casein substrate by SDS-PAGE based autoradiography	B	O=C(Nc1nc2cc3c(cc2[nH]1)OC(F)(F)O3)c1csc(NC(=O)c2ccccc2OC(F)(F)F)n1		CHEMBL3337845	=	IC50	nM	810.0	CHEMBL5084	Homo sapiens	IC50	uM	0.81
Not Active	15109344	CHEMBL3379412	Inhibition of GST-tagged human CK1gamma3 expressed in Escherichia coli assessed as residual enzyme activity at 10 uM using using GST-p53 (1 to 64 residues) substrate by SDS-PAGE based autoradiography	B	O=C(Nc1nc2cc3c(cc2[nH]1)OC(F)(F)O3)c1csc(NC(=O)c2ccccc2OC(F)(F)F)n1		CHEMBL3337845		Inhibition	%		CHEMBL5084	Homo sapiens	INH		
Not Active	15109345	CHEMBL3379412	Inhibition of GST-tagged human CK1gamma3 expressed in Escherichia coli assessed as residual enzyme activity at 10 uM using using GST-p53 (1 to 64 residues) substrate by SDS-PAGE based autoradiography	B	COc1cccc(C(=O)Nc2nc3cc4c(cc3[nH]2)OC(F)(F)O4)c1		CHEMBL3337846		Inhibition	%		CHEMBL5084	Homo sapiens	INH		
Not Active	15109346	CHEMBL3379412	Inhibition of GST-tagged human CK1gamma3 expressed in Escherichia coli assessed as residual enzyme activity at 10 uM using using GST-p53 (1 to 64 residues) substrate by SDS-PAGE based autoradiography	B	COc1cncc(C(=O)Nc2nc3cc4c(cc3[nH]2)OC(F)(F)O4)c1		CHEMBL3337847		Inhibition	%		CHEMBL5084	Homo sapiens	INH		
Not Active	15109347	CHEMBL3379412	Inhibition of GST-tagged human CK1gamma3 expressed in Escherichia coli assessed as residual enzyme activity at 10 uM using using GST-p53 (1 to 64 residues) substrate by SDS-PAGE based autoradiography	B	COc1cc(C(=O)Nc2nc3cc4c(cc3[nH]2)OC(F)(F)O4)ccn1		CHEMBL3337848		Inhibition	%		CHEMBL5084	Homo sapiens	INH		
Not Active	15109348	CHEMBL3379412	Inhibition of GST-tagged human CK1gamma3 expressed in Escherichia coli assessed as residual enzyme activity at 10 uM using using GST-p53 (1 to 64 residues) substrate by SDS-PAGE based autoradiography	B	CN(C)c1cccc(C(=O)Nc2nc3cc4c(cc3[nH]2)OC(F)(F)O4)c1		CHEMBL3337849		Inhibition	%		CHEMBL5084	Homo sapiens	INH		
Not Active	15109349	CHEMBL3379412	Inhibition of GST-tagged human CK1gamma3 expressed in Escherichia coli assessed as residual enzyme activity at 10 uM using using GST-p53 (1 to 64 residues) substrate by SDS-PAGE based autoradiography	B	CN(C)c1cc(C(=O)Nc2nc3cc4c(cc3[nH]2)OC(F)(F)O4)ccn1		CHEMBL3337850		Inhibition	%		CHEMBL5084	Homo sapiens	INH		
Not Active	15109350	CHEMBL3379412	Inhibition of GST-tagged human CK1gamma3 expressed in Escherichia coli assessed as residual enzyme activity at 10 uM using using GST-p53 (1 to 64 residues) substrate by SDS-PAGE based autoradiography	B	O=C(Nc1nc2cc3c(cc2[nH]1)OC(F)(F)O3)c1cccc(OC(F)F)c1		CHEMBL3337851		Inhibition	%		CHEMBL5084	Homo sapiens	INH		
Not Active	15109351	CHEMBL3379412	Inhibition of GST-tagged human CK1gamma3 expressed in Escherichia coli assessed as residual enzyme activity at 10 uM using using GST-p53 (1 to 64 residues) substrate by SDS-PAGE based autoradiography	B	COC(=O)c1cccc(C(=O)Nc2nc3cc4c(cc3[nH]2)OC(F)(F)O4)c1		CHEMBL3337852		Inhibition	%		CHEMBL5084	Homo sapiens	INH		
Not Active	15109352	CHEMBL3379412	Inhibition of GST-tagged human CK1gamma3 expressed in Escherichia coli assessed as residual enzyme activity at 10 uM using using GST-p53 (1 to 64 residues) substrate by SDS-PAGE based autoradiography	B	O=C(Nc1nc2cc3c(cc2[nH]1)OC(F)(F)O3)c1cccc(-c2nnn[nH]2)c1		CHEMBL3337853		Inhibition	%		CHEMBL5084	Homo sapiens	INH		
	15149948	CHEMBL3395921	Inhibition of CSNK1G3 (CK1) (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CC2)ccn1		CHEMBL3394102	<	Inhibition	%	50.0	CHEMBL5084	Homo sapiens	INH	%	50.0
	15149949	CHEMBL3395921	Inhibition of CSNK1G3 (CK1) (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CCCCC2)ccn1		CHEMBL3394105	<	Inhibition	%	50.0	CHEMBL5084	Homo sapiens	INH	%	50.0
	15149950	CHEMBL3395921	Inhibition of CSNK1G3 (CK1) (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2CC2CCCO2)ccn1		CHEMBL3394108	<	Inhibition	%	50.0	CHEMBL5084	Homo sapiens	INH	%	50.0
	15149951	CHEMBL3395921	Inhibition of CSNK1G3 (CK1) (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	COC(Cn1c(SC2CCC(C(=O)O)CC2O)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1)OC		CHEMBL3394112	<	Inhibition	%	50.0	CHEMBL5084	Homo sapiens	INH	%	50.0
	15149952	CHEMBL3395921	Inhibition of CSNK1G3 (CK1) (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(Sc3cccc(I)n3)n2C2CCCCC2)ccn1		CHEMBL3394118	<	Inhibition	%	50.0	CHEMBL5084	Homo sapiens	INH	%	50.0
	15236108	CHEMBL3424699	Inhibition of human Casein kinase 1 gamma 3 assessed as residual activity at 10 uM relative to control	B	CCCCCCCCCCCCCCC[C@@H](O)[C@H](C)N		CHEMBL1835439	=	Activity	%	100.0	CHEMBL5084	Homo sapiens	Activity	%	100.0
	15236130	CHEMBL3424699	Inhibition of human Casein kinase 1 gamma 3 assessed as residual activity at 10 uM relative to control	B	CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)[C@@H](C)O		CHEMBL3422705	=	Activity	%	82.0	CHEMBL5084	Homo sapiens	Activity	%	82.0
	15236164	CHEMBL3424699	Inhibition of human Casein kinase 1 gamma 3 assessed as residual activity at 10 uM relative to control	B	CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CC(C)C		CHEMBL3422697	=	Activity	%	93.0	CHEMBL5084	Homo sapiens	Activity	%	93.0
	15236188	CHEMBL3424699	Inhibition of human Casein kinase 1 gamma 3 assessed as residual activity at 10 uM relative to control	B	CCCCCCCCC[C@@H](O)[C@@H](N)Cc1ccccc1		CHEMBL3422700	=	Activity	%	71.0	CHEMBL5084	Homo sapiens	Activity	%	71.0
	15258348	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Thermal melting change	degrees C	3.8	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	3.8
	15258408	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Thermal melting change	degrees C	0.2	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.2
	15258468	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Thermal melting change	degrees C	3.2	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	3.2
	15258528	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Thermal melting change	degrees C	2.8	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	2.8
	15258588	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Thermal melting change	degrees C	1.0	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	1.0
	15258648	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Thermal melting change	degrees C	1.3	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	1.3
	15258708	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Thermal melting change	degrees C	0.5	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.5
	15258768	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	O=C(O)Cc1ccc(O)c([N+](=O)[O-])c1		CHEMBL501822	=	Thermal melting change	degrees C	0.5	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.5
	15258828	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL319467	=	Thermal melting change	degrees C	2.2	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	2.2
	15258888	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Thermal melting change	degrees C	3.6	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	3.6
	15258948	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	CS(=O)(=O)O.Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1642	=	Thermal melting change	degrees C	0.3	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.3
	15259008	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Thermal melting change	degrees C	3.4	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	3.4
	15259068	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Thermal melting change	degrees C	1.6	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	1.6
	15259128	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL216543	=	Thermal melting change	degrees C	2.7	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	2.7
	15259188	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Thermal melting change	degrees C	5.3	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	5.3
	15259248	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	Cn1cc(/C=C2/C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL3430785	=	Thermal melting change	degrees C	0.2	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.2
	15259308	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B			CHEMBL3430786	=	Thermal melting change	degrees C	0.0	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.0
	15259368	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	CCOc1ccc(/C=C2/SC(=O)N(CCN)C2=O)cc1		CHEMBL262615	=	Thermal melting change	degrees C	-0.1	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	-0.1
	15259428	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	O=c1c(-c2ccc(F)cc2)c(-c2ccncc2)[nH]n1-c1ccc(Cl)cc1		CHEMBL408678	=	Thermal melting change	degrees C	0.5	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.5
	15259488	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Thermal melting change	degrees C	3.4	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	3.4
	15259548	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Thermal melting change	degrees C	2.4	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	2.4
	15259608	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2[C@H]2CC[C@H](O)CC2)n1		CHEMBL97162	=	Thermal melting change	degrees C	1.2	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	1.2
	15259668	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Thermal melting change	degrees C	0.5	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.5
	15259728	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Thermal melting change	degrees C	4.9	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	4.9
	15259788	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	CCCNC(=O)Nc1ccc(Oc2ncnc3cc(OC)c(OC)cc23)cc1Cl		CHEMBL406381	=	Thermal melting change	degrees C	-3.7	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	-3.7
	15259848	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Thermal melting change	degrees C	0.3	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.3
	15259908	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Thermal melting change	degrees C	0.5	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.5
	15259968	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	Cl.NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL558969	=	Thermal melting change	degrees C	5.9	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	5.9
	15260028	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)c(C)c1C(=O)N1CCN(C)CC1		CHEMBL261641	=	Thermal melting change	degrees C	1.1	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	1.1
	15260088	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Thermal melting change	degrees C	1.1	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	1.1
	15260148	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Thermal melting change	degrees C	0.8	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.8
	15260208	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B			CHEMBL3430787	=	Thermal melting change	degrees C	9.3	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	9.3
	15260268	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Thermal melting change	degrees C	0.2	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.2
	15260328	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	CN(c1cccnc1)c1cc2c(Nc3ccc(F)c(Cl)c3)c(C#N)cnc2cn1		CHEMBL261238	=	Thermal melting change	degrees C	3.7	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	3.7
	15260388	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Thermal melting change	degrees C	1.3	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	1.3
	15260448	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Thermal melting change	degrees C	-4.3	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	-4.3
	15260508	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	Cc1nc(N)sc1-c1ccnc(Nc2cccc([N+](=O)[O-])c2)n1		CHEMBL298445	=	Thermal melting change	degrees C	1.3	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	1.3
	15260568	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Thermal melting change	degrees C	2.2	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	2.2
	15260628	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B			CHEMBL3430788	=	Thermal melting change	degrees C	2.6	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	2.6
	15260688	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Thermal melting change	degrees C	1.1	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	1.1
	15260748	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Thermal melting change	degrees C	0.9	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.9
	15260808	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	CN1CCc2[nH]c(=S)c(C#N)c(-c3cccs3)c2C1		CHEMBL261211	=	Thermal melting change	degrees C	0.2	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.2
	15260868	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(O)c1c(F)cccc1F		CHEMBL259605	=	Thermal melting change	degrees C	16.7	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	16.7
	15260928	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Thermal melting change	degrees C	1.2	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	1.2
	15260988	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	Thermal melting change	degrees C	-0.2	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	-0.2
	15261048	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	CN1CCC(Nc2ncc3ncnc(Nc4ccc(F)c(Cl)c4)c3n2)CC1		CHEMBL258940	=	Thermal melting change	degrees C	0.0	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.0
	15261108	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Thermal melting change	degrees C	0.3	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.3
	15261191	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Thermal melting change	degrees C	2.6	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	2.6
	15261251	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Thermal melting change	degrees C	-0.3	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	-0.3
	15261311	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	Nc1cc2ncnc(Nc3cccc(Br)c3)c2cc1N		CHEMBL328216	=	Thermal melting change	degrees C	0.4	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.4
	15261371	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Thermal melting change	degrees C	-0.2	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	-0.2
	15261426	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	NC1=N/C(=C2/CCNC(=O)c3[nH]ccc32)C(=O)N1		CHEMBL255465	=	Thermal melting change	degrees C	2.4	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	2.4
	15261486	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	COc1cc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)ccc1O		CHEMBL435734	=	Thermal melting change	degrees C	0.2	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.2
	15261546	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	O=C1C=C2C(=Nc3c2c2c(c4c3=NC3=C4CCC=C3)C=NC=2)CC1		CHEMBL408953	=	Thermal melting change	degrees C	0.8	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.8
	15261606	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC.[Cl-]		CHEMBL258893	=	Thermal melting change	degrees C	0.2	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.2
	15261679	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC		CHEMBL29197	=	Thermal melting change	degrees C	-0.1	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	-0.1
	15261739	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	C[S+]([O-])c1ccc(CSc2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL111456	=	Thermal melting change	degrees C	-0.1	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	-0.1
	15261799	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12		CHEMBL28	=	Thermal melting change	degrees C	0.7	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.7
	15261859	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12		CHEMBL44	=	Thermal melting change	degrees C	1.6	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	1.6
	15261915	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Thermal melting change	degrees C	0.7	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.7
	15261975	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	CC(C)c1cc(/C=C(\C#N)C(=O)NCCCc2ccccc2)cc(C(C)C)c1O		CHEMBL261508	=	Thermal melting change	degrees C	0.7	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.7
	15262035	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Thermal melting change	degrees C	1.1	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	1.1
	15262095	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B			CHEMBL3430782	=	Thermal melting change	degrees C	0.8	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.8
	15262168	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Thermal melting change	degrees C	0.5	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.5
	15262228	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Thermal melting change	degrees C	0.6	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.6
	15262288	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL99203	=	Thermal melting change	degrees C	2.7	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	2.7
	15262348	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	O=C(O)c1cc(NCc2cc(O)ccc2O)ccc1O		CHEMBL319620	=	Thermal melting change	degrees C	0.3	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.3
	15262408	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	OC[C@H]1O[C@@H](n2cnc3cc(Cl)c(Cl)cc32)[C@H](O)[C@@H]1O		CHEMBL375530	=	Thermal melting change	degrees C	1.0	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	1.0
	15262468	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	O=C(O)c1cc(N(Cc2ccccc2O)Cc2cc(O)ccc2O)ccc1O		CHEMBL103552	=	Thermal melting change	degrees C	0.8	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.8
	15262528	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	O=C1Nc2ccc(I)cc2/C1=C\c1cc(Br)c(O)c(Br)c1		CHEMBL264949	=	Thermal melting change	degrees C	0.0	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.0
	15262588	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Thermal melting change	degrees C	1.1	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	1.1
	15262648	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	CN(C)c1ncnc2nc[nH]c12		CHEMBL407391	=	Thermal melting change	degrees C	0.5	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.5
	15262708	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	Cc1ccc2c(c1)C(=O)c1cc(O)cc(O)c1C2=O		CHEMBL405992	=	Thermal melting change	degrees C	2.3	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	2.3
	15262768	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	O=c1ccc2ccc(O)c(O)c2o1		CHEMBL244948	=	Thermal melting change	degrees C	0.4	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.4
	15262828	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	COc1cc(O)c2c(c1)oc(=O)c1c3cc(O)c(O)cc3oc21		CHEMBL97453	=	Thermal melting change	degrees C	1.5	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	1.5
	15262888	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Thermal melting change	degrees C	2.5	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	2.5
	15262948	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Thermal melting change	degrees C	0.3	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.3
	15263008	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Thermal melting change	degrees C	0.4	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.4
	15263068	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Thermal melting change	degrees C	0.9	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.9
	15263128	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	N#CC(C#N)=Cc1ccc(O)c(O)c1		CHEMBL76904	=	Thermal melting change	degrees C	0.3	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.3
	15263188	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Thermal melting change	degrees C	0.5	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.5
	15263248	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)Nc1ccccc1		CHEMBL56731	=	Thermal melting change	degrees C	1.2	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	1.2
	15263308	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	CCOc1cc(/C=C(\C#N)C(N)=O)cc(CSc2ccccc2)c1O		CHEMBL485070	=	Thermal melting change	degrees C	0.4	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.4
	15263368	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	C/C(O)=C(\C#N)C(=O)Nc1cc(Br)ccc1Br		CHEMBL228043	=	Thermal melting change	degrees C	0.3	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.3
	15263404	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Thermal melting change	degrees C	-1.1	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	-1.1
	15263464	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Thermal melting change	degrees C	0.4	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.4
	15263519	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	O=C1c2ccccc2-c2n[nH]c3cccc1c23		CHEMBL7064	=	Thermal melting change	degrees C	2.0	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	2.0
	15263579	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B			CHEMBL3430783	=	Thermal melting change	degrees C	0.7	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.7
	15263639	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccccc2)c2ccc(F)cc2)CC1		CHEMBL259388	=	Thermal melting change	degrees C	0.3	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.3
	15263699	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	Cc1c2ccncc2c(C)c2c1[nH]c1ccccc12		CHEMBL123	=	Thermal melting change	degrees C	0.7	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.7
	15263773	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Thermal melting change	degrees C	0.2	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.2
	15263833	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Thermal melting change	degrees C	0.3	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.3
	15263893	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	CN(C)c1ccc(CC2C(=O)Nc3ccccc32)cc1		CHEMBL1373282	=	Thermal melting change	degrees C	0.8	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.8
	15263953	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	O=C1Nc2ccccc2/C1=C/c1cc2c([nH]1)CCC(Br)C2		CHEMBL408565	=	Thermal melting change	degrees C	0.2	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.2
	15264007	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	CCOC(=O)c1cnc2oc3ccc(O)cc3c2c1-c1ccccc1		CHEMBL132904	=	Thermal melting change	degrees C	1.1	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	1.1
	15264067	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21.[Cl-]		CHEMBL258765	=	Thermal melting change	degrees C	-0.8	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	-0.8
	15264127	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O		CHEMBL278315	=	Thermal melting change	degrees C	0.4	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.4
	15264187	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Thermal melting change	degrees C	0.3	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.3
	15264260	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	O=C1Nc2ccccc2/C1=C/c1cnc[nH]1		CHEMBL261692	=	Thermal melting change	degrees C	1.5	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	1.5
	15264320	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	O=S(=O)(c1cccc2c(Cl)cccc12)N1CCCNCC1		CHEMBL429298	=	Thermal melting change	degrees C	0.1	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.1
	15264380	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O		CHEMBL116438	=	Thermal melting change	degrees C	0.3	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.3
	15264440	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Br)cc32)N1		CHEMBL361708	=	Thermal melting change	degrees C	3.5	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	3.5
	15264496	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Thermal melting change	degrees C	2.7	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	2.7
	15264556	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	COC(=O)[C@]1(O)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL416056	=	Thermal melting change	degrees C	0.2	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.2
	15264616	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Thermal melting change	degrees C	0.0	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.0
	15264676	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	Cl.NCCNS(=O)(=O)c1cccc2c(Cl)cccc12		CHEMBL1255867	=	Thermal melting change	degrees C	0.4	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.4
	15264748	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	Cc1cc(C=C2C(=O)C=CC2=O)cc(C)c1O		CHEMBL437612	=	Thermal melting change	degrees C	-0.1	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	-0.1
	15264808	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	CC(C)(C)c1cc(C=C2C(=O)C=CC2=O)cc(C(C)(C)C)c1O		CHEMBL258726	=	Thermal melting change	degrees C	0.2	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.2
	15264868	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Thermal melting change	degrees C	0.8	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.8
	15264928	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	CC(C)N(CCO)c1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL126254	=	Thermal melting change	degrees C	6.7	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	6.7
	15264984	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	N=C(N)NCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL143054	=	Thermal melting change	degrees C	0.3	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.3
	15265044	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	CNC(=O)c1cc(Oc2ccc(Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL3430784	=	Thermal melting change	degrees C	0.1	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.1
	15265104	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Thermal melting change	degrees C	0.6	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.6
	15265164	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	CCn1cnc2c(N)nc(N(c3cccc(Cl)c3)[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL411901	=	Thermal melting change	degrees C	5.5	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	5.5
	15265237	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Thermal melting change	degrees C	7.0	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	7.0
	15265297	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21		CHEMBL280074	=	Thermal melting change	degrees C	0.0	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.0
	15265357	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	CC(C)n1cnc2c(NCc3ccccc3O)nc(NCCCO)nc21		CHEMBL419931	=	Thermal melting change	degrees C	0.5	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.5
	15265417	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Thermal melting change	degrees C	1.7	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	1.7
	15265473	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Thermal melting change	degrees C	0.1	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.1
	15265533	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Thermal melting change	degrees C	0.3	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.3
	15265593	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Thermal melting change	degrees C	0.1	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.1
	15265653	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	C[C@@H]1C[C@H]2O[C@@H]2/C=C\C=C\C(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1		CHEMBL414883	=	Thermal melting change	degrees C	0.1	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.1
	15265725	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Thermal melting change	degrees C	0.0	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.0
	15265785	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Thermal melting change	degrees C	0.9	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.9
	15265845	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	O=C(O)/C=C/c1cc(CO)ccc1CO		CHEMBL407534	=	Thermal melting change	degrees C	0.4	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.4
	15265905	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Thermal melting change	degrees C	0.1	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.1
	15265962	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Thermal melting change	degrees C	0.6	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.6
	15266022	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	Oc1cc(O)cc(/C=C/c2ccc(O)c(O)c2)c1		CHEMBL69863	=	Thermal melting change	degrees C	0.5	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.5
	15266082	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	N#C/C(=C(/N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL261237	=	Thermal melting change	degrees C	0.6	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.6
	15266142	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	O=C1Nc2ccc(I)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL411645	=	Thermal melting change	degrees C	1.8	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	1.8
	15266202	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	O=C1Nc2ccc(S(=O)(=O)O)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL440411	=	Thermal melting change	degrees C	3.7	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	3.7
	15266214	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	O=C1CC(=O)c2[nH]c3c4[nH]c5c(c4c4cn(Br)cc4c3c2C1)CCC=C5		CHEMBL264685	=	Thermal melting change	degrees C	0.2	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.2
	15266274	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Thermal melting change	degrees C	0.1	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.1
	15266334	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Thermal melting change	degrees C	0.4	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.4
	15266394	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	O=C1Nc2ccccc2/C1=C\c1ccc[nH]1		CHEMBL101797	=	Thermal melting change	degrees C	1.8	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	1.8
	15266454	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL50	=	Thermal melting change	degrees C	2.9	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	2.9
	15266509	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	CC(=O)O/N=C1C(=C2/C(=O)Nc3cc(Br)ccc32)/Nc2ccccc2/1		CHEMBL430226	=	Thermal melting change	degrees C	0.5	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.5
	15266569	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Thermal melting change	degrees C	0.3	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.3
	15266629	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	CC(=O)O.Cn1cc(C2=C(c3cn(CCCN)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL3430781	=	Thermal melting change	degrees C	0.4	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.4
	15266689	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Thermal melting change	degrees C	0.7	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.7
	15266762	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Thermal melting change	degrees C	0.5	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.5
	15266822	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Thermal melting change	degrees C	0.5	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.5
	15266882	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Thermal melting change	degrees C	-1.3	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	-1.3
	15266942	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Thermal melting change	degrees C	0.4	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.4
	15266997	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	CS(=O)(=O)O.Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL1591531	=	Thermal melting change	degrees C	1.0	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	1.0
	15267057	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	Cl.Cn1cc(C2=C(c3ccc4cc5n(c4c3)CCC(CN)C5)C(=O)NC2=O)c2ccccc21		CHEMBL541401	=	Thermal melting change	degrees C	0.6	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.6
	15267117	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	CN(C)CC1CCn2c(c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc32)C1		CHEMBL372585	=	Thermal melting change	degrees C	0.8	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.8
	15267177	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	CN[C@@H]1CC2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL162	=	Thermal melting change	degrees C	1.9	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	1.9
	15267250	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Thermal melting change	degrees C	0.5	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.5
	15267310	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	COc1cc2ncnc(Nc3cccc(O)c3)c2cc1OC		CHEMBL127907	=	Thermal melting change	degrees C	0.8	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.8
	15267370	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Thermal melting change	degrees C	1.1	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	1.1
	15267430	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Thermal melting change	degrees C	0.4	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.4
	15267485	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	O=c1sn(Cc2ccccc2)c(=S)n1Cc1ccccc1		CHEMBL24338	=	Thermal melting change	degrees C	0.4	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.4
	15267545	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	C=CNC#N		CHEMBL259526	=	Thermal melting change	degrees C	0.8	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.8
	15267605	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(/N)Sc1ccccc1N		CHEMBL100473	=	Thermal melting change	degrees C	0.2	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.2
	15267665	CHEMBL3430807	Delta TM value showing the stabilisation of CK1G3 produced by compound binding	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Thermal melting change	degrees C	0.8	CHEMBL5084	Homo sapiens	Thermal melting change	degrees C	0.8
	15756054	CHEMBL3632317	Inhibition of CK1gamma3 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	5.39	CHEMBL5084	Homo sapiens	INH	%	5.39
	15757009	CHEMBL3632317	Inhibition of CK1gamma3 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	3.82	CHEMBL5084	Homo sapiens	INH	%	3.82
	15758668	CHEMBL3632317	Inhibition of CK1gamma3 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	0.42	CHEMBL5084	Homo sapiens	INH	%	0.42
	16413428	CHEMBL3743716	Inhibition of CK1gamma3 (unknown origin)	B	O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1		CHEMBL3741589	>	IC50	nM	10000.0	CHEMBL5084	Homo sapiens	IC50	uM	10.0
	16431785	CHEMBL3748989	Inhibition of human CK1gamma3 using [KRRRAL[pS]VASLPGL] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL5084	Homo sapiens	IC50	uM	10.0
	16450792	CHEMBL3762310	Inhibition of CK1gamma3 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	1.8	CHEMBL5084	Homo sapiens	INH	%	1.8
	16495368	CHEMBL3778348	Inhibition of N-terminal His6-tagged recombinant human CK1gamam3 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-4.0	CHEMBL5084	Homo sapiens	Activity	%	-4.0
Not Active	16506533	CHEMBL3776528	Inhibition of full length recombinant human GST-tagged CSNK1G3 expressed in baculovirus expression system at 5 uM by lantha screen kinase binding assay relative to control	B	O=C1NC(=S)S/C1=C\c1ccc2ncsc2c1		CHEMBL3775393		Inhibition	%		CHEMBL5084	Homo sapiens	INH		
	16506534	CHEMBL3776529	Inhibition of full length recombinant human GST-tagged CSNK1G3 expressed in baculovirus expression system at 1 uM by lantha screen kinase binding assay relative to control	B	O=C1NC(=S)S/C1=C\c1ccc2ncccc2c1		CHEMBL3774448	=	Inhibition	%	17.0	CHEMBL5084	Homo sapiens	INH	%	17.0
	16508137	CHEMBL3778348	Inhibition of N-terminal His6-tagged recombinant human CK1gamam3 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	-36.0	CHEMBL5084	Homo sapiens	Activity	%	-36.0
	16509114	CHEMBL3778348	Inhibition of N-terminal His6-tagged recombinant human CK1gamam3 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-9.0	CHEMBL5084	Homo sapiens	Activity	%	-9.0
	16614431	CHEMBL3817297	Inhibition of human CK1gamma3 at 1 uM using [KRRRAL[pS]VASLPGL] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	-3.0	CHEMBL5084	Homo sapiens	INH	%	-3.0
	16618258	CHEMBL3817066	Inhibition of full length recombinant human GST-tagged CK1gamma3 expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL5084	Homo sapiens	INH	%	50.0
Active	17894493	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Kd	nM	7536.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	7536.0
Inactive	17894494	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894495	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894496	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894497	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894498	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894499	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894500	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894501	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894502	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17894503	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	=	Kd	nM	19295.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	19295.0
Inactive	17894504	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894505	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894506	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894507	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894508	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894509	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Active	17894510	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	2946.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	2946.0
Inactive	17894511	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894512	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894513	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Active	17894514	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	=	Kd	nM	97.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	97.0
Inactive	17894515	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894516	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894517	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894518	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894519	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894520	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894521	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894522	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894523	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894524	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894525	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894526	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894527	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894528	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894529	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894530	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894531	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894532	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894533	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894534	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894535	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894536	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894537	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894538	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894539	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894540	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894541	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Active	17894542	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	427.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	427.0
Inactive	17894543	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894544	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894545	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894546	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894547	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894548	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894549	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894550	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894551	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894552	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894553	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894554	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894555	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894556	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894557	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894558	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894559	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894560	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894561	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894562	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894563	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894564	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894565	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894566	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894567	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894568	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894569	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Active	17894570	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	2722.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	2722.0
Inactive	17894571	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894572	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894573	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894574	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894575	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894576	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894577	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894578	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894579	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894580	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894581	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894582	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894583	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894584	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894585	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894586	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894587	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894588	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894589	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894590	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894591	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894592	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894593	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894594	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894595	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894596	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894597	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894598	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894599	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894600	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894601	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894602	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894603	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894604	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894605	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894606	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894607	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894608	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894609	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894610	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894611	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894612	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894613	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894614	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894615	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894616	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894617	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894618	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894619	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894620	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894621	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894622	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894623	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894624	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894625	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894626	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894627	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894628	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894629	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894630	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894631	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894632	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894633	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894634	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894635	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894636	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894637	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894638	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894639	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894640	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894641	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894642	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894643	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894644	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894645	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894646	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894647	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894648	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894649	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894650	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894651	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894652	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894653	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894654	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894655	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894656	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894657	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894658	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894659	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894660	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894661	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894662	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894663	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894664	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894665	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894666	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894667	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894668	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894669	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894670	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894671	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894672	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894673	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894674	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894675	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894676	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894677	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894678	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894679	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894680	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894681	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894682	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894683	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894684	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894685	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894686	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894687	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894688	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894689	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894690	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894691	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894692	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894693	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894694	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894695	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894696	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894697	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894698	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894699	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894700	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894701	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894702	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Active	17894703	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	=	Kd	nM	2861.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	2861.0
Inactive	17894704	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894705	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894706	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894707	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894708	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Active	17894709	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	=	Kd	nM	782.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	782.0
Inactive	17894710	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894711	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894712	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894713	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894714	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894715	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894716	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894717	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894718	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894719	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894720	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894721	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894722	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894723	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894724	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894725	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894726	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894727	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894728	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894729	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894730	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894731	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894732	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894733	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894734	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894735	CHEMBL3991679	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL5084	Homo sapiens	Kd apparent	nM	30000.0
	17997592	CHEMBL4001602	Inhibition of full length GST-tagged recombinant human CSNK1G3 expressed in baculovirus expression system	B	Cn1nc(-c2cnc(N)c(-c3ccc(C(N)=O)c(F)c3)n2)nc1C1(c2ccccc2)CC1		CHEMBL4101902	=	IC50	nM	460.0	CHEMBL5084	Homo sapiens	IC50	uM	0.46
	17997595	CHEMBL4001605	Inhibition of full length GST-tagged recombinant human CSNK1G3 expressed in baculovirus expression system at 1 uM relative to control	B	Cn1nc(-c2cnc(N)c(-c3ccc(C(N)=O)c(F)c3)n2)nc1C1(c2ccccc2)CC1		CHEMBL4101902	>	Inhibition	%	70.0	CHEMBL5084	Homo sapiens	INH	%	70.0
	18007224	CHEMBL4003432	Inhibition of CK1 gamma3 (unknown origin) assessed as residual activity at 1 uM relative to control	B	C=CC(=O)Nc1cccc(C(=O)Nc2ccc(Nc3cc(-c4[nH]c(SC)nc4C)ccn3)cc2)c1		CHEMBL4082278	=	Activity	%	10.0	CHEMBL5084	Homo sapiens	Activity	%	10.0
	18114414	CHEMBL4025080	Inhibition of wild-type human full length CSNK1G3 (M1 to K447 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	90.0	CHEMBL5084	Homo sapiens	Activity	%	90.0
	18203604	CHEMBL4043891	Inhibition of wild-type human full length CSNK1G3 (M1 to K447 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL5084	Homo sapiens	Activity	%	100.0
	18253769	CHEMBL4055169	Inhibition of wild-type human full length CK1G3 (M1 to K447 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL5084	Homo sapiens	Activity	%	100.0
	18253770	CHEMBL4055169	Inhibition of wild-type human full length CK1G3 (M1 to K447 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL5084	Homo sapiens	Activity	%	100.0
	18265763	CHEMBL4057213	Inhibition of CSNK1G3 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	-0.7	CHEMBL5084	Homo sapiens	INH	%	-0.7
	18265970	CHEMBL4057420	Inhibition of CSNK1G3 (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	2.3	CHEMBL5084	Homo sapiens	INH	%	2.3
	18282707	CHEMBL4120292	Inhibition of CK1-gamma3 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	-0.7	CHEMBL5084	Homo sapiens	INH	%	-0.7
	18282934	CHEMBL4120519	Inhibition of CK1-gamma3 (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	1.0	CHEMBL5084	Homo sapiens	INH	%	1.0
	18283158	CHEMBL4120743	Inhibition of CK1-gamma3 (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	5.3	CHEMBL5084	Homo sapiens	INH	%	5.3
	18440146	CHEMBL4156970	Binding affinity to wild-type human full length CSNK1G3 (M1 to K447 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL5084	Homo sapiens	Activity	%	100.0
	18484586	CHEMBL4185749	Binding affinity to wild-type human full length CSNK1G3 (M1 to K447 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	97.0	CHEMBL5084	Homo sapiens	Activity	%	97.0
	18485035	CHEMBL4185749	Binding affinity to wild-type human full length CSNK1G3 (M1 to K447 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	100.0	CHEMBL5084	Homo sapiens	Activity	%	100.0
Active	18500779	CHEMBL4189203	Inhibition of human GST-tagged CK1gamma3 at 10 uM using alpha-casein as substrate after 30 mins in presence of [gamma-32P]-ATP by Cherenkov counting method	B	Cc1ccc2nc(NC(=O)CSc3nc4c(c(=O)n3Cc3ccccc3)SCC4)sc2c1		CHEMBL1257114		Inhibition	%		CHEMBL5084	Homo sapiens	INH		
Active	18500792	CHEMBL4189203	Inhibition of human GST-tagged CK1gamma3 at 10 uM using alpha-casein as substrate after 30 mins in presence of [gamma-32P]-ATP by Cherenkov counting method	B	Cc1ccc2nc(NC(=O)CSc3nc4c(c(=O)n3-c3ccc(F)cc3)SCC4)sc2c1		CHEMBL1257089		Inhibition	%		CHEMBL5084	Homo sapiens	INH		
Active	18500825	CHEMBL4189233	Inhibition of human GST-tagged CK1gamma3 at 1 uM using alpha-casein as substrate after 30 mins in presence of [gamma-32P]-ATP by Cherenkov counting method	B	O=C(CSc1nc2c(c(=O)n1-c1ccccc1)SCC2)Nc1nc2ccc(C(F)(F)F)cc2s1		CHEMBL2324266		Inhibition	%		CHEMBL5084	Homo sapiens	INH		
Active	18500831	CHEMBL4189233	Inhibition of human GST-tagged CK1gamma3 at 1 uM using alpha-casein as substrate after 30 mins in presence of [gamma-32P]-ATP by Cherenkov counting method	B	O=C(CSc1nc2c(c(=O)n1Cc1ccccc1)SCC2)Nc1nc2ccc(C(F)(F)F)cc2s1		CHEMBL4212803		Inhibition	%		CHEMBL5084	Homo sapiens	INH		
Active	18500837	CHEMBL4189233	Inhibition of human GST-tagged CK1gamma3 at 1 uM using alpha-casein as substrate after 30 mins in presence of [gamma-32P]-ATP by Cherenkov counting method	B	COc1ccc(Cn2c(SCC(=O)Nc3nc4ccc(C(F)(F)F)cc4s3)nc3c(c2=O)SCC3)cc1		CHEMBL4204681		Inhibition	%		CHEMBL5084	Homo sapiens	INH		
Active	18500850	CHEMBL4189233	Inhibition of human GST-tagged CK1gamma3 at 1 uM using alpha-casein as substrate after 30 mins in presence of [gamma-32P]-ATP by Cherenkov counting method	B	COc1cccc(Cn2c(SCC(=O)Nc3nc4ccc(C(F)(F)F)cc4s3)nc3c(c2=O)SCC3)c1OC		CHEMBL4213046		Inhibition	%		CHEMBL5084	Homo sapiens	INH		
Active	18500856	CHEMBL4189233	Inhibition of human GST-tagged CK1gamma3 at 1 uM using alpha-casein as substrate after 30 mins in presence of [gamma-32P]-ATP by Cherenkov counting method	B	O=C(CSc1nc2c(c(=O)n1Cc1cccc(C(F)(F)F)c1)SCC2)Nc1nc2ccc(C(F)(F)F)cc2s1		CHEMBL4208290		Inhibition	%		CHEMBL5084	Homo sapiens	INH		
Active	18500862	CHEMBL4189233	Inhibition of human GST-tagged CK1gamma3 at 1 uM using alpha-casein as substrate after 30 mins in presence of [gamma-32P]-ATP by Cherenkov counting method	B	O=C(CSc1nc2c(c(=O)n1Cc1ccc(C(F)(F)F)cc1)SCC2)Nc1nc2ccc(C(F)(F)F)cc2s1		CHEMBL4215433		Inhibition	%		CHEMBL5084	Homo sapiens	INH		
Active	18500868	CHEMBL4189233	Inhibition of human GST-tagged CK1gamma3 at 1 uM using alpha-casein as substrate after 30 mins in presence of [gamma-32P]-ATP by Cherenkov counting method	B	O=C(CSc1nc2c(c(=O)n1Cc1ccc(OC(F)(F)F)cc1)SCC2)Nc1nc2ccc(C(F)(F)F)cc2s1		CHEMBL4209726		Inhibition	%		CHEMBL5084	Homo sapiens	INH		
	18507846	CHEMBL4190916	Inhibition of recombinant human CK1gamma3 (1 to 330 residues) at 1 uM using KRRRALS(p)VASLPGL as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	9.0	CHEMBL5084	Homo sapiens	INH	%	9.0
	18653699	CHEMBL4230054	Inhibition of CK1-gamma3 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	2.0	CHEMBL5084	Homo sapiens	INH	%	2.0
	18653700	CHEMBL4230054	Inhibition of CK1-gamma3 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21	Outside typical range	CHEMBL4247506	=	Inhibition	%	-16.0	CHEMBL5084	Homo sapiens	INH	%	-16.0
	18655586	CHEMBL4230649	Binding affinity to wild-type human full length CSNK1G3 (M1 to K447 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	92.0	CHEMBL5084	Homo sapiens	Activity	%	92.0
	18751144	CHEMBL4263770	Inhibition of CK1-GAMMA3 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	-2.0	CHEMBL5084	Homo sapiens	INH	%	-2.0
	18751665	CHEMBL4264238	Binding affinity to wild-type human full length CSNK1G3 (M1 to K447 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	90.0	CHEMBL5084	Homo sapiens	Activity	%	90.0
	18857907	CHEMBL4307753	Binding affinity to wild-type human full length CSNK1G3 (M1 to K447 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	96.0	CHEMBL5084	Homo sapiens	Activity	%	96.0
	18892845	CHEMBL4314811	Inhibition of recombinant human CK1gamma3 K91E/R174G/E302D mutant (1 to 330 residues) assessed as residual activity at 10 uM using KRRRALS(p)VASLPGL as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	106.5	CHEMBL5084	Homo sapiens	Activity	%	106.5
	18937831	CHEMBL4327641	Inhibition of human CK1gamma3 assessed as residual activity at 1 uM using KRRRAL[pS]VASLPGL as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	107.63	CHEMBL5084	Homo sapiens	Activity	%	107.63
	18937832	CHEMBL4327641	Inhibition of human CK1gamma3 assessed as residual activity at 1 uM using KRRRAL[pS]VASLPGL as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	104.18	CHEMBL5084	Homo sapiens	Activity	%	104.18
	18938486	CHEMBL4328006	Inhibition of human CK1gamma3 assessed as residual activity at 100 uM using KRRRAL[pS]VASLPGL as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL5084	Homo sapiens	Activity	%	65.0
	18938861	CHEMBL4328370	Inhibition of human CK1gamma3 using KRRRAL[pS]VASLPGL as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	3370.0	CHEMBL5084	Homo sapiens	IC50	10'-6M	3.37
	18958824	CHEMBL4333343	Binding affinity to wild-type human full length CSNK1G3 (M1 to K447 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	77.0	CHEMBL5084	Homo sapiens	Activity	%	77.0
	18964181	CHEMBL4335027	Inhibition of recombinant human CK1gamma3 K91E/R174G/E302D mutant (1 to 330 residues) assessed as residual activity at 1 uM using KRRRALS(p)VASLPGL as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	97.0	CHEMBL5084	Homo sapiens	Activity	%	97.0
	18964182	CHEMBL4335027	Inhibition of recombinant human CK1gamma3 K91E/R174G/E302D mutant (1 to 330 residues) assessed as residual activity at 1 uM using KRRRALS(p)VASLPGL as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	121.0	CHEMBL5084	Homo sapiens	Activity	%	121.0
	18971844	CHEMBL4336854	Inhibition of recombinant human CK1gamma3 K91E/R174G/E302D mutant (1 to 330 residues) assessed as residual activity at 10 uM using KRRRALS(p)VASLPGL as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	45.0	CHEMBL5084	Homo sapiens	Activity	%	45.0
Not Active	19039837	CHEMBL4351805	Inhibition of recombinant human CK1gamma3 K91E/R174G/E302D mutant (1 to 330 residues) at 10 uM using KRRRALS(p)VASLPGL as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL5084	Homo sapiens	INH		
Active	19041335	CHEMBL4352596	Inhibition of human CK1gamma3 at 10 uM using KRRRAL[pS]VASLPGL as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL5084	Homo sapiens	INH		
	19059526	CHEMBL4357827	Binding affinity to wild-type human full length CSNK1G3 (M1 to K447 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL5084	Homo sapiens	Activity	%	100.0
	19090097	CHEMBL4365671	Inhibition of wild-type human full length CSNK1G3 (M1 to K447 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	69.0	CHEMBL5084	Homo sapiens	Activity	%	69.0
	19091879	CHEMBL4366353	Inhibition of human CK1gamma3 at 100 nM using KRRRAL[pS]VASLPGL as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	-3.55	CHEMBL5084	Homo sapiens	INH	%	-3.55
	19144706	CHEMBL4377722	Inhibition of recombinant human CK1gamma3 K91E/R174G/E302D mutant (1 to 330 residues) at 1 uM using KRRRALS(p)VASLPGL as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	11.0	CHEMBL5084	Homo sapiens	INH	%	11.0
	19147797	CHEMBL4379193	Inhibition of recombinant human CK1gamma3 K91E/R174G/E302D triple mutant (1 to 330 residues) using KRRRALS(p)VAS as substrate incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL5084	Homo sapiens	IC50	uM	10.0
	19159354	CHEMBL4382458	Binding affinity to wild-type human full length CSNK1G3 (M1 to K447 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	89.0	CHEMBL5084	Homo sapiens	Activity	%	89.0
	19191653	CHEMBL4389177	Inhibition of wild-type human full length CSNK1G3 (M1 to K447 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	99.0	CHEMBL5084	Homo sapiens	INH	%	99.0
	19191840	CHEMBL4389654	Inhibition of wild-type human full length CSNK1G3 (M1 to K447 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	94.0	CHEMBL5084	Homo sapiens	INH	%	94.0
	19199942	CHEMBL4391280	Binding affinity to wild-type human full length CSNK1G3 (M1 to K447 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	80.0	CHEMBL5084	Homo sapiens	Activity	%	80.0
	19266375	CHEMBL4405325	Inhibition of wild-type human full length CSNK1G3 (M1 to K447 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL5084	Homo sapiens	INH	%	50.0
	19275959	CHEMBL4407962	Inhibition of recombinant human CK1gamma3 (1 to 330 residues) at 1 uM using KRRRALS(p)VAS as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	0.0	CHEMBL5084	Homo sapiens	INH	%	0.0
	20600499	CHEMBL4603451	Inhibition of recombinant human full-length GST-tagged CSNK1G3 expressed in baculovirus expression system using FRET-labeled Ser/Thr 05 peptide as substrate measured after 1 hr in presence of ATP by Z'-lyte assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL5084	Homo sapiens	IC50	uM	100.0
	22423713	CHEMBL4674432	Inhibition of human CK1gamma3 using KRRRAL[pS]VASLPGL as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	96.57	CHEMBL5084	Homo sapiens	Activity	%	96.57
	22423714	CHEMBL4674432	Inhibition of human CK1gamma3 using KRRRAL[pS]VASLPGL as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	94.21	CHEMBL5084	Homo sapiens	Activity	%	94.21
	22843440	CHEMBL4720437	Inhibition of human CK1gamma3 assessed as residual activity using KRRRAL[pS]VASLPGL as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	89.68	CHEMBL5084	Homo sapiens	Activity	%	89.68
	22843791	CHEMBL4720777	Inhibition of human CK1gamma3 using KRRRAL[pS]VASLPGL as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1980.0	CHEMBL5084	Homo sapiens	IC50	10^-6M	1.98
	22844669	CHEMBL4721344	Inhibition of CK1g3 (unknown origin) assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	92.33	CHEMBL5084	Homo sapiens	Activity	%	92.33
	22883483	CHEMBL4727568	Inhibition of CK1gamma3 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)[C@H]2CN(c3ccc(C4CC4)nc3)CCO2)n1		CHEMBL4744428	<=	IC50	nM	500.0	CHEMBL5084	Homo sapiens	IC50	nM	500.0
	22886583	CHEMBL4728286	Binding affinity to CSNK1G3 (unknown origin)	B	CCN1/C(=C\C(C)=O)Sc2ccc(OC)cc21		CHEMBL1349996	=	Kd	nM	100.0	CHEMBL5084	Homo sapiens	Kd	nM	100.0
	22935141	CHEMBL4739360	Binding affinity to wild-type human full length CSNK1G3 (M1 to K447 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	Nc1nc(NCc2ccccc2)nc2nc(-c3cc(O)cc(O)c3)nn12		CHEMBL4742954	=	Activity	%	14.0	CHEMBL5084	Homo sapiens	Activity	%	14.0
	22943992	CHEMBL4742512	Inhibition of CSNK1G3 (unknown origin) assessed as residual ligand binding level at 10000 nM relative to control	B	COCc1cc(C)nc2sc(C(N)=O)c(N)c12		CHEMBL4780986	=	Activity	%	67.0	CHEMBL5084	Homo sapiens	Activity	%	67.0
	22952794	CHEMBL4766731	Inhibition of recombinant human CK1gamma3 (1 to 330 residues) assessed as residual activity at 10 uM using KRRRALS(p)VASLPGL as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	28.0	CHEMBL5084	Homo sapiens	Activity	%	28.0
	23120111	CHEMBL4804310	Inhibition of wild-type human full length CSNK1G3 (M1 to K447 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	Nc1ncc(-c2cc([N+](=O)[O-])ccc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4874241	=	Activity	%	0.0	CHEMBL5084	Homo sapiens	Activity	%	0.0
	23120132	CHEMBL4804331	Inhibition of wild-type human full length CSNK1G3 (M1 to K447 residues) expressed in bacterial expression system by Kinomescan method	B	Nc1ncc(-c2cc([N+](=O)[O-])ccc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4874241	=	IC50	nM	4.68	CHEMBL5084	Homo sapiens	IC50	nM	4.68
	23120326	CHEMBL4804370	Inhibition of CK1g3 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	IC50	nM	90400.0	CHEMBL5084	Homo sapiens	IC50	uM	90.4
	23120327	CHEMBL4804370	Inhibition of CK1g3 in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	IC50	nM	93800.0	CHEMBL5084	Homo sapiens	IC50	uM	93.8
	23120328	CHEMBL4804370	Inhibition of CK1g3 in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	IC50	nM	10800.0	CHEMBL5084	Homo sapiens	IC50	uM	10.8
	23120329	CHEMBL4804370	Inhibition of CK1g3 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	IC50	nM	88200.0	CHEMBL5084	Homo sapiens	IC50	uM	88.2
	23120330	CHEMBL4804370	Inhibition of CK1g3 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	IC50	nM	87200.0	CHEMBL5084	Homo sapiens	IC50	uM	87.2
	23120331	CHEMBL4804370	Inhibition of CK1g3 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	IC50	nM	93000.0	CHEMBL5084	Homo sapiens	IC50	uM	93.0
	23121367	CHEMBL4804552	Inhibition of CK1g3 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	>	Inhibition	%	90.0	CHEMBL5084	Homo sapiens	INH	%	90.0
	23121368	CHEMBL4804552	Inhibition of CK1g3 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	>	Inhibition	%	90.0	CHEMBL5084	Homo sapiens	INH	%	90.0
	23121369	CHEMBL4804552	Inhibition of CK1g3 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL5084	Homo sapiens	INH	%	0.0
	23121370	CHEMBL4804552	Inhibition of CK1g3 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	75.0	CHEMBL5084	Homo sapiens	INH	%	75.0
	23121371	CHEMBL4804552	Inhibition of CK1g3 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	75.0	CHEMBL5084	Homo sapiens	INH	%	75.0
	23121372	CHEMBL4804552	Inhibition of CK1g3 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	>	Inhibition	%	90.0	CHEMBL5084	Homo sapiens	INH	%	90.0
	23122512	CHEMBL4804863	Inhibition of human CSNK1G3 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	76.0	CHEMBL5084	Homo sapiens	Activity	%	76.0
	23123207	CHEMBL4805451	Inhibition of human CSNK1G3 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	100.0	CHEMBL5084	Homo sapiens	Activity	%	100.0
	23123684	CHEMBL4805928	Inhibition of DNA-tagged human CSNK1G3 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	90.0	CHEMBL5084	Homo sapiens	Activity	%	90.0
	23124504	CHEMBL4806468	Inhibition of human CSNK1G3 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	95.0	CHEMBL5084	Homo sapiens	Activity	%	95.0
	23124505	CHEMBL4806468	Inhibition of human CSNK1G3 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	80.0	CHEMBL5084	Homo sapiens	Activity	%	80.0
	23127966	CHEMBL4807797	Inhibition of CK1gamma3 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL5084	Homo sapiens	Activity	%	75.0
	23127967	CHEMBL4807797	Inhibition of CK1gamma3 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL5084	Homo sapiens	Activity	%	75.0
	23127968	CHEMBL4807797	Inhibition of CK1gamma3 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL5084	Homo sapiens	Activity	%	75.0
Not Active	23317347	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	98.0	CHEMBL5084	Homo sapiens	% Control	%	98.0
Not Active	23317815	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23318485	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	71.0	CHEMBL5084	Homo sapiens	% Control	%	71.0
Not Active	23318965	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23319604	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23320077	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23320755	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23321223	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	86.0	CHEMBL5084	Homo sapiens	% Control	%	86.0
Not Active	23321853	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23322321	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23323010	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23323478	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23323976	CHEMBL4880595	CK1gamma3 (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	21.0	CHEMBL5084	Homo sapiens	% inhibition	%	21.0
Not Active	23324332	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23324967	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23325435	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23326082	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	74.0	CHEMBL5084	Homo sapiens	% Control	%	74.0
Not Active	23326550	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23327250	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23327718	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23328305	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23328773	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23329298	CHEMBL4881005	CK1gamma3 (h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	96.0	CHEMBL5084	Homo sapiens	% residual kinase activity	%	96.0
Not Active	23329719	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23330187	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23330943	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23331411	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23331998	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	93.7	CHEMBL5084	Homo sapiens	% Control	%	93.7
Not Active	23332466	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23333182	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23333821	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	99.0	CHEMBL5084	Homo sapiens	% Control	%	99.0
Not Active	23334289	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	93.0	CHEMBL5084	Homo sapiens	% Control	%	93.0
Not Active	23335268	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23335736	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23336363	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	89.0	CHEMBL5084	Homo sapiens	% Control	%	89.0
Not Active	23336831	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23337559	CHEMBL4881930	CSNK1G3 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	99.0	CHEMBL5084	Homo sapiens	% Ctrl	%	99.0
Not Active	23337912	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	95.0	CHEMBL5084	Homo sapiens	% Control	%	95.0
Not Active	23338380	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23338992	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23339460	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23340097	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23340565	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	96.0	CHEMBL5084	Homo sapiens	% Control	%	96.0
Not Active	23341222	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23341690	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23342306	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	99.0	CHEMBL5084	Homo sapiens	% Control	%	99.0
Not Active	23342774	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23343404	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23343872	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	94.0	CHEMBL5084	Homo sapiens	% Control	%	94.0
Not Active	23344510	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23345083	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23345551	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23346128	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	99.9	CHEMBL5084	Homo sapiens	% Control	%	99.9
Not Active	23346597	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	89.1	CHEMBL5084	Homo sapiens	% Control	%	89.1
Not Active	23347205	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	87.9	CHEMBL5084	Homo sapiens	% Control	%	87.9
Not Active	23347688	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23348267	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23348735	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23349322	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	83.0	CHEMBL5084	Homo sapiens	% Control	%	83.0
Not Active	23349940	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	86.0	CHEMBL5084	Homo sapiens	% Control	%	86.0
Not Active	23350408	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	86.0	CHEMBL5084	Homo sapiens	% Control	%	86.0
Not Active	23351013	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23351481	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23352010	CHEMBL4882701	CSNK1G3 (CK1 gamma 3) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	2.153	CHEMBL5084	Homo sapiens	% Inhibition	%	2.1528
Not Active	23352505	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	95.0	CHEMBL5084	Homo sapiens	% Control	%	95.0
Not Active	23352973	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23353855	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23354323	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23355055	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23355523	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23356159	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23356627	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23357236	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23357883	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23358351	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23358937	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	96.6	CHEMBL5084	Homo sapiens	% Control	%	96.6
Not Active	23359535	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23360003	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23360588	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	81.0	CHEMBL5084	Homo sapiens	% Control	%	81.0
Not Active	23361056	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	78.0	CHEMBL5084	Homo sapiens	% Control	%	78.0
Not Active	23361629	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	74.0	CHEMBL5084	Homo sapiens	% Control	%	74.0
Not Active	23362165	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	95.0	CHEMBL5084	Homo sapiens	% Control	%	95.0
Not Active	23362633	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	93.0	CHEMBL5084	Homo sapiens	% Control	%	93.0
Not Active	23364275	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	91.0	CHEMBL5084	Homo sapiens	% Control	%	91.0
Not Active	23364743	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	75.0	CHEMBL5084	Homo sapiens	% Control	%	75.0
Not Active	23365482	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23366025	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	95.0	CHEMBL5084	Homo sapiens	% Control	%	95.0
Not Active	23366615	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23367083	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23367517	CHEMBL4883870	CK1-gamma3 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	95.0	CHEMBL5084	Homo sapiens	% Residual activity with Skepinone-L	%	95.0
Not Active	23367961	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	87.0	CHEMBL5084	Homo sapiens	% Control	%	87.0
Not Active	23368429	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	80.0	CHEMBL5084	Homo sapiens	% Control	%	80.0
Not Active	23369028	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23369496	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23370020	CHEMBL4884264	CK1gamma3(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	105.0	CHEMBL5084	Homo sapiens	% residual kinase activity	%	105.0
Not Active	23370464	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23370932	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23371741	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23372209	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
	23372713	CHEMBL4884678	CK1gamma3(C1G3LGI5) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL5084	Homo sapiens	pIC50		6.0
	23373122	CHEMBL4884969	CK1gamma3(C1G3LGI5) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL5084	Homo sapiens	pIC50		6.0
	23373483	CHEMBL4885260	CK1gamma3(C1G3LGI5) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL5084	Homo sapiens	pIC50		6.0
Not Active	23375636	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	67.0	CHEMBL5084	Homo sapiens	% Control	%	67.0
Not Active	23376104	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	99.0	CHEMBL5084	Homo sapiens	% Control	%	99.0
Not Active	23376681	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23377151	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23378009	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	84.0	CHEMBL5084	Homo sapiens	% Control	%	84.0
Not Active	23378477	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	89.0	CHEMBL5084	Homo sapiens	% Control	%	89.0
Not Active	23379644	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	93.0	CHEMBL5084	Homo sapiens	% Control	%	93.0
Not Active	23380112	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	76.0	CHEMBL5084	Homo sapiens	% Control	%	76.0
Not Active	23380806	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23381454	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23381922	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23382546	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23383014	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	100.0	CHEMBL5084	Homo sapiens	% Control	%	100.0
Not Active	23383753	CHEMBL4887396	CSNK1G3 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	99.0	CHEMBL5084	Homo sapiens	% Ctrl	%	99.0
Not Active	23384227	CHEMBL4887822	CK1gamma3(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O	Outside typical range	CHEMBL4802045		Inhibition	%	-28.46	CHEMBL5084	Homo sapiens	% inhibition	%	-28.46
Not Active	23384929	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	72.0	CHEMBL5084	Homo sapiens	% Control	%	72.0
Not Active	23385396	CHEMBL4879653	KinomeScan assay: inhibition of CSNK1G3	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	71.0	CHEMBL5084	Homo sapiens	% Control	%	71.0
